首页 » 细胞株Cell Lines 90及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 90及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV90
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   ND37306

AC   CVCL_FT84

DR   Coriell; ND37306

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND37321

AC   CVCL_FT85

DR   Coriell; ND37321

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND37346

AC   CVCL_FT86

DR   Coriell; ND37346

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND37356

AC   CVCL_FT87

DR   Coriell; ND37356

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND37357

AC   CVCL_FT88

DR   Coriell; ND37357

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND37377

AC   CVCL_FT89

DR   Coriell; ND37377

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND37378

AC   CVCL_FT90

DR   Coriell; ND37378

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND37428

AC   CVCL_FT91

DR   Coriell; ND37428

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND37503

AC   CVCL_FT92

DR   Coriell; ND37503

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND37517

AC   CVCL_EZ19

DR   Coriell; ND37517

DR   NHCDR; ND37517

CC   Discontinued: Coriell; ND37517; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND37601

AC   CVCL_FT93

DR   Coriell; ND37601

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND37609

AC   CVCL_EZ20

DR   Coriell; ND37609

DR   NHCDR; ND37609

CC   Discontinued: Coriell; ND37609; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND37624

AC   CVCL_EE19

DR   Coriell; ND37624

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C95802; Ischemic cerebrovascular accident

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND37710

AC   CVCL_HS09

DR   Coriell; ND37710

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND37731

AC   CVCL_EZ21

DR   Coriell; ND37731

DR   NHCDR; ND37731

CC   Discontinued: Coriell; ND37731; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND37732

AC   CVCL_EZ22

DR   Coriell; ND37732

DR   NHCDR; ND37732

CC   Discontinued: Coriell; ND37732; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND37757

AC   CVCL_EZ23

DR   Coriell; ND37757

DR   NHCDR; ND37757

CC   Discontinued: Coriell; ND37757; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND37766

AC   CVCL_FT94

DR   Coriell; ND37766

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38020

AC   CVCL_EZ24

DR   Coriell; ND38020

DR   NHCDR; ND38020

CC   Discontinued: Coriell; ND38020; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND38136

AC   CVCL_EZ25

DR   Coriell; ND38136

DR   NHCDR; ND38136

CC   Discontinued: Coriell; ND38136; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND38155

AC   CVCL_HS10

DR   Coriell; ND38155

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38170

AC   CVCL_HS11

DR   Coriell; ND38170

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2882; Arteriovenous hemangioma/malformation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38181

AC   CVCL_HS12

DR   Coriell; ND38181

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND38208

AC   CVCL_IH83

DR   Coriell; ND38208

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C50485; Cerebral hemorrhage

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND38209

AC   CVCL_FT95

DR   Coriell; ND38209

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38258

AC   CVCL_FT96

DR   Coriell; ND38258

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND38262

AC   CVCL_EZ26

DR   Coriell; ND38262

DR   NHCDR; ND38262

CC   Discontinued: Coriell; ND38262; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND38409

AC   CVCL_FT97

DR   Coriell; ND38409

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38473

AC   CVCL_IG62

DR   Coriell; ND38473

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38477

AC   CVCL_Y812

DR   Coriell; ND38477

DR   NHCDR; ND38477

WW   http://shared.eagle-i.net/i/00000144-7f70-38a8-5797-c9ee80000000

CC   Discontinued: Coriell; ND38477; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y811 ! ND29543

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND38528

AC   CVCL_EZ27

DR   Coriell; ND38528

DR   NHCDR; ND38528

CC   Discontinued: Coriell; ND38528; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND38530

AC   CVCL_EZ28

DR   Coriell; ND38530

DR   NHCDR; ND38530

CC   Discontinued: Coriell; ND38530; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND38534

AC   CVCL_FT98

DR   Coriell; ND38534

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38545

AC   CVCL_Y814

DR   Coriell; ND38545

DR   NHCDR; ND38545

WW   http://shared.eagle-i.net/i/00000144-7e91-07f1-5797-c9ee80000000

CC   Discontinued: Coriell; ND38545; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M952 ! GM04689

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND38546

AC   CVCL_Y815

DR   Coriell; ND38546

DR   NHCDR; ND38546

WW   http://shared.eagle-i.net/i/00000144-7e97-1585-5797-c9ee80000000

CC   Discontinued: Coriell; ND38546; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V574 ! GM04887

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND38547

AC   CVCL_Y816

DR   Coriell; ND38547

DR   NHCDR; ND38547

WW   http://shared.eagle-i.net/i/00000144-7e9b-b6d6-5797-c9ee80000000

CC   Discontinued: Coriell; ND38547; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y854 ! GM04777

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND38548

AC   CVCL_Y817

DR   Coriell; ND38548

DR   NHCDR; ND38548

WW   http://shared.eagle-i.net/i/00000144-7ea8-2088-5797-c9ee80000000

CC   Discontinued: Coriell; ND38548; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V568 ! GM04717

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND38549

AC   CVCL_Y818

DR   Coriell; ND38549

DR   NHCDR; ND38549

WW   http://shared.eagle-i.net/i/00000144-7eb0-1cdb-5797-c9ee80000000

CC   Discontinued: Coriell; ND38549; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y964 ! GM04805

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND38551

AC   CVCL_Y819

DR   Coriell; ND38551

DR   NHCDR; ND38551

WW   http://shared.eagle-i.net/i/00000144-7eb7-c27a-5797-c9ee80000000

CC   Discontinued: Coriell; ND38551; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y859 ! GM04287

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND38552

AC   CVCL_Y820

DR   Coriell; ND38552

DR   NHCDR; ND38552

WW   http://shared.eagle-i.net/i/00000144-7ebd-2803-5797-c9ee80000000

CC   Discontinued: Coriell; ND38552; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y861 ! GM04687

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND38554

AC   CVCL_Y821

DR   Coriell; ND38554

DR   NHCDR; ND38554

WW   http://shared.eagle-i.net/i/00000144-7ec0-a8b8-5797-c9ee80000000

CC   Discontinued: Coriell; ND38554; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y882 ! GM04729

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND38555

AC   CVCL_Y822

DR   Coriell; ND38555

DR   NHCDR; ND38555

WW   http://shared.eagle-i.net/i/00000144-7ec4-d5f1-5797-c9ee80000000

CC   Discontinued: Coriell; ND38555; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y885 ! GM04797

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND38558

AC   CVCL_FT99

DR   Coriell; ND38558

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38582

AC   CVCL_FU00

DR   Coriell; ND38582

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38594

AC   CVCL_IG92

DR   Coriell; ND38594

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C84626; Cerebral cavernous malformation

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND38630

AC   CVCL_FU01

DR   Coriell; ND38630

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38689

AC   CVCL_HS13

DR   Coriell; ND38689

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38724

AC   CVCL_FV33

DR   Coriell; ND38724

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35078; Tourette syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38771

AC   CVCL_FU02

DR   Coriell; ND38771

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38782

AC   CVCL_GP56

DR   Coriell; ND38782

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND38791

AC   CVCL_EZ29

DR   Coriell; ND38791

DR   NHCDR; ND38791

CC   Discontinued: Coriell; ND38791; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND38836

AC   CVCL_FU03

DR   Coriell; ND38836

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38865

AC   CVCL_EZ30

DR   Coriell; ND38865

DR   NHCDR; ND38865

CC   Discontinued: Coriell; ND38865; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND38912

AC   CVCL_FU04

DR   Coriell; ND38912

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND38947

AC   CVCL_FU05

DR   Coriell; ND38947

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND38960

AC   CVCL_FV34

DR   Coriell; ND38960

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35078; Tourette syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND38965

AC   CVCL_FU06

DR   Coriell; ND38965

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND39021

AC   CVCL_EZ31

DR   Coriell; ND39021

DR   NHCDR; ND39021

CC   Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (SOD1-Ile112Thr).

CC   Discontinued: Coriell; ND39021; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND39022

AC   CVCL_EZ32

DR   Coriell; ND39022

DR   NHCDR; ND39022

CC   Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (SOD1-Ala4Val).

CC   Discontinued: Coriell; ND39022; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND39023

AC   CVCL_Y806

DR   Coriell; ND39023

DR   NHCDR; ND39023

CC   Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (SOD1-Ala4Val).

CC   Discontinued: Coriell; ND39023; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND39025

AC   CVCL_T864

DR   Coriell; ND39025

DR   NHCDR; ND39025

RX   PubMed=25760436;

CC   Discontinued: Coriell; ND39025; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND39026

AC   CVCL_T862

DR   Coriell; ND39026

DR   NHCDR; ND39026

RX   PubMed=25760436;

CC   Discontinued: Coriell; ND39026; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND39027

AC   CVCL_T855

DR   Coriell; ND39027

DR   NHCDR; ND39027

RX   PubMed=25760436;

WW   http://shared.eagle-i.net/i/00000144-7a25-3bf7-5797-c9ee80000000

CC   Discontinued: Coriell; ND39027; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_U113 ! ND10734

SX   Female

CA   Finite cell line

//

ID   ND39030

AC   CVCL_Y823

DR   Coriell; ND39030

DR   NHCDR; ND39030

RX   PubMed=25760436;

CC   Discontinued: Coriell; ND39030; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_T849 ! ND29149

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND39032

AC   CVCL_Y824

DR   Coriell; ND39032

DR   NHCDR; ND39032

RX   PubMed=25760436;

WW   http://shared.eagle-i.net/i/00000144-7a3d-fbd0-5797-c9ee80000000

CC   Discontinued: Coriell; ND39032; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EY26 ! ND29415

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND39034

AC   CVCL_Y825

DR   Coriell; ND39034

DR   NHCDR; ND39034

RX   PubMed=25760436;

WW   http://shared.eagle-i.net/i/00000144-7a2d-e548-5797-c9ee80000000

CC   Discontinued: Coriell; ND39034; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y894 ! ND29563

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND39036

AC   CVCL_Y826

DR   Coriell; ND39036

DR   NHCDR; ND39036

WW   http://shared.eagle-i.net/i/00000144-7b3d-14ab-5797-c9ee80000000

CC   Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (SOD1-Gly86Arg).

CC   Discontinued: Coriell; ND39036; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND39037

AC   CVCL_Y827

DR   Coriell; ND39037

DR   NHCDR; ND39037

RX   PubMed=25760436;

WW   http://shared.eagle-i.net/i/00000144-7b44-8ef4-5797-c9ee80000000

CC   Discontinued: Coriell; ND39037; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND39064

AC   CVCL_FV35

DR   Coriell; ND39064

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35078; Tourette syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND39131

AC   CVCL_FU07

DR   Coriell; ND39131

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND39132

AC   CVCL_FU08

DR   Coriell; ND39132

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND39183

AC   CVCL_EZ33

DR   Coriell; ND39183

DR   NHCDR; ND39183

CC   Discontinued: Coriell; ND39183; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND39276

AC   CVCL_FV36

DR   Coriell; ND39276

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35078; Tourette syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND39277

AC   CVCL_EE20

DR   Coriell; ND39277

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C95802; Ischemic cerebrovascular accident

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND39326

AC   CVCL_FV37

DR   Coriell; ND39326

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35078; Tourette syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND39450

AC   CVCL_EZ34

DR   Coriell; ND39450

DR   NHCDR; ND39450

CC   Discontinued: Coriell; ND39450; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND39472

AC   CVCL_FU09

DR   Coriell; ND39472

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND39508

AC   CVCL_EE21

DR   Coriell; ND39508

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C95802; Ischemic cerebrovascular accident

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND39510

AC   CVCL_EZ35

DR   Coriell; ND39510

DR   NHCDR; ND39510

CC   Discontinued: Coriell; ND39510; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND39515

AC   CVCL_FU10

DR   Coriell; ND39515

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND39518

AC   CVCL_FU11

DR   Coriell; ND39518

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND39528

AC   CVCL_EZ36

DR   Coriell; ND39528

DR   NHCDR; ND39528

CC   Discontinued: Coriell; ND39528; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND39538

AC   CVCL_EZ37

DR   Coriell; ND39538

DR   NHCDR; ND39538

CC   Discontinued: Coriell; ND39538; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND39701

AC   CVCL_EE22

DR   Coriell; ND39701

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C95802; Ischemic cerebrovascular accident

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND39708

AC   CVCL_FU12

DR   Coriell; ND39708

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND39757

AC   CVCL_FU13

DR   Coriell; ND39757

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND39793

AC   CVCL_FU14

DR   Coriell; ND39793

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND39826

AC   CVCL_EH99

DR   Coriell; ND39826

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C85028; Progressive supranuclear palsy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND39876

AC   CVCL_IG63

DR   Coriell; ND39876

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND39896

AC   CVCL_Y828

DR   Coriell; ND39896

DR   NHCDR; ND39896

WW   http://shared.eagle-i.net/i/00000144-7f77-6a7f-5797-c9ee80000000

CC   Discontinued: Coriell; ND39896; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND39955

AC   CVCL_EZ38

DR   Coriell; ND39955

DR   NHCDR; ND39955

CC   Discontinued: Coriell; ND39955; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND39957

AC   CVCL_EZ39

DR   Coriell; ND39957

DR   NHCDR; ND39957

CC   Discontinued: Coriell; ND39957; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND39985

AC   CVCL_FU15

DR   Coriell; ND39985

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND39997

AC   CVCL_FV38

DR   Coriell; ND39997

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35078; Tourette syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND39999

AC   CVCL_EZ40

DR   Coriell; ND39999

DR   NHCDR; ND39999

CC   Discontinued: Coriell; ND39999; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND40018

AC   CVCL_Y829

DR   Coriell; ND40018

WW   http://shared.eagle-i.net/i/00000144-7f5f-52f0-5797-c9ee80000000

CC   Discontinued: Coriell; ND40018; probable.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND40019

AC   CVCL_Y830

DR   Coriell; ND40019

DR   NHCDR; ND40019

WW   http://shared.eagle-i.net/i/00000144-7f66-8a66-5797-c9ee80000000

CC   Discontinued: Coriell; ND40019; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y831 ! ND40020

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND40020

AC   CVCL_Y831

DR   Coriell; ND40020

DR   NHCDR; ND40020

WW   http://shared.eagle-i.net/i/00000144-7f6b-64ac-5797-c9ee80000000

CC   Discontinued: Coriell; ND40020; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y830 ! ND40019

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND40021

AC   CVCL_FU16

DR   Coriell; ND40021

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND40026

AC   CVCL_FU17

DR   Coriell; ND40026

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND40061

AC   CVCL_EZ41

DR   Coriell; ND40061

DR   NHCDR; ND40061

CC   Discontinued: Coriell; ND40061; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND40064

AC   CVCL_EZ42

DR   Coriell; ND40064

DR   NHCDR; ND40064

CC   Discontinued: Coriell; ND40064; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND40065

AC   CVCL_EZ43

DR   Coriell; ND40065

DR   NHCDR; ND40065

CC   Discontinued: Coriell; ND40065; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40066

AC   CVCL_EZ44

DR   Coriell; ND40066

DR   NHCDR; ND40066

CC   Discontinued: Coriell; ND40066; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND40067

AC   CVCL_EZ45

DR   Coriell; ND40067

DR   NHCDR; ND40067

CC   Discontinued: Coriell; ND40067; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40068

AC   CVCL_EY29

DR   Coriell; ND40068

DR   NHCDR; ND40068

CC   Discontinued: Coriell; ND40068; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40069

AC   CVCL_EZ46

DR   Coriell; ND40069

DR   NHCDR; ND40069

CC   Discontinued: Coriell; ND40069; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40070

AC   CVCL_EZ47

DR   Coriell; ND40070

DR   NHCDR; ND40070

CC   Discontinued: Coriell; ND40070; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40071

AC   CVCL_EZ48

DR   Coriell; ND40071

DR   NHCDR; ND40071

CC   Discontinued: Coriell; ND40071; true.

DI   NCIt; C84719; Frontotemporal dementia

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND40072

AC   CVCL_EZ49

DR   Coriell; ND40072

DR   NHCDR; ND40072

CC   Discontinued: Coriell; ND40072; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40074

AC   CVCL_EZ50

DR   Coriell; ND40074

DR   NHCDR; ND40074

CC   Discontinued: Coriell; ND40074; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND40075

AC   CVCL_EZ51

DR   Coriell; ND40075

DR   NHCDR; ND40075

CC   Discontinued: Coriell; ND40075; true.

DI   NCIt; C35527; Familial dystonia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND40076

AC   CVCL_EZ52

DR   Coriell; ND40076

DR   NHCDR; ND40076

CC   Discontinued: Coriell; ND40076; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40077

AC   CVCL_EZ53

DR   Coriell; ND40077

DR   NHCDR; ND40077

CC   Discontinued: Coriell; ND40077; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40078

AC   CVCL_EZ54

DR   Coriell; ND40078

DR   NHCDR; ND40078

CC   Discontinued: Coriell; ND40078; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40079

AC   CVCL_EZ55

DR   Coriell; ND40079

DR   NHCDR; ND40079

CC   Discontinued: Coriell; ND40079; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40080

AC   CVCL_EZ56

DR   Coriell; ND40080

DR   NHCDR; ND40080

CC   Discontinued: Coriell; ND40080; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40081

AC   CVCL_EZ57

DR   Coriell; ND40081

DR   NHCDR; ND40081

CC   Discontinued: Coriell; ND40081; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40082

AC   CVCL_EZ58

DR   Coriell; ND40082

DR   NHCDR; ND40082

CC   Discontinued: Coriell; ND40082; true.

DI   NCIt; C84719; Frontotemporal dementia

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40260

AC   CVCL_EZ59

DR   Coriell; ND40260

DR   NHCDR; ND40260

CC   Discontinued: Coriell; ND40260; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND40268

AC   CVCL_GP57

DR   Coriell; ND40268

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND40346

AC   CVCL_FV39

DR   Coriell; ND40346

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35078; Tourette syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND40365

AC   CVCL_IG64

DR   Coriell; ND40365

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND40459

AC   CVCL_FU18

DR   Coriell; ND40459

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND40534

AC   CVCL_EZ60

DR   NHCDR; ND40534

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND40536

AC   CVCL_EZ61

DR   NHCDR; ND40536

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND40608

AC   CVCL_EI00

DR   Coriell; ND40608

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C85028; Progressive supranuclear palsy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND40629

AC   CVCL_FU19

DR   Coriell; ND40629

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND40636

AC   CVCL_EE23

DR   Coriell; ND40636

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C95802; Ischemic cerebrovascular accident

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND40653

AC   CVCL_FU20

DR   Coriell; ND40653

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND40809

AC   CVCL_EI01

DR   Coriell; ND40809

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C85028; Progressive supranuclear palsy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND40874

AC   CVCL_FU21

DR   Coriell; ND40874

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND40877

AC   CVCL_FU22

DR   Coriell; ND40877

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3020; Seizure disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND40985

AC   CVCL_HS14

DR   Coriell; ND40985

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND40992

AC   CVCL_EZ62

DR   NHCDR; ND40992

DI   NCIt; C84719; Frontotemporal dementia

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND41001

AC   CVCL_EZ63

DR   NHCDR; ND41001

DI   NCIt; C123412; Familial Alzheimer's disease, type 3

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND41003

AC   CVCL_EZ64

DR   Coriell; ND41003

DR   NHCDR; ND41003

CC   Discontinued: Coriell; ND41003; true.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND41004

AC   CVCL_EZ65

DR   NHCDR; ND41004

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND41006

AC   CVCL_EZ66

DR   NHCDR; ND41006

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND41007

AC   CVCL_EZ67

DR   NHCDR; ND41007

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND41010

AC   CVCL_EZ68

DR   Coriell; ND41010

DR   NHCDR; ND41010

CC   Discontinued: Coriell; ND41010; true.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND41014

AC   CVCL_EZ69

DR   NHCDR; ND41014

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND41015

AC   CVCL_EZ70

DR   NHCDR; ND41015

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND41016

AC   CVCL_EZ71

DR   NHCDR; ND41016

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND41113

AC   CVCL_Y809

DR   Coriell; ND41113

DR   NHCDR; ND41113

WW   http://shared.eagle-i.net/i/00000144-7ec9-6442-5797-c9ee80000000

CC   Discontinued: Coriell; ND41113; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W557 ! GM02183

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND41114

AC   CVCL_Y832

DR   Coriell; ND41114

DR   NHCDR; ND41114

WW   http://shared.eagle-i.net/i/00000144-7ecd-9a6f-5797-c9ee80000000

CC   Discontinued: Coriell; ND41114; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F173 ! GM03814

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND41125

AC   CVCL_EZ72

DR   NHCDR; ND41125

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND41375

AC   CVCL_HS15

DR   Coriell; ND41375

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ND41654

AC   CVCL_Y833

DR   Coriell; ND41654

DR   NHCDR; ND41654

CC   Discontinued: Coriell; ND41654; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y895 ! ND30625

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND41656

AC   CVCL_Y834

DR   Coriell; ND41656

DR   NHCDR; ND41656

WW   http://shared.eagle-i.net/i/00000144-7ee8-93f9-5797-c9ee80000000

CC   Discontinued: Coriell; ND41656; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y897 ! ND33392

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND41657

AC   CVCL_Y835

DR   Coriell; ND41657

DR   NHCDR; ND41657

WW   http://shared.eagle-i.net/i/00000144-7eed-289b-5797-c9ee80000000

CC   Discontinued: Coriell; ND41657; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y897 ! ND33392

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND41658

AC   CVCL_Y836

DR   Coriell; ND41658

DR   NHCDR; ND41658

CC   Discontinued: Coriell; ND41658; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y895 ! ND30625

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND41864

AC   CVCL_1N97

DR   Coriell; ND41864

DR   NHCDR; ND41864

CC   Discontinued: Coriell; ND41864; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y837 ! ND41865

OI   CVCL_Y838 ! ND41866

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND41865

AC   CVCL_Y837

DR   Coriell; ND41865

DR   NHCDR; ND41865

WW   http://shared.eagle-i.net/i/00000144-7b68-c50f-5797-c9ee80000000

CC   Discontinued: Coriell; ND41865; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1N97 ! ND41864

OI   CVCL_Y838 ! ND41866

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND41866

AC   CVCL_Y838

DR   Coriell; ND41866

DR   NHCDR; ND41866

WW   http://shared.eagle-i.net/i/00000144-7b6c-c519-5797-c9ee80000000

CC   Discontinued: Coriell; ND41866; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1N97 ! ND41864

OI   CVCL_Y837 ! ND41865

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND41867

AC   CVCL_Y839

DR   Coriell; ND41867

DR   NHCDR; ND41867

CC   Discontinued: Coriell; ND41867; true.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y840 ! ND41869

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND41869

AC   CVCL_Y840

DR   Coriell; ND41869

DR   NHCDR; ND41869

WW   http://shared.eagle-i.net/i/00000144-7b53-63e4-5797-c9ee80000000

CC   Discontinued: Coriell; ND41869; true.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y839 ! ND41867

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND41870

AC   CVCL_Y841

DR   Coriell; ND41870

DR   NHCDR; ND41870

WW   http://shared.eagle-i.net/i/00000144-7b59-c1fd-5797-c9ee80000000

CC   Discontinued: Coriell; ND41870; true.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y842 ! ND41871

OI   CVCL_Y843 ! ND41872

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND41871

AC   CVCL_Y842

DR   Coriell; ND41871

DR   NHCDR; ND41871

CC   Discontinued: Coriell; ND41871; true.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y841 ! ND41870

OI   CVCL_Y843 ! ND41872

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND41872

AC   CVCL_Y843

DR   Coriell; ND41872

DR   NHCDR; ND41872

WW   http://shared.eagle-i.net/i/00000144-7b61-d831-5797-c9ee80000000

CC   Discontinued: Coriell; ND41872; true.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y841 ! ND41870

OI   CVCL_Y842 ! ND41871

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND42222

AC   CVCL_Y844

DR   Coriell; ND42222

DR   NHCDR; ND42222

CC   Discontinued: Coriell; ND42222; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1N95 ! ND42223

OI   CVCL_Y845 ! ND42224

OI   CVCL_GP60 ! ND50034

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42223

AC   CVCL_1N95

DR   Coriell; ND42223

CC   Discontinued: Coriell; ND42223; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y844 ! ND42222

OI   CVCL_Y845 ! ND42224

OI   CVCL_GP60 ! ND50034

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42224

AC   CVCL_Y845

DR   Coriell; ND42224

DR   NHCDR; ND42224

CC   Discontinued: Coriell; ND42224; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y844 ! ND42222

OI   CVCL_1N95 ! ND42223

OI   CVCL_GP60 ! ND50034

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42228

AC   CVCL_1N96

DR   Coriell; ND42228

CC   Discontinued: Coriell; ND42228; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8519 ! GM04281

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42229

AC   CVCL_Y846

DR   Coriell; ND42229

CC   Discontinued: Coriell; ND42229; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8519 ! GM04281

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42230

AC   CVCL_Y847

DR   Coriell; ND42230

DR   NHCDR; ND42230

CC   Discontinued: Coriell; ND42230; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8519 ! GM04281

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42235

AC   CVCL_Y848

DR   Coriell; ND42235

DR   NHCDR; ND42235

CC   Discontinued: Coriell; ND42235; true.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y861 ! GM04687

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42240

AC   CVCL_Y849

DR   Coriell; ND42240

DR   NHCDR; ND42240

CC   Discontinued: Coriell; ND42240; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F173 ! GM03814

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42241

AC   CVCL_Y850

DR   Coriell; ND42241

DR   NHCDR; ND42241

CC   Discontinued: Coriell; ND42241; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F173 ! GM03814

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42242

AC   CVCL_Y851

DR   Coriell; ND42242

DR   NHCDR; ND42242

CC   Discontinued: Coriell; ND42242; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y898 ! ND30014

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42245

AC   CVCL_Y852

DR   Coriell; ND42245

DR   NHCDR; ND42245

CC   Discontinued: Coriell; ND42245; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND42485

AC   CVCL_EZ73

DR   NHCDR; ND42485

CC   Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (MAPT-Pro301Leu).

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND42487

AC   CVCL_EZ74

DR   NHCDR; ND42487

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND42490

AC   CVCL_EZ75

DR   NHCDR; ND42490

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND42491

AC   CVCL_EZ76

DR   NHCDR; ND42491

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND42492

AC   CVCL_EZ77

DR   NHCDR; ND42492

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND42493

AC   CVCL_EY30

DR   NHCDR; ND42493

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND42494

AC   CVCL_EZ78

DR   NHCDR; ND42494

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND42496

AC   CVCL_EZ79

DR   NHCDR; ND42496

CC   Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (C9orf72 (GGGGCC)n expansion).

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND42497

AC   CVCL_EZ80

DR   NHCDR; ND42497

CC   Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (MAPT IVS10+16).

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND42498

AC   CVCL_EZ81

DR   NHCDR; ND42498

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND42503

AC   CVCL_EZ82

DR   NHCDR; ND42503

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND42504

AC   CVCL_EZ83

DR   NHCDR; ND42504

CC   Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (C9orf72 (GGGGCC)n expansion).

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND42506

AC   CVCL_EZ84

DR   NHCDR; ND42506

CC   Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (C9orf72 (GGGGCC)n expansion).

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND42619

AC   CVCL_EE24

DR   Coriell; ND42619

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C95802; Ischemic cerebrovascular accident

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ND42716

AC   CVCL_EZ85

DR   NHCDR; ND42716

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ND42717

AC   CVCL_EZ86

DR   NHCDR; ND42717

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   ND42765

AC   CVCL_1N98

DR   Coriell; ND42765

CC   Discontinued: Coriell; ND42765; true.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1N99 ! ND43208

OI   CVCL_GP61 ! ND50035

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND42767

AC   CVCL_EZ87

DR   Coriell; ND42767

DR   NHCDR; ND42767

CC   Discontinued: Coriell; ND42767; true.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND43208

AC   CVCL_1N99

DR   Coriell; ND43208

CC   Discontinued: Coriell; ND43208; true.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1N98 ! ND42765

OI   CVCL_GP61 ! ND50035

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND43209

AC   CVCL_EZ88

DR   Coriell; ND43209

DR   NHCDR; ND43209

CC   Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (mutation in GRN).

CC   Discontinued: Coriell; ND43209; true.

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ND50012

AC   CVCL_EZ89

DR   NHCDR; ND50012

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EY29 ! ND40068

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND50013

AC   CVCL_EZ90

DR   NHCDR; ND50013

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EY29 ! ND40068

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND50014

AC   CVCL_EZ91

DR   NHCDR; ND50014

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EY29 ! ND40068

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND50015

AC   CVCL_EZ92

DR   NHCDR; ND50015

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EY30 ! ND42493

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND50016

AC   CVCL_EZ93

DR   NHCDR; ND50016

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EY30 ! ND42493

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND50017

AC   CVCL_EZ94

DR   NHCDR; ND50017

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_EY30 ! ND42493

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND50032

AC   CVCL_GP58

DR   NHCDR; ND50032

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8519 ! GM04281

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND50033

AC   CVCL_GP59

DR   NHCDR; ND50033

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8519 ! GM04281

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND50034

AC   CVCL_GP60

DR   NHCDR; ND50034

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y844 ! ND42222

OI   CVCL_1N95 ! ND42223

OI   CVCL_Y845 ! ND42224

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND50035

AC   CVCL_GP61

DR   NHCDR; ND50035

DI   NCIt; C84719; Frontotemporal dementia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1N98 ! ND42765

OI   CVCL_1N99 ! ND43208

SX   Female

CA   Induced pluripotent stem cell

//

ID   ND7/23

AC   CVCL_4259

DR   CLO; CLO_0008144

DR   CLDB; cl3680

DR   ECACC; 92090903

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2132 ! N18TG2

CA   Hybrid cell line

//

ID   ND8

AC   CVCL_G216

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2132 ! N18TG2

CA   Hybrid cell line

//

ID   ND8/34

AC   CVCL_4260

DR   CLO; CLO_0008145

DR   ECACC; 92090904

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_G216 ! ND8

CA   Hybrid cell line

//

ID   NDCS-1

AC   CVCL_EJ23

SY   NDCS1

DR   Cosmic; 1602482

RX   PubMed=17653762;

RX   PubMed=22057234;

CC   Doubling time: 30 hours (PubMed=17653762).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C6476; Dedifferentiated chondrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NDDLS-1

AC   CVCL_M831

RX   PubMed=21790860;

DI   NCIt; C3704; Dedifferentiated liposarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NDS-758

AC   CVCL_F569

SY   758; TER125; TER214

DR   IMGT/HLA; 12014

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NDS-AN

AC   CVCL_F570

DR   IMGT/HLA; 11787

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NDS-DG

AC   CVCL_F571

SY   TER93

DR   IMGT/HLA; 11131

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NDS-HM

AC   CVCL_F572

SY   TER153; TER223

DR   IMGT/HLA; 12739

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NDS-IH

AC   CVCL_F573

DR   IMGT/HLA; 12173

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NDS-JD

AC   CVCL_F574

SY   TER86; TER177; TER218; TER242; TER266

DR   IMGT/HLA; 11132

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NDS-MA

AC   CVCL_F575

DR   IMGT/HLA; 11133

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NDS-NH

AC   CVCL_F576

SY   TER122; TER254; TER256; TER334

DR   IMGT/HLA; 11134

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NE

AC   CVCL_3554

DR   CLO; CLO_0008149

DR   ATCC; CRL-2070

RX   PubMed=2098280;

CC   Breed/subspecies: C3H/J.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_5T97 ! ME [Mouse teratocarcinoma]

CA   Cancer cell line

//

ID   Ne Col

AC   CVCL_U789

DR   ATCC; CRL-1345

CC   Discontinued: ATCC; CRL-1345; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Ne Loc

AC   CVCL_3555

DR   CLO; CLO_0008150

DR   ATCC; CRL-1205

CC   Discontinued: ATCC; CRL-1205; true.

DI   NCIt; C118636; Stiff skin syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   NE-1

AC   CVCL_E306

SY   NE1; NE1-E6E7

RX   PubMed=15489894;

WW   http://www.addexbio.com/productdetail?pid=75

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NE-18

AC   CVCL_7083

SY   NE18

DR   BTO; BTO:0003018

DR   Cosmic; 844590

DR   Cosmic; 877396

DR   Cosmic; 1028951

DR   Cosmic; 1152491

RX   PubMed=3422461;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7114 ! RH-SLC-L11

SX   Female

CA   Cancer cell line

//

ID   NE-4C

AC   CVCL_B063

DR   BTO; BTO:0005624

DR   ATCC; CRL-2925

RX   PubMed=9057134;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   NE-GFP-4C

AC   CVCL_L103

DR   BTO; BTO:0005625

DR   ATCC; CRL-2926

RX   PubMed=15246825;

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Discontinued: ATCC; CRL-2926; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B063 ! NE-4C

CA   Transformed cell line

//

ID   NE-MD

AC   CVCL_6C06

SY   nNOS-EGFP Expressing Macula Densa

RX   PubMed=16412259;

RX   PubMed=17233813;

RX   PubMed=19340543;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   Ne2/1b4.14

AC   CVCL_0E04

SY   NE2/1B4-14; NE2-1B4.14

DR   ATCC; CRL-2356

CC   Discontinued: ATCC; CRL-2356; true.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   Ne8/4c6.3

AC   CVCL_0E05

SY   NE8/4C6.3; NE8-4C6.3; NE8 4C6.3

DR   ATCC; CRL-2355

CC   Discontinued: ATCC; CRL-2355; true.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   NEAmp-48.2

AC   CVCL_L101

SY   NEAMP 48.2

DR   ATCC; PTA-5295

RX   Patent=US7101980;

CC   Monoclonal antibody target: ChEBI; CHEBI:132237; rac-3,4-methylenedioxy-N-ethylamphetamine.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6972 ! FO [Mouse myeloma]

CA   Hybridoma

//

ID   NEAmp-62.1

AC   CVCL_L102

SY   NEAMP 62.1

DR   ATCC; PTA-5294

RX   Patent=US7101980;

CC   Monoclonal antibody target: ChEBI; CHEBI:132237; rac-3,4-methylenedioxy-N-ethylamphetamine.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6972 ! FO [Mouse myeloma]

CA   Hybridoma

//

ID   NEAU-Ms-941015

AC   CVCL_IM40

RX   DOI=10.3969/j.issn.1005-9369.2000.04.006;

CC   Group: Insect cell line.

OX   NCBI_TaxID=271217; ! Mythimna separata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NEAU-Ms-947311

AC   CVCL_IM41

RX   DOI=10.3969/j.issn.1005-9369.2000.04.006;

CC   Group: Insect cell line.

OX   NCBI_TaxID=271217; ! Mythimna separata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NEAU-Ms-980312

AC   CVCL_AV36

SY   NEAU-MS-980312

RX   CelloPub=CLPUB00314;

CC   Group: Insect cell line.

CC   Doubling time: 47.82 hours (CelloPub=CLPUB00314).

OX   NCBI_TaxID=271217; ! Mythimna separata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NEAU-Xc-730E

AC   CVCL_0A25

SY   Xc730E

RX   CelloPub=CLPUB00221;

RX   DOI=10.3969/j.issn.1005-9369.2000.04.006;

CC   Group: Insect cell line.

OX   NCBI_TaxID=987431; ! Xestia c-nigrum

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NEAU-Xc-960716H

AC   CVCL_0A13

RX   CelloPub=CLPUB00221;

CC   Group: Insect cell line.

CC   Doubling time: ~63 hours (CelloPub=CLPUB00221).

OX   NCBI_TaxID=987431; ! Xestia c-nigrum

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NEC-DUE1

AC   CVCL_AS96

RX   PubMed=24551139;

CC   Derived from metastatic site: Liver.

ST   Source(s): PubMed=24551139

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D10S1248: 16,17

ST   D12S391: 18

ST   D13S317: 12

ST   D16S539: 10

ST   D18S51: 13,20

ST   D19S433: 13,16

ST   D1S1656: 14,15

ST   D21S11: 32.2

ST   D22S1045: 15,16

ST   D2S1338: 19,20

ST   D2S441: 11

ST   D3S1358: 16,17

ST   D5S818: 13

ST   D7S820: 10,11

ST   D8S1179: 12,13

ST   FGA: 20,25

ST   SE33: 25.2

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C126323; Gastroesophageal junction large cell neuroendocrine carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NEC-DUE2

AC   CVCL_AS97

RX   PubMed=24551139;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=24551139

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D10S1248: 14

ST   D12S391: 17,23

ST   D13S317: 8,12

ST   D16S539: 10,11

ST   D18S51: 12,15

ST   D19S433: 15,16

ST   D1S1656: 12,14

ST   D21S11: 29

ST   D22S1045: 11,16

ST   D2S1338: 17

ST   D2S441: 11

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 8,11

ST   D8S1179: 12,13

ST   FGA: 21

ST   SE33: 22.2,24.2

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C96157; Colorectal large cell neuroendocrine carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NEC14

AC   CVCL_3070

DR   CLO; CLO_0051392

DR   BioSample; SAMN03470816

DR   BioSample; SAMN03472271

DR   JCRB; JCRB0162

DR   RCB; RCB0490

RX   PubMed=2445169;

RX   PubMed=3618218;

ST   Source(s): JCRB; RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9,11

ST   D5S818: 13 (JCRB)

ST   D5S818: 12,13 (RCB)

ST   D7S820: 10,12

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 14,17

DI   NCIt; C6341; Testicular embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NEC15

AC   CVCL_3929

DR   CLO; CLO_0051393

DR   BioSample; SAMN03472273

DR   RCB; RCB0494

RX   PubMed=2445169;

RX   PubMed=3618218;

RX   PubMed=24812411;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,14

ST   D16S539: 11

ST   D5S818: 10,11

ST   D7S820: 10,11

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C6341; Testicular embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NEC8

AC   CVCL_1604

SY   NEC-8

DR   CLO; CLO_0051391

DR   BioSample; SAMN03471665

DR   ChEMBL-Cells; CHEMBL3308176

DR   ChEMBL-Targets; CHEMBL2366340

DR   Cosmic; 910942

DR   Cosmic-CLP; 910942

DR   GDSC; 910942

DR   GEO; GSM827251

DR   GEO; GSM1670276

DR   JCRB; JCRB0250

DR   RCB; RCB0489

RX   PubMed=520758;

RX   PubMed=2445169;

RX   PubMed=3618218;

RX   PubMed=9290701;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 13,15

ST   D13S317: 12

ST   D16S539: 9,10

ST   D5S818: 10,14

ST   D7S820: 8

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 14,15

DI   NCIt; C6341; Testicular embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NEC8 cl-1

AC   CVCL_IW43

SY   NEC8 clone-1

RX   PubMed=2445169;

DI   NCIt; C6341; Testicular embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1604 ! NEC8

SX   Male

CA   Cancer cell line

//

ID   NECS-L

AC   CVCL_L212

RX   PubMed=11070410;

DI   NCIt; C60639; Rectal small cell neuroendocrine carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L213 ! NECS-P

SX   Male

CA   Cancer cell line

//

ID   NECS-P

AC   CVCL_L213

RX   PubMed=11070410;

DI   NCIt; C60639; Rectal small cell neuroendocrine carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L212 ! NECS-L

SX   Male

CA   Cancer cell line

//

ID   NEF

AC   CVCL_D900

DR   BTO; BTO:0005262

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Nef-ER 31

AC   CVCL_1H35

SY   Nef-ER #31; Nef-ER #31 Clone

DR   NIH-ARP; 6453-91

RX   PubMed=11134296;

DI   NCIt; C7210; Childhood T lymphoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1714 ! SUP-T1

SX   Male

CA   Cancer cell line

//

ID   NEF26.Ov

AC   CVCL_6422

SY   NFF26.Ov

DR   CLO; CLO_0008151

DR   ATCC; CRL-6175

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6175; true.

OX   NCBI_TaxID=9685; ! Felis catus

SX   Female

CA   Undefined cell line type

//

ID   NEF36.Sg

AC   CVCL_6423

SY   NFF36.Sg

DR   CLO; CLO_0008152

DR   ATCC; CRL-6176

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6176; true.

OX   NCBI_TaxID=9685; ! Felis catus

SX   Female

CA   Undefined cell line type

//

ID   NeHepBaHT

AC   CVCL_0F42

DR   ATCC; CRL-4022

RX   Patent=US20090155232;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: ATCC; CRL-4022; true.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 10,11

ST   D5S818: 11,12

ST   D7S820: 8,13

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C465 ! NeHepLxHT

OI   CVCL_0F41 ! NeHepMsHT

SX   Male

CA   Telomerase immortalized cell line

//

ID   NeHepLxHT

AC   CVCL_C465

DR   ATCC; CRL-4020

DR   BioSample; SAMN03471727

RX   Patent=US20090155232;

RX   PubMed=19565302;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: ATCC; CRL-4020; probable.

ST   Source(s): ATCC; PubMed=19565302

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 10,11

ST   D5S818: 11,12

ST   D7S820: 8,13

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0F42 ! NeHepBaHT

OI   CVCL_0F41 ! NeHepMsHT

SX   Male

CA   Telomerase immortalized cell line

//

ID   NeHepMsHT

AC   CVCL_0F41

DR   ATCC; CRL-4021

RX   Patent=US20090155232;

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: ATCC; CRL-4021; true.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 10,11

ST   D5S818: 11,12

ST   D7S820: 8,13

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0F42 ! NeHepBaHT

OI   CVCL_C465 ! NeHepLxHT

SX   Male

CA   Telomerase immortalized cell line

//

ID   NEM157

AC   CVCL_IT35

RX   PubMed=25534822;

RX   PubMed=25939062;

CC   Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).

CC   Doubling time: 30 hours (PubMed=25534822).

ST   Source(s): PubMed=25939062

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 12

ST   D21S11: 30

ST   D5S818: 11,12

ST   D7S820: 11

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 15,16

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NEM163

AC   CVCL_IT36

RX   PubMed=25534822;

RX   PubMed=25939062;

CC   Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).

CC   Doubling time: 36 hours (PubMed=25534822).

ST   Source(s): PubMed=25939062

ST   Amelogenin: X,Y

ST   CSF1PO: 8,10

ST   D13S317: 10,11

ST   D16S539: 11

ST   D21S11: 28,30

ST   D5S818: 12,13

ST   D7S820: 9

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NEM165

AC   CVCL_IT37

RX   PubMed=25534822;

RX   PubMed=25939062;

CC   Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).

CC   Doubling time: 32 hours (PubMed=25534822).

ST   Source(s): PubMed=25939062

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D16S539: 11

ST   D21S11: 29,33.2

ST   D5S818: 12,13

ST   D7S820: 12

ST   TH01: 8,9.3

ST   TPOX: 10,11

ST   vWA: 15

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NEM168

AC   CVCL_IT38

RX   PubMed=25534822;

RX   PubMed=25939062;

CC   Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).

CC   Doubling time: 34 hours (PubMed=25534822).

ST   Source(s): PubMed=25939062

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,13

ST   D16S539: 11

ST   D21S11: 29,29.2

ST   D5S818: 11,13

ST   D7S820: 8,9

ST   TH01: 6,9.3

ST   TPOX: 10,11

ST   vWA: 18,19

DI   NCIt; C94764; Diffuse intrinsic pontine glioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Nemo-1

AC   CVCL_1E49

RX   PubMed=833871;

DI   NCIt; C3269; Schwannoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Neo Jurkat

AC   CVCL_U621

DR   ATCC; CRL-2898

RX   PubMed=10567572;

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 11

ST   D5S818: 9

ST   D7S820: 8,12

ST   TH01: 6,9.3

ST   TPOX: 8,10

ST   vWA: 18

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0065 ! Jurkat

SX   Male

CA   Cancer cell line

//

ID   neo6/C8161.1

AC   CVCL_6815

RX   PubMed=8302587;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6813 ! C8161

HI   CVCL_6C50 ! MCH262A1.D6

CA   Hybrid cell line

//

ID   neo6/C8161.2

AC   CVCL_6816

RX   PubMed=8302587;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6813 ! C8161

HI   CVCL_6C50 ! MCH262A1.D6

CA   Hybrid cell line

//

ID   neo6/C8161.3

AC   CVCL_6817

RX   PubMed=8302587;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6813 ! C8161

HI   CVCL_6C50 ! MCH262A1.D6

CA   Hybrid cell line

//

ID   Neopu

AC   CVCL_Z995

DR   CLO; CLO_0008153

DR   CLDB; cl3681

DR   ECACC; 90070561

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   nEPN1

AC   CVCL_IR49

RX   PubMed=20978004;

DI   NCIt; C3017; Ependymoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   nEPN2

AC   CVCL_IR50

RX   PubMed=20978004;

DI   NCIt; C3017; Ependymoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NEPS

AC   CVCL_IS66

RX   PubMed=19756736;

DI   NCIt; C3714; Epithelioid sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Neu7

AC   CVCL_AZ70

SY   Neu-7; Neu 7

DR   BTO; BTO:0005800

RX   PubMed=7583324;

RX   PubMed=10516297;

CC   Transformant: Activated Erbb2/neu.

CC   Caution: Erroneously indicated as originating from mouse in BTO BTO:0005800.

CC   Breed/subspecies: CFHB Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   NeuCHO

AC   CVCL_IR07

SY   NeuCho

RX   Patent=US20160017277;

WW   http://www.neuclone.com/technology/

CC   Registration: International Depositary Authority, Cell Bank Australia; CBA20130024.

CC   Transfected with: HGNC; 4261; GH1.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_7180 ! CHO-DG44

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Neuro-2a

AC   CVCL_0470

SY   NEURO-2A; Neuro 2a; Neuro2a; Neuro2A; N-2a; N2a; N2A; Nb2a; NB2a

DR   BTO; BTO:0001976

DR   CLO; CLO_0008154

DR   CLO; CLO_0050180

DR   MCCL; MCC:0000368

DR   CLDB; cl3682

DR   CLDB; cl3683

DR   CLDB; cl3684

DR   CLDB; cl3685

DR   CLDB; cl4956

DR   CLDB; cl5236

DR   ATCC; CCL-131

DR   BCRC; 60026

DR   BCRJ; 0189

DR   CCLV; CCLV-RIE 0132

DR   CCLV; CCLV-RIE 0229

DR   CCRID; 3111C0001CCC000291

DR   CCRID; 3131C0001000800029

DR   ChEMBL-Cells; CHEMBL3307521

DR   ChEMBL-Targets; CHEMBL614062

DR   CLS; 400394/p451_Neuro-2A

DR   DSMZ; ACC-148

DR   ECACC; 89121404

DR   ICLC; ATL99007

DR   IFO; IFO50081

DR   IZSLER; BS TCL 128

DR   KCB; KCB 2014025YJ

DR   PRIDE; PXD002290

DR   RCB; RCB2639

DR   TKG; TKG 0509

DR   TOKU-E; 2746

DR   TOKU-E; 3552

DR   TOKU-E; 3563

DR   Wikidata; Q18391478

RX   PubMed=19903493;

RX   PubMed=25193168;

WW   https://en.wikipedia.org/wiki/N2a_cell

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-213.html

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-384.html

WW   https://www.researchgate.net/post/What_are_the_details_of_N2A_cell_differentiation_methods

CC   Characteristics: Capable of differentiating into various types of neurons.

CC   Doubling time: ~70 hours (DSMZ).

CC   Omics: Deep proteome analysis.

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4343 ! C-1300

SX   Male

CA   Cancer cell line

//

ID   Neuro-2a NucLight Green

AC   CVCL_DF49

WW   http://www.essenbioscience.com/essen-products/reagents-and-consumables/neuro-2a-nuclight-green-cells/

CC   Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0470 ! Neuro-2a

SX   Male

CA   Cancer cell line

//

ID   Neuro-2a NucLight Red

AC   CVCL_DF50

WW   http://www.essenbioscience.com/essen-products/reagents-and-consumables/neuro-2a-nuclight-red-cells/

CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.

CC   Transfected with: mKate2; a bright red fluorescent protein derived from eqFP578.

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0470 ! Neuro-2a

SX   Male

CA   Cancer cell line

//

ID   Neuro-2a-Luc

AC   CVCL_K046

SY   Neuro2A-Luc

DR   BTO; BTO:0003958

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0470 ! Neuro-2a

SX   Male

CA   Cancer cell line

//

ID   Neuro-2aTG

AC   CVCL_F275

DR   IFO; IFO50495

RX   PubMed=7763725;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0470 ! Neuro-2a

SX   Male

CA   Cancer cell line

//

ID   Newton

AC   CVCL_U800

DR   Cosmic; 928703

RX   PubMed=9354451;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NEYS

AC   CVCL_M893

RX   PubMed=19624308;

DI   NCIt; C9192; Ovarian carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NF

AC   CVCL_W770

RX   PubMed=2156601;

DI   NCIt; C9192; Ovarian carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NF-1

AC   CVCL_3556

DR   CLO; CLO_0008155

DR   ATCC; CRL-2075

RX   PubMed=6137898;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   NF2C

AC   CVCL_HE74

RX   Patent=US6825394;

RX   PubMed=10417352;

CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 96092754.

CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). Dies at the restrictive temperature (39 Celsius).

CC   Breed/subspecies: Sprague-Dawley SV40-tsA58 transgenic.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Conditionally immortalized cell line

//

ID   NF2S-1

AC   CVCL_7691

SY   Nf2S-1

RX   PubMed=17304235;

DI   NCIt; C21997; Mouse schwannoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFkappaB-TIME

AC   CVCL_Z064

DR   ATCC; CRL-4049

CC   Transfected with: HGNC; 11730; TERT.

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 8,9

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0047 ! TIME

SX   Male

CA   Telomerase immortalized cell line

//

ID   NFL/T

AC   CVCL_D888

SY   Normal Fetal Liver/Transformed

RX   PubMed=7777587;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   NFPE

AC   CVCL_3557

DR   CLO; CLO_0008158

DR   ATCC; CRL-2069

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3556 ! NF-1

SX   Male

CA   Cancer cell line

//

ID   NFS-1

AC   CVCL_1Y69

DR   Cosmic; 1132065

DR   Cosmic; 1801807

RX   PubMed=18650488;

RX   PubMed=23437333;

CC   Misspelling: 'NSF-1' in Cosmic 1801807.

DI   NCIt; C3798; Malignant peripheral nerve sheath tumor

DI   NCIt; C3273; Neurofibromatosis type 1

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NFS-1.0 C-1

AC   CVCL_0E46

SY   NFS-1.0 C1

DR   ATCC; CRL-1705

RX   PubMed=6330201;

CC   Breed/subspecies: NFS.C58v1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFS-107

AC   CVCL_5230

SY   NFS107

RX   PubMed=3014527;

CC   Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.

CC   Breed/subspecies: NFS.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFS-124

AC   CVCL_5231

SY   NFS124

RX   PubMed=3014527;

CC   Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.

CC   Breed/subspecies: NFS.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFS-2

AC   CVCL_W494

RX   PubMed=12237927;

CC   Derived from metastatic site: Retroperitoneal space.

DI   NCIt; C3043; Fibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NFS-22

AC   CVCL_5211

SY   NFS22

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFS-25 C-3

AC   CVCL_3558

SY   NFS-25 C3

DR   CLO; CLO_0008159

DR   CLDB; cl3688

DR   ATCC; CRL-1695

DR   ECACC; 93090713

RX   PubMed=6330201;

CC   Breed/subspecies: NFS.C58v1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFS-5 C-1

AC   CVCL_3559

SY   NFS-5 C1

DR   CLO; CLO_0008160

DR   CLDB; cl3689

DR   ATCC; CRL-1693

DR   ECACC; 88041904

RX   PubMed=6330201;

CC   Breed/subspecies: NFS/N.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFS-58

AC   CVCL_5232

SY   NFS 58; NFS58

RX   PubMed=2656885;

RX   PubMed=3014527;

CC   Breed/subspecies: NFS x DBA/2.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFS-60

AC   CVCL_3543

SY   M-NFS-60; NFS 60; NFS60

DR   CLO; CLO_0007812

DR   ATCC; CRL-1838

DR   BCRJ; 0175

DR   ChEMBL-Cells; CHEMBL3307327

DR   ChEMBL-Targets; CHEMBL614199

DR   CLS; 400301/p2732_NFS-60

DR   CLS; 400301-SF/p12832_NFS-60

DR   NCBI_Iran; C482

DR   NCBI_Iran; C603

RX   PubMed=2497280;

RX   PubMed=2656885;

RX   PubMed=3014527;

WW   http://www.atcc.org/support/faqs/d0d1f/MNFS60%20ATCC%20CRL1338-1076.aspx

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=NFS-60

CC   Characteristics: IL3 dependent.

CC   Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.

CC   Breed/subspecies: NFS x DBA/2.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFS-61

AC   CVCL_5233

SY   NFS61

RX   PubMed=3014527;

CC   Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.

CC   Breed/subspecies: NFS.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFS-70 C-10

AC   CVCL_3560

SY   NFS-70 C10

DR   CLO; CLO_0008161

DR   CLDB; cl3690

DR   ATCC; CRL-1694

DR   ECACC; 88041905

RX   PubMed=6330201;

CC   Breed/subspecies: NFS/N.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFS-78

AC   CVCL_5234

SY   NFS78

RX   PubMed=3014527;

CC   Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.

CC   Breed/subspecies: NFS.

DI   NCIt; C21604; Mouse leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFSa Y83

AC   CVCL_H735

SY   NFSaY83

DR   CLO; CLO_0050201

DR   RCB; RCB0282

CC   Breed/subspecies: C3Hf/Bu.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NFSC

AC   CVCL_M103

SY   Normal Fat Storing Cells

DR   BTO; BTO:0003521

RX   PubMed=1753710;

RX   PubMed=17760834;

CC   Breed/subspecies: Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NG-3Y1-D303

AC   CVCL_H236

DR   RCB; RCB0359

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4563 ! 3Y1-B clone 1

SX   Female

CA   Transformed cell line

//

ID   NG-3Y1-T15L

AC   CVCL_H227

DR   JCRB; JCRB0739

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4563 ! 3Y1-B clone 1

SX   Female

CA   Transformed cell line

//

ID   NG-3Y1-T18D

AC   CVCL_H237

DR   RCB; RCB0371

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4563 ! 3Y1-B clone 1

SX   Female

CA   Transformed cell line

//

ID   NG-3Y1-T308

AC   CVCL_H228

DR   JCRB; JCRB0740

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4563 ! 3Y1-B clone 1

SX   Female

CA   Transformed cell line

//

ID   NG-3Y1-T6R

AC   CVCL_H229

DR   JCRB; JCRB0741

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4563 ! 3Y1-B clone 1

SX   Female

CA   Transformed cell line

//

ID   NG115-401L

AC   CVCL_3938

DR   CLO; CLO_0008163

DR   CLDB; cl3692

DR   ECACC; 87032003

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Hybrid cell line

//

ID   NG125

AC   CVCL_U379

SY   NG 125; NG-125

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-451.html

DI   NCIt; C85184; Tay-Sachs disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NG2-2.16

AC   CVCL_4Y73

RX   PubMed=3428508;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: SIM.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_7221 ! PSA1-NG2

CA   Cancer cell line

//

ID   NG97

AC   CVCL_A660

RX   PubMed=11775071;

RX   PubMed=15885136;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NG97ht

AC   CVCL_A661

RX   PubMed=19009596;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A660 ! NG97

SX   Male

CA   Cancer cell line

//

ID   NGC-0295

AC   CVCL_DF66

SY   NGC0295

RX   PubMed=20664524;

RX   PubMed=22113314;

RX   PubMed=22655593;

CC   Biotechnology: Used in NsG0202, an encapsulated cell biodelivery device capable of local delivery of NGF to the brain so at to treat the cognitive decline in Alzheimer disease patients.

CC   Transfected with: HGNC; 7808; NGF.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0145 ! ARPE-19

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NGC-0301

AC   CVCL_DF67

SY   C101

RX   Patent=US20080286250;

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2732.

CC   Biotechnology: Used in NsG0301, an encapsulated cell biodelivery device capable of local delivery of GDNF to the brain so at to treat Parkinson disease patients.

CC   Transfected with: HGNC; 4232; GDNF.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0145 ! ARPE-19

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NGC-0363

AC   CVCL_DF68

SY   C63

RX   Patent=US20080286250;

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2733.

CC   Transfected with: HGNC; 4232; GDNF.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0145 ! ARPE-19

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NGC-407

AC   CVCL_DF59

RX   Patent=US8088567;

RX   PubMed=17555745;

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2718.

CC   Characteristics: Neural progenitor cell line that can differentiate into neurons, astrocytes and dopaminergic neurons depending on the differentiation conditions.

CC   Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.

CC   Transformant: v-Myc.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NGC0211

AC   CVCL_DF65

RX   DOI=10.2174/1875043501205010035;

RX   PubMed=22113314;

CC   Biotechnology: Used in NsG0202.1, an encapsulated cell biodelivery device capable of local delivery of NGF to the brain so at to treat the cognitive decline in Alzheimer disease patients.

CC   Characteristics: Contains 4 integrated copies of the NGF gene.

CC   Transfected with: HGNC; 7808; NGF.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0145 ! ARPE-19

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NGF-2

AC   CVCL_W098

RX   PubMed=18034678;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7962; ! Cyprinus carpio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NGF-3

AC   CVCL_W099

RX   PubMed=18034678;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7962; ! Cyprinus carpio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NGM

AC   CVCL_0R16

DR   BCRJ; 0190

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   NGP

AC   CVCL_2141

DR   BioSample; SAMN03473431

DR   Cosmic; 717421

DR   Cosmic; 923823

DR   Cosmic; 930071

DR   Cosmic; 1019937

DR   Cosmic; 1109120

DR   Cosmic; 1161999

DR   Cosmic; 1167422

DR   Cosmic; 1167988

DR   Cosmic; 1526637

DR   Cosmic; 2058106

DR   Cosmic; 2393638

DR   DSMZ; ACC-676

DR   GEO; GSM453633

DR   GEO; GSM692865

DR   LINCS; 51099

RX   DOI=10.1007/0-306-46872-7_2;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=922665;

RX   PubMed=6888561;

RX   PubMed=11550280;

RX   PubMed=15150091;

RX   PubMed=22213050;

RX   PubMed=23202128;

CC   Doubling time: ~50-70 hours (DSMZ).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lung.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 8,11

ST   D5S818: 11,12

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 6,9

ST   vWA: 16,21

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NGP-C4

AC   CVCL_0B58

SY   NGP-c4

DR   Cosmic; 1518071

DR   Cosmic; 2239464

CC   Derived from metastatic site: Lung.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2141 ! NGP

SX   Male

CA   Cancer cell line

//

ID   NGP.1A.TR1

AC   CVCL_AX38

RX   PubMed=1679663;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Derived from metastatic site: Lung.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2141 ! NGP

SX   Male

CA   Cancer cell line

//

ID   NGR50

AC   CVCL_J705

DR   CLO; CLO_0050340

DR   RCB; RCB2040

RX   PubMed=8794950;

CC   Monoclonal antibody target: Sulfoglucuronosyl paragloboside.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   NGR53

AC   CVCL_U838

RX   PubMed=7734848;

CC   Monoclonal antibody target: IV6-NeuAcalpha-nLc4Cer gangliosides.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   NGR54

AC   CVCL_J706

DR   CLO; CLO_0050338

DR   RCB; RCB2037

RX   PubMed=7734848;

CC   Monoclonal antibody target: IV3-NeuAcalpha-nLc4Cer gangliosides.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   NGUK-1

AC   CVCL_7692

DR   CLO; CLO_0008168

DR   CLDB; cl3697

RX   PubMed=2718262;

RX   PubMed=21116501;

WW   http://www.rccc.cytspb.rssi.ru/ecellbank/animal/anguk.htm

DI   NCIt; C60465; Rat malignant schwannoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   NH-12

AC   CVCL_1605

SY   NH12

DR   CLO; CLO_0050267

DR   BioSample; SAMN01821709

DR   BioSample; SAMN03472526

DR   ChEMBL-Cells; CHEMBL3308211

DR   ChEMBL-Targets; CHEMBL2366263

DR   Cosmic; 801745

DR   Cosmic; 908447

DR   Cosmic; 947719

DR   Cosmic; 1037350

DR   Cosmic; 1099147

DR   Cosmic; 1153788

DR   Cosmic; 2131593

DR   Cosmic-CLP; 908447

DR   GDSC; 908447

DR   GEO; GSM313808

DR   GEO; GSM333802

DR   GEO; GSM1670277

DR   JCRB; JCRB0833

DR   RCB; RCB2108

DR   TKG; TKG 0448

RX   PubMed=9290701;

RX   PubMed=18923524;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; JCRB; RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,9

ST   D16S539: 11

ST   D5S818: 10,11

ST   D7S820: 11,13

ST   TH01: 9,10

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NH-6

AC   CVCL_1606

SY   NH6

DR   CLO; CLO_0050089

DR   BioSample; SAMN01821710

DR   BioSample; SAMN03472525

DR   CCLE; NH6_AUTONOMIC_GANGLIA

DR   ChEMBL-Cells; CHEMBL3308801

DR   ChEMBL-Targets; CHEMBL1075551

DR   Cosmic; 925344

DR   GEO; GSM887455

DR   GEO; GSM888535

DR   JCRB; JCRB0832

DR   RCB; RCB2109

DR   TKG; TKG 0468

RX   PubMed=9290701;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): JCRB; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,13

ST   D16S539: 9,11

ST   D5S818: 13

ST   D7S820: 11

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 14,17

DI   NCIt; C4827; Adrenal gland neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NH-GEN1

AC   CVCL_W169

RX   PubMed=7933662;

RX   PubMed=8007420;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9913; ! Bos taurus

CA   Transformed cell line

//

ID   NH15-CA2

AC   CVCL_4545

DR   ECACC; 08062525

RX   PubMed=41246;

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0464 ! 108CC15

HI   CVCL_4253 ! N115-BU-8

CA   Hybrid cell line

//

ID   NH17

AC   CVCL_2657

DR   CLO; CLO_0008169

DR   CLDB; cl3698

DR   ECACC; 92111101

RX   PubMed=11892817;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0013 ! MOLT-4

SX   Male

CA   Cancer cell line

//

ID   NHBE-T

AC   CVCL_S124

RX   PubMed=19608870;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0112 ! 16HBE14o-

SX   Male

CA   Transformed cell line

//

ID   NHEK/SV3

AC   CVCL_9Q50

WW   http://www.evercyte.com/nhek-sv3.html

CC   Characteristics: SV40-transformed but with a finite life span (max PDL is 30).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   NHEK/SVTERT3-5

AC   CVCL_9Q51

WW   http://www.evercyte.com/nhek-svtert3-5.html

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   NHEM2493

AC   CVCL_B447

SY   NHEM 2493

DR   BTO; BTO:0004821

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   NHEM693

AC   CVCL_B448

SY   NHEM 693

DR   BTO; BTO:0004820

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   NHI-5B

AC   CVCL_M461

RX   PubMed=2842785;

CC   Transfected with: HGNC; 6081; INS.

CC   Breed/subspecies: NEDH.

DI   NCIt; C121566; Rat insulinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_M446 ! MSL-G2

CA   Cancer cell line

//

ID   NHI-6F

AC   CVCL_M462

SY   NHI-6F-INS; NHI-Ins; NHI-ins

RX   PubMed=2842785;

CC   Transfected with: HGNC; 6081; INS.

CC   Breed/subspecies: NEDH.

DI   NCIt; C121566; Rat insulinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_M446 ! MSL-G2

CA   Cancer cell line

//

ID   NHI-6F-28

AC   CVCL_M463

SY   NHI-6F-Tu28; NHI 6F Tu28; NHI-Glu; NHI-glu

CC   Transfected with: HGNC; 6081; INS.

CC   Breed/subspecies: NEDH.

DI   NCIt; C121566; Rat insulinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_M462 ! NHI-6F

CA   Cancer cell line

//

ID   NHIK 3016

AC   CVCL_Z877

SY   Norsk Hydro's Institute for Kreftforskning 3016

RX   CelloPub=CLPUB00088;

RX   CelloPub=CLPUB00205;

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NHIK 3017

AC   CVCL_Z878

SY   Norsk Hydro's Institute for Kreftforskning 3017

RX   CelloPub=CLPUB00088;

RX   CelloPub=CLPUB00205;

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NHIK 3025

AC   CVCL_U089

SY   NHIK-3025; NHIK3025; Norsk Hydro's Institute for Kreftforskning 3025

DR   ChEMBL-Cells; CHEMBL3307328

DR   ChEMBL-Targets; CHEMBL614201

RX   CelloPub=CLPUB00088;

RX   CelloPub=CLPUB00205;

RX   PubMed=369700;

RX   PubMed=4066771;

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NHIK 3043

AC   CVCL_Z879

SY   Norsk Hydro's Institute for Kreftforskning 3043

RX   CelloPub=CLPUB00088;

RX   CelloPub=CLPUB00205;

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NHOS

AC   CVCL_6688

SY   Nishi-Hirosaki osteosarcoma

DR   CLO; CLO_0050198

DR   RCB; RCB1741

RX   PubMed=11429054;

RX   PubMed=18630519;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C24021; Mouse osteosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   NHSF46

AC   CVCL_G283

DR   CLO; CLO_0050707

DR   BioSample; SAMN03472341

DR   RCB; RCB0162

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,10

ST   D16S539: 10,14

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   NI 1 alpha 364/3B3-14

AC   CVCL_K161

DR   ECACC; 92030611

CC   Monoclonal antibody target: UniProtKB; P01583; Human IL1A.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NI 1 alpha 364/8C4-8

AC   CVCL_K162

DR   ECACC; 92030612

CC   Monoclonal antibody target: UniProtKB; P01583; Human IL1A.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NI 3 416/6C6-6

AC   CVCL_J845

DR   ECACC; 92030615

RX   PubMed=1790303;

CC   Monoclonal antibody target: UniProtKB; P08700; Human IL3.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NI 3 416/7B5-5

AC   CVCL_J846

DR   ECACC; 92030616

RX   PubMed=1790303;

CC   Monoclonal antibody target: UniProtKB; P08700; Human IL3.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NI 4 426/1A6-10

AC   CVCL_J847

DR   ECACC; 92030617

RX   PubMed=1790303;

CC   Monoclonal antibody target: UniProtKB; P05112; Human IL4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NI 4 426/7A3-3

AC   CVCL_J848

DR   ECACC; 92030618

DR   NCBI_Iran; H123

RX   PubMed=1790303;

CC   Monoclonal antibody target: UniProtKB; P05112; Human IL4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NI 4 426/8B1-7

AC   CVCL_J849

DR   ECACC; 92030619

RX   PubMed=1790303;

CC   Monoclonal antibody target: UniProtKB; P05112; Human IL4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NI G 386/3B6-12

AC   CVCL_J850

DR   ECACC; 92030614

CC   Monoclonal antibody target: UniProtKB; P09919; Human CSF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NI G 386/3D1-16

AC   CVCL_J851

DR   ECACC; 92030613

CC   Monoclonal antibody target: UniProtKB; P09919; Human CSF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NI GM 465/7A6-37

AC   CVCL_J852

SY   NI GM465/7A6-37

DR   ECACC; 92030620

DR   NCBI_Iran; H124

CC   Monoclonal antibody target: UniProtKB; P04141; Human CSF2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NI-1

AC   CVCL_GT45

RX   PubMed=22583069;

CC   Miscellaneous: Gender from personal communication of Willmann M.

CC   Breed/subspecies: Mixed breed.

DI   NCIt; C129077; Canine mastocytoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   NIAS-AeAl-2

AC   CVCL_Z549

SY   NIAS-AeAl 2; AeAl2

DR   NISES; SK0013

DR   RCB; RCB0277

RX   CelloPub=CLPUB00194;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275011

CC   Group: Insect cell line.

CC   Doubling time: ~30 hours (CelloPub=CLPUB00194).

CC   Misspelling: Occasionally 'NIAS-AeA-2'.

CC   Discontinued: RCB; RCB0277; true.

OX   NCBI_TaxID=7160; ! Aedes albopictus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-Bm-aff3

AC   CVCL_Z559

RX   PubMed=15827172;

RX   PubMed=19734648;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-Bm-ao1

AC   CVCL_Z560

RX   PubMed=15827172;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIAS-Bm-Ke1

AC   CVCL_Z561

SY   Ke1

RX   DOI=10.11416/konchubiotec.75.45;

RX   PubMed=22302376;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-Bm-Ke17

AC   CVCL_Z562

RX   PubMed=22302376;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7091; ! Bombyx mori

HI   CVCL_Z561 ! NIAS-Bm-Ke1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-Bm-Oyanagi 1

AC   CVCL_Z563

SY   NIAS-Bm-oyanagi1; NBO1

RX   DOI=10.11416/jibs.74.117;

RX   PubMed=15827172;

CC   Group: Insect cell line.

CC   Breed/subspecies: N137 x C146.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-Bm-Oyanagi 2

AC   CVCL_Z564

SY   NIAS-Bm-oyanagi2; NBO2

RX   DOI=10.11416/jibs.74.117;

RX   PubMed=19734648;

CC   Group: Insect cell line.

CC   Breed/subspecies: N137 x C146.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-Bm-SLBEM-1228

AC   CVCL_Z565

SY   NBS1228

RX   DOI=10.11416/jibs.74.117;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-Bm-SLBEM-1230

AC   CVCL_Z566

SY   NBS1230

RX   DOI=10.11416/jibs.74.117;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-Boma-529b

AC   CVCL_Z092

RX   PubMed=19460387;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7092; ! Bombyx mandarina

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-LeSe-11

AC   CVCL_Z368

SY   LeSe-11

DR   CLO; CLO_0050505

DR   NISES; SK0008

DR   RCB; RCB0405

RX   DOI=10.1303/aez.18.533;

RX   PubMed=10358729;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275012

CC   Group: Insect cell line.

OX   NCBI_TaxID=271217; ! Mythimna separata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-MaBr-85

AC   CVCL_Z126

RX   DOI=10.1111/j.1440-169X.1981.00063.x;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275010

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-MaBr-92

AC   CVCL_Z124

DR   CLO; CLO_0050228

DR   NISES; SK0006

DR   RCB; RCB0279

RX   DOI=10.1111/j.1440-169X.1985.00599.x;

RX   PubMed=1367489;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275019

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-MaBr-93

AC   CVCL_Z125

DR   CLO; CLO_0050229

DR   NISES; SK0009

DR   RCB; RCB0414

RX   DOI=10.1111/j.1440-169X.1985.00599.x;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275020

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-Mb-19

AC   CVCL_Z121

SY   NIAS-MB-19

RX   DOI=10.1111/j.1440-169X.1977.00337.x;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275006

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIAS-Mb-25

AC   CVCL_Z122

SY   NIAS-MB-25

DR   CLO; CLO_0050504

DR   NISES; SK0005

DR   RCB; RCB0278

RX   DOI=10.1111/j.1440-169X.1977.00337.x;

RX   PubMed=1367489;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275007

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIAS-Mb-32

AC   CVCL_Z123

SY   NIAS-MB-32

DR   CLO; CLO_0050503

DR   NISES; SK0001

DR   RCB; RCB0413

RX   DOI=10.1111/j.1440-169X.1977.00337.x;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275008

CC   Group: Insect cell line.

OX   NCBI_TaxID=55057; ! Mamestra brassicae

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIAS-PRC-819A

AC   CVCL_Z118

SY   NIAS-PRC819A

RX   PubMed=14505438;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275054

CC   Group: Insect cell line.

OX   NCBI_TaxID=64459; ! Pieris rapae

OI   CVCL_Z119 ! NIAS-PRC-819B

OI   CVCL_Z120 ! NIAS-PRC-819C

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIAS-PRC-819B

AC   CVCL_Z119

SY   NIAS-PRC819B

RX   PubMed=14505438;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275055

CC   Group: Insect cell line.

OX   NCBI_TaxID=64459; ! Pieris rapae

OI   CVCL_Z118 ! NIAS-PRC-819A

OI   CVCL_Z120 ! NIAS-PRC-819C

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIAS-PRC-819C

AC   CVCL_Z120

SY   NIAS-PRC819C

RX   PubMed=14505438;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275056

CC   Group: Insect cell line.

OX   NCBI_TaxID=64459; ! Pieris rapae

OI   CVCL_Z118 ! NIAS-PRC-819A

OI   CVCL_Z119 ! NIAS-PRC-819B

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIAS-Px-58

AC   CVCL_Z132

SY   NIAS-PX-58; NIAS-Px 58; PX-58; Px 58

DR   CLO; CLO_0050002

DR   NISES; SK0012

DR   RCB; RCB0556

RX   DOI=10.1303/aez.8.64;

RX   DOI=10.1016/B978-0-12-470270-7.50007-0;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275004

CC   Group: Insect cell line.

OX   NCBI_TaxID=66420; ! Papilio xuthus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIAS-Px-64

AC   CVCL_Z134

SY   NIAS-PX-64; PX-64; Px 64

DR   CLO; CLO_0050001

DR   NISES; SK0017

DR   RCB; RCB0412

RX   DOI=10.1303/aez.8.64;

RX   DOI=10.1016/B978-0-12-470270-7.50007-0;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275005

CC   Group: Insect cell line.

OX   NCBI_TaxID=66420; ! Papilio xuthus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIAS-SL64

AC   CVCL_HF61

RX   PubMed=25172011;

CC   Group: Insect cell line.

CC   Doubling time: 24 hours (PubMed=25172011).

OX   NCBI_TaxID=69820; ! Spodoptera litura

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIAS-SpSe-1

AC   CVCL_Z545

RX   CelloPub=CLPUB00195;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275013

CC   Group: Insect cell line.

CC   Doubling time: ~3 days (CelloPub=CLPUB00195).

OX   NCBI_TaxID=1426856; ! Spilarctia seriatopunctata

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIC

AC   CVCL_F577

SY   TER73; TER160

DR   IMGT/HLA; 11140

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NIE

AC   CVCL_F578

SY   TER146; TER265; TER348

DR   IMGT/HLA; 11141

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NIH 2/4

AC   CVCL_5I45

SY   NIH2/4

RX   PubMed=17486118;

RX   PubMed=18483401;

WW   https://www.kerafast.com/product/2292/nih-24-cell-line

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH 3T3

AC   CVCL_0594

SY   NIH/3T3; NIH-3T3; NIH3T3; 3T3; 3T3NIH; 3T3-Swiss; Swiss-3T3; Swiss/3T3; Swiss 3T3; Swiss3T3

DR   BTO; BTO:0000944

DR   BTO; BTO:0005065

DR   CLO; CLO_0008172

DR   CLO; CLO_0009227

DR   CLO; CLO_0050548

DR   EFO; EFO_0001222

DR   MCCL; MCC:0000362

DR   CLDB; cl3702

DR   CLDB; cl3704

DR   CLDB; cl3705

DR   CLDB; cl3706

DR   CLDB; cl3707

DR   CLDB; cl3708

DR   CLDB; cl3709

DR   CLDB; cl3710

DR   CLDB; cl3711

DR   CLDB; cl4451

DR   CLDB; cl7203

DR   ATCC; CRL-1658

DR   ATCC; CRL-6442

DR   BCRC; 60008

DR   BCRJ; 0191

DR   CCRID; 3111C0001CCC000018

DR   CCRID; 3111C0002000000034

DR   CCRID; 3131C0001000300006

DR   CCRID; 3142C0001000000030

DR   ChEMBL-Cells; CHEMBL3307716

DR   ChEMBL-Targets; CHEMBL614822

DR   CLS; 400101/p677_NIH-3T3

DR   DSMZ; ACC-59

DR   ECACC; 93061524

DR   ENCODE; ENCBS117ENC

DR   ENCODE; ENCBS990YBC

DR   GEO; GSM1014177

DR   ICLC; AL07001

DR   IZSLER; BS CL 165

DR   KCB; KCB 200645YJ

DR   KCLB; 21658

DR   MeSH; D041681

DR   NCBI_Iran; C156

DR   NIH-ARP; 9946-386

DR   PRIDE; PXD001241

DR   PRIDE; PXD004929

DR   RCB; RCB2767

DR   TKG; TKG 0299

DR   TOKU-E; 2753

DR   TOKU-E; 3547

DR   Wikidata; Q4636420

RX   PubMed=2463382;

RX   PubMed=9753870;

RX   PubMed=23321776;

WW   https://en.wikipedia.org/wiki/3T3_cells

WW   http://nih3t3.com/

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=3T3

WW   http://www.atcc.org/support/faqs/89140/ATCC%20CCL92%20vs%20ATCC%20CRL1658-453.aspx

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/NIH-3T3_Stam_protocol.pdf

WW   http://www.proteinatlas.org/learn/cellines

CC   Part of: ENCODE project mouse cell lines.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Doubling time: ~20 hours (DSMZ).

CC   Discontinued: ATCC; CRL-6442; true.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH 3T3 Duo

AC   CVCL_HC51

SY   NIH3T3duo

RX   PubMed=23929981;

RX   PubMed=25255091;

WW   https://www.kerafast.com/product/2293/nih-3t3-duo-cell-line

CC   Characteristics: Cell developed for the induction and visualization of double-strand breaks chromosomal damage at specific sites of the mammalian genome. Sytem based on the stable integration of endonuclease ISceI recognition sites flanked by LacO/TetO operator arrays, coupled with retroviral-mediated integration of their fluorescent repressors (LacR/TetR) to visualize the LacO/TetO sites.

CC   Characteristics: Integrates one copy of a LacO-ISceI construct (256 copies of LacO), two copies of a TetO-ISceI-TetO construct (96 copies of TetO) as well as a LacR-GFP and a TetR-mCherry constructs.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.

CC   Transfected with: UniProtKB; P03023; E.coli lacI.

CC   Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_HC50 ! NIH 3T3 Duo Parental

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH 3T3 Duo-BFP53BP1

AC   CVCL_HC52

RX   PubMed=23929981;

WW   https://www.kerafast.com/product/2295/nih-3t3-duo-bfp53bp1-cell-line

CC   Characteristics: Cell developed for the induction and visualization of double-strand breaks chromosomal damage at specific sites of the mammalian genome. Sytem based on the stable integration of endonuclease ISceI recognition sites flanked by LacO/TetO operator arrays, coupled with retroviral-mediated integration of their fluorescent repressors (LacR/TetR) to visualize the LacO/TetO sites.

CC   Characteristics: Integrates one copy of a LacO-ISceI construct (256 copies of LacO), two copies of a TetO-ISceI-TetO construct (96 copies of TetO) as well as a LacR-GFP and a TetR-mCherry constructs.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.

CC   Transfected with: UniProtKB; Q8ISF8; Entacmaea quadricolor eqFP611 (modified to produce the BFP mTagBFP).

CC   Transfected with: UniProtKB; P03023; E.coli lacI.

CC   Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.

CC   Transfected with: MGI; MGI:1351320; Trp53bp1.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_HC51 ! NIH 3T3 Duo

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH 3T3 Duo Parental

AC   CVCL_HC50

RX   PubMed=23929981;

RX   PubMed=25255091;

WW   https://www.kerafast.com/product/2294/nih-3t3-duo-parental-cell-line

CC   Characteristics: Cell developed for the induction and visualization of double-strand breaks chromosomal damage at specific sites of the mammalian genome. Sytem based on the stable integration of endonuclease ISceI recognition sites flanked by LacO/TetO operator arrays, coupled with retroviral-mediated integration of their fluorescent repressors (LacR/TetR) to visualize the LacO/TetO sites.

CC   Characteristics: Integrates one copy of a LacO-ISceI construct (256 copies of LacO) and two copies of a TetO-ISceI-TetO construct (96 copies of TetO).

CC   Transfected with: UniProtKB; P03023; E.coli lacI.

CC   Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH 3T3 p-7 cl-3

AC   CVCL_L994

DR   IFO; IFO50019

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH 3T3-IL-7

AC   CVCL_D675

SY   3T3 IL-7

DR   BCRJ; 0018

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH 3T3-ras

AC   CVCL_5845

SY   NIH-3T3-ras; NIH3T3-ras; A51; GhrasT-NIH/Swiss

DR   BTO; BTO:0005549

DR   CLS; 400100/p2750_NIH-3T3-RAS

RX   PubMed=3858844;

RX   PubMed=26254261;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH 3T3-TK-

AC   CVCL_9116

SY   NIH 3T3 TK-; 3T3 NIH TK-; TK- NIH/3T3

DR   CLO; CLO_0001349

DR   CLDB; cl68

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH 3T3/DC-SIGN

AC   CVCL_0R23

SY   NIH 3T3/MX-DC-SIGN

DR   NIH-ARP; 9947-49

RX   PubMed=12021323;

CC   Transfected with: HGNC; 1641; CD209.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH 3T3/L-SIGN

AC   CVCL_0R24

SY   NIH 3T3/MX-L-SIGN (L6)

DR   NIH-ARP; 9948-54

RX   PubMed=12021323;

CC   Transfected with: HGNC; 13523; CLEC4M.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH-3T3 4-2

AC   CVCL_7219

DR   CLO; CLO_0008173

DR   CLDB; cl3700

DR   ECACC; 86041101

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH-3T3 clone 5611

AC   CVCL_7220

SY   NIH/3T3 clone 5611

DR   JCRB; JCRB0615

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH-3T3-A14

AC   CVCL_L990

SY   NIH 3T3-A14; NIH3T3-A14; A14

DR   BTO; BTO:0004245

RX   PubMed=2022184;

CC   Transfected with: HGNC; 6091; INSR.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH-3T3-G185

AC   CVCL_L991

SY   NIH 3T3-G185; NIH 3T3 G185; NIH3T3-G185; NIH MDR1-G185; G185

DR   BTO; BTO:0002396

RX   PubMed=1356986;

CC   Transfected with: HGNC; 40; ABCB1.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH-3T3D4

AC   CVCL_7218

SY   NIH 3T3 D4; NIH-3T3 D4; NIH3T3-D4; NIH 3T3 clone D4; NIH3T3 clone D4

DR   CLO; CLO_0008174

DR   CLDB; cl3701

DR   ECACC; 85111801

DR   IZSLER; BS CL 213

DR   NCBI_Iran; C155

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH-SaPe-4

AC   CVCL_Z550

SY   NIH-Sape-4; NIH SaPe4

DR   NISES; SK0014

DR   RCB; RCB0280

RX   DOI=10.1111/j.1440-169X.1980.00011.x;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275009

CC   Group: Insect cell line.

CC   Discontinued: RCB; RCB0280; true.

OX   NCBI_TaxID=7386; ! Sarcophaga peregrina

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIH/3T3 Tet-On 3G

AC   CVCL_V360

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_3G_Cell_Lines

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIH3T3-3

AC   CVCL_L992

DR   RCB; RCB0150

CC   Discontinued: RCB; RCB0150; true.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Transformed cell line

//

ID   NIH3T3-3-4

AC   CVCL_L993

DR   CLO; CLO_0050553

DR   RCB; RCB1862

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_L992 ! NIH3T3-3

SX   Male

CA   Transformed cell line

//

ID   NIH3T3/13C7

AC   CVCL_M025

DR   CLO; CLO_0050550

DR   RCB; RCB0057

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Transformed cell line

//

ID   NIH3T3/14-1

AC   CVCL_L995

DR   CLO; CLO_0050549

DR   RCB; RCB0056

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Transformed cell line

//

ID   NIH3T3/ATCC/CMV-Luc

AC   CVCL_4Y01

DR   JCRB; JCRB1503

DR   JCRB; NIHS0730

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIID-CTR

AC   CVCL_Z827

RX   PubMed=22706601;

CC   Group: Insect cell line.

CC   Doubling time: 20 hours (at 30th passage in the presence of 12% FBS), 46 hours (at 60th passage in 5% FBS), 76 hours (at 60th passage in the absence of FBS) (PubMed=22706601).

OX   NCBI_TaxID=7178; ! Culex tritaeniorhynchus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIL 1c1

AC   CVCL_8737

SY   Nil1C1

DR   CLO; CLO_0050253

DR   RCB; RCB0245

RX   PubMed=4337244;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_8743 ! NIL B1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIL 2c1

AC   CVCL_8739

SY   Nil2C1

DR   CLO; CLO_0050254

DR   RCB; RCB0244

RX   PubMed=4337244;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_8742 ! Nil-2E

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIL 2c2

AC   CVCL_8740

SY   Nil2C2

DR   CLO; CLO_0050255

DR   RCB; RCB0243

RX   PubMed=4337244;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_8742 ! Nil-2E

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIL 2c3

AC   CVCL_8741

SY   Nil2C3

RX   PubMed=4337244;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_8742 ! Nil-2E

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIL B1

AC   CVCL_8743

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_8738 ! Nil-2

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Nil-1

AC   CVCL_W454

RX   PubMed=6039764;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

OI   CVCL_8738 ! Nil-2

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Nil-2

AC   CVCL_8738

AS   CVCL_3071

SY   NIL-2; NIL 2; Nil 2; NIL2; NIL

DR   ATCC; CRL-6443

DR   IFO; IFO50018

RX   PubMed=6039764;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6443; true.

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

OI   CVCL_W454 ! Nil-1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Nil-2E

AC   CVCL_8742

SY   NIL 2e; NIL 2E; Nil-2 clone E

RX   PubMed=5650922;

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_8738 ! Nil-2

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NIL-SF2

AC   CVCL_3072

DR   IFO; IFO50426

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_8738 ! Nil-2

CA   Spontaneously immortalized cell line

//

ID   NIM-1

AC   CVCL_5344

SY   NIM

DR   Cosmic; 849974

DR   Cosmic; 931240

RX   PubMed=1372885;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=NIM-1

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NIPBC-1

AC   CVCL_U921

RX   PubMed=24502646;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NIPBC-2

AC   CVCL_U922

RX   PubMed=24502646;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Nips-B2

AC   CVCL_T775

SY   iPS-B2

DR   RCB; HPS0223

DR   SKIP; SKIP000266

RX   PubMed=22912751;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NIS-G

AC   CVCL_6005

DR   CLS; 300303/p580_NIS-G

ST   Source(s): CLS

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 21

ST   D21S11: 31,31.2

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 12

ST   D8S1179: 12,14

ST   FGA: 21

ST   Penta D: 9

ST   Penta E: 12,13

ST   TH01: 7,9.3

ST   TPOX: 8,10

ST   vWA: 14,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NISES-AnPe-426

AC   CVCL_Z103

DR   NISES; SK0024

RX   PubMed=1748622;

RX   DOI=10.11416/kontyushigen1930.64.79;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7119; ! Antheraea pernyi

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISES-AnPe-428

AC   CVCL_AV48

RX   CelloPub=CLPUB00320;

RX   DOI=10.11416/jibs.72.79;

RX   DOI=10.11416/kontyushigen1930.64.79;

CC   Group: Insect cell line.

CC   Group: Recombinant protein production insect cell line.

OX   NCBI_TaxID=7119; ! Antheraea pernyi

HI   CVCL_Z103 ! NISES-AnPe-426

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISES-Anya-0611

AC   CVCL_Z107

SY   Anya-0611

RX   PubMed=12892519;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275035

CC   Group: Insect cell line.

OX   NCBI_TaxID=7121; ! Antheraea yamamai

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NISES-BoMo-15AIIc

AC   CVCL_Z420

SY   NISES-BoMo-15 AIIc

DR   NISES; SK0018

RX   CelloPub=CLPUB00184;

CC   Group: Insect cell line.

CC   Breed/subspecies: Kuroko.

OX   NCBI_TaxID=7091; ! Bombyx mori

HI   CVCL_Z419 ! SES-BoMo-15AII

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISES-BoMo-Cam1

AC   CVCL_Z844

SY   NIAS-BoMo-Cam1

DR   NISES; SK0026

RX   CelloPub=CLPUB00197;

RX   PubMed=15827172;

RX   PubMed=16756546;

CC   Group: Insect cell line.

CC   Breed/subspecies: Cambodge.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NISES-BoMo-DZ

AC   CVCL_Z552

RX   DOI=10.1303/aez.34.259;

RX   PubMed=16756546;

CC   Group: Insect cell line.

CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17389.

CC   Breed/subspecies: Daizo.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISES-BoMo-E2

AC   CVCL_Z556

RX   PubMed=16756546;

CC   Group: Insect cell line.

CC   Breed/subspecies: J147 x C145.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISES-BoMo-E3

AC   CVCL_Z557

SY   NIAS-BoMo-E3

RX   DOI=10.11416/jibs.74.117;

CC   Group: Insect cell line.

CC   Breed/subspecies: N137 x C146.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISES-BoMo-E4

AC   CVCL_Z558

SY   NIAS-BoMo-E4

RX   DOI=10.11416/jibs.74.117;

CC   Group: Insect cell line.

CC   Breed/subspecies: N137 x C146.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISES-BoMo-KG

AC   CVCL_Z553

RX   DOI=10.1303/aez.34.259;

CC   Group: Insect cell line.

CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17390.

CC   Breed/subspecies: Kokuga.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISES-BoMo-MK

AC   CVCL_Z554

RX   DOI=10.1303/aez.34.259;

RX   PubMed=16756546;

CC   Group: Insect cell line.

CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17391.

CC   Breed/subspecies: Murasaki kaiko.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISES-BoMo-OH

AC   CVCL_Z555

RX   DOI=10.1303/aez.34.259;

RX   PubMed=16756546;

CC   Group: Insect cell line.

CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17392.

CC   Breed/subspecies: Ohha.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISES-SaCy-12

AC   CVCL_Z104

DR   NISES; SK0025

RX   DOI=10.11416/kontyushigen1930.64.270;

WW   http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275033

CC   Group: Insect cell line.

CC   Misspelling: Occasionally 'NISE-Sacy-12'.

OX   NCBI_TaxID=7127; ! Samia cynthia

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NISH

AC   CVCL_U225

RX   PubMed=9590506;

CC   Breed/subspecies: Booroola x Assaf.

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIT-1

AC   CVCL_3561

DR   CLO; CLO_0008175

DR   ATCC; CRL-2055

DR   BCRC; 60452

DR   IZSLER; BS TCL 192

RX   PubMed=1647994;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: NOD/Lt-Tg(RIPTag)1Lt.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   NIT-2

AC   CVCL_3562

DR   CLO; CLO_0008176

DR   ATCC; CRL-2364

RX   PubMed=9348219;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BLKS/J-Cpefat/1 x NOD/Lt-Tg(RIPTag)1Lt.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   NIT-3

AC   CVCL_U269

RX   PubMed=9348219;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BLKS/J-Cpefat/1 x NOD/Lt-Tg(RIPTag)1Lt.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   NIV-AA-706

AC   CVCL_Z268

RX   PubMed=19533252;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7159; ! Aedes aegypti

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIV-AK-453

AC   CVCL_Z347

DR   Wikidata; Q28470898

RX   PubMed=1429352;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=1579483; ! Aedes krombeini

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIV-BM-1296

AC   CVCL_Z309

RX   PubMed=12362558;

RX   PubMed=16037617;

CC   Group: Insect cell line.

CC   Misspelling: 'NIV-HA-1296' in PubMed=16037617.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIV-BM-197

AC   CVCL_Z310

RX   PubMed=12362558;

RX   PubMed=16037617;

CC   Group: Insect cell line.

CC   Misspelling: 'NIV-HA-197' in PubMed=16037617.

OX   NCBI_TaxID=7091; ! Bombyx mori

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIV-BtEPC

AC   CVCL_T049

RX   PubMed=24056599;

CC   Group: Bat cell line.

OX   NCBI_TaxID=1081694; ! Pipistrellus ceylonicus

CA   Spontaneously immortalized cell line

//

ID   NIV-CT-894

AC   CVCL_Z348

RX   PubMed=12693860;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7178; ! Culex tritaeniorhynchus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIV-HA-1195

AC   CVCL_Z308

RX   PubMed=12561972;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=29058; ! Helicoverpa armigera

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIV-HA-197

AC   CVCL_Z307

RX   PubMed=12418922;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=29058; ! Helicoverpa armigera

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIV-PTM-1095

AC   CVCL_Z349

RX   PubMed=15802757;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=192464; ! Phthorimaea operculella

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIV-SU-1095

AC   CVCL_Z306

RX   PubMed=11411040;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=69820; ! Spodoptera litura

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIV-SU-893

AC   CVCL_Z350

RX   PubMed=9112123;

RX   PubMed=10475268;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=69820; ! Spodoptera litura

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIV-SU-992

AC   CVCL_Z351

RX   CelloPub=CLPUB00176;

RX   PubMed=10475268;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=69820; ! Spodoptera litura

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NIVI-CH-440

AC   CVCL_Z885

RX   DOI=10.1007/BF02624190;

CC   Group: Insect cell line.

OX   NCBI_TaxID=757355; ! Cimex hemipterus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIVI-CH-442

AC   CVCL_Z886

RX   DOI=10.1007/BF02624190;

CC   Group: Insect cell line.

OX   NCBI_TaxID=757355; ! Cimex hemipterus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NIVI-CH-445

AC   CVCL_Z887

RX   DOI=10.1007/BF02624190;

CC   Group: Insect cell line.

OX   NCBI_TaxID=757355; ! Cimex hemipterus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NJB

AC   CVCL_L113

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=4530294;

RX   PubMed=14114966;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NJG

AC   CVCL_3073

DR   BioSample; SAMN03470970

DR   IFO; IFO50322

RX   PubMed=3611867;

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 11

ST   D16S539: 12

ST   D18S51: 17

ST   D19S433: 14

ST   D21S11: 30

ST   D2S1338: 23

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 10

ST   D8S1179: 12

ST   FGA: 23

ST   Penta D: 9

ST   Penta E: 18

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C4646; Gestational choriocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NK 62

AC   CVCL_8267

SY   NK62; NK line 62

RX   PubMed=10318937;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   NK 70

AC   CVCL_8268

SY   NK70; NK line 70

RX   PubMed=10318937;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   NK m-1

AC   CVCL_8269

SY   NK line m-1

RX   PubMed=10318937;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   NK-92

AC   CVCL_2142

SY   NK92

DR   BTO; BTO:0003287

DR   CLO; CLO_0008177

DR   ATCC; CRL-2407

DR   ATCC; PTA-6670

DR   BCRC; 60414

DR   BioSample; SAMN03471836

DR   CCRID; 3131C0001000200020

DR   Cosmic; 1534874

DR   Cosmic; 1542071

DR   Cosmic; 2025326

DR   Cosmic; 2390215

DR   DSMZ; ACC-488

DR   GEO; GSM472001

DR   Wikidata; Q17149636

RX   PubMed=8152260;

RX   PubMed=9118301;

RX   PubMed=10803505;

RX   PubMed=11454312;

RX   PubMed=19194464;

RX   PubMed=21052088;

RX   PubMed=25586472;

WW   https://en.wikipedia.org/wiki/NK-92

WW   http://www2.kumc.edu/soalab/LabLinks/cell%20lines/nk92.htm

CC   Characteristics: IL2 dependent.

CC   Characteristics: Does not express FCGR3A/CD16.

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; PTA-6670; true.

ST   Source(s): ATCC; DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,12

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 18 (ATCC)

ST   vWA: 16,18 (DSMZ)

DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NK-92CI

AC   CVCL_U271

SY   NK-92 ci; NK92CI; NK-92 transfected with pCEP4-LTR-hIL2

DR   ATCC; CRL-2409

DR   ATCC; PTA-6672

DR   BioSample; SAMN03471837

RX   Patent=US8034332;

RX   PubMed=10365666;

CC   Transfected with: HGNC; 6001; IL2.

CC   Discontinued: ATCC; CRL-2409; true.

CC   Discontinued: ATCC; PTA-6672; probable.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,12

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2142 ! NK-92

SX   Male

CA   Cancer cell line

//

ID   NK-92MI

AC   CVCL_3755

SY   NK-92 MI; NK-92 mi; NK92-MI; NK92MI; NK-92 transfected with MFG-hIL2

DR   CLO; CLO_0008178

DR   ATCC; CRL-2408

DR   ATCC; PTA-6671

DR   BCRC; 60438

DR   CCRID; 3111C0002000000065

DR   CCRID; 3131C0001000200022

DR   Cosmic-CLP; 1330981

DR   GDSC; 1330981

DR   GEO; GSM1670278

DR   KCB; KCB 200677YJ

RX   Patent=US8034332;

RX   PubMed=10365666;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transfected with: HGNC; 6001; IL2.

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: ATCC; PTA-6671; probable.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,12

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2142 ! NK-92

SX   Male

CA   Cancer cell line

//

ID   NK-YS

AC   CVCL_8461

AS   CVCL_AX40

SY   NKYS

DR   Cosmic; 1534872

DR   Cosmic; 1542075

DR   Cosmic; 2025325

DR   Cosmic; 2390119

DR   GEO; GSM472002

RX   PubMed=9694726;

RX   PubMed=10803505;

RX   PubMed=19194464;

RX   PubMed=21052088;

RX   PubMed=25586472;

CC   Characteristics: IL2 dependent.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NK14

AC   CVCL_DG47

SY   NK1-4; NKI-4

DR   Cosmic; 928726

RX   PubMed=4549213;

RX   PubMed=6090953;

RX   PubMed=23039341;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NK3.3

AC   CVCL_7994

SY   NK 3.3

DR   Lonza; 78

RX   PubMed=6982944;

WW   http://www2.kumc.edu/soalab/LabLinks/cell%20lines/nk33.htm

WW   http://www.slu.edu/x27874.xml

CC   Characteristics: IL2 dependent.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Factor-dependent cell line

//

ID   NK7801

AC   CVCL_F976

SY   NK-7801; Nara Kidney Tumor

DR   TKG; TKG 0133

RX   CelloPub=CLPUB00283;

CC   Breed/subspecies: BDIX.

DI   NCIt; C64111; Carcinoma of the rat kidney

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   NKB-1

AC   CVCL_3919

SY   NKB1

DR   BTO; BTO:0003481

DR   TKG; TKG 0699

RX   PubMed=9183630;

ST   Source(s): TKG

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 10

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 18,19

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NKC3

AC   CVCL_6006

RX   PubMed=6983881;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=NKC3

CC   Characteristics: IL2 dependent.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Factor-dependent cell line

//

ID   NKK1

AC   CVCL_G365

RX   PubMed=9183637;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NKL

AC   CVCL_0466

DR   MCCL; MCC:0000364

DR   Cosmic; 1534875

DR   Cosmic; 2025324

RX   PubMed=10803505;

DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NKM-1

AC   CVCL_1607

DR   BioSample; SAMN03472796

DR   ChEMBL-Cells; CHEMBL3308212

DR   ChEMBL-Targets; CHEMBL2366133

DR   Cosmic; 908448

DR   Cosmic; 1523824

DR   Cosmic; 2131549

DR   Cosmic; 2306228

DR   Cosmic-CLP; 908448

DR   GDSC; 908448

DR   GEO; GSM1670279

DR   IFO; IFO50476

RX   PubMed=1701353;

RX   PubMed=9737686;

RX   PubMed=9738977;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,13

ST   D16S539: 9,12

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   TH01: 6,9

ST   TPOX: 9,11

ST   vWA: 17

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NKNT-3

AC   CVCL_S905

RX   PubMed=10678831;

RX   PubMed=10937342;

RX   PubMed=16970284;

CC   Characteristics: The SV40 T antigen is flanked by LoxP recombination targets so that it can be excised by Cre/Lox site-specific recombination.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NKY113

AC   CVCL_J276

DR   IFO; IFO50279

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   NL/T4

AC   CVCL_HA80

RX   PubMed=2472008;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pZIPneoSV(X)1/SV40T].

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NL20

AC   CVCL_3756

SY   NL20SV; NL-20

DR   CLO; CLO_0008179

DR   ATCC; CRL-2503

DR   BCRC; 60361

DR   BioSample; SAMN03471599

DR   GEO; GSM185872

RX   PubMed=21566947;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 12

ST   TH01: 6,7

ST   TPOX: 9,11

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   NL20T-A

AC   CVCL_3757

SY   NL20-TA; NL20TA

DR   CLO; CLO_0008180

DR   ATCC; CRL-2504

DR   GEO; GSM827477

RX   PubMed=8521416;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 12

ST   TH01: 6,7

ST   TPOX: 9,11

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3756 ! NL20

SX   Female

CA   Transformed cell line

//

ID   NL9980

AC   CVCL_X187

RX   PubMed=21310132;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X186 ! WCQH-9801

CA   Cancer cell line

//

ID   NLF

AC   CVCL_E217

DR   Cosmic; 697276

DR   Cosmic; 717423

DR   Cosmic; 848928

DR   Cosmic; 923824

DR   Cosmic; 930072

DR   Cosmic; 1019953

DR   Cosmic; 1162000

DR   Cosmic; 1526638

DR   Cosmic; 2393639

RX   DOI=10.1007/0-306-46872-7_2;

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=6888561;

RX   PubMed=11550280;

RX   PubMed=23202128;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NLS-6-5

AC   CVCL_U863

DR   CLO; CLO_0050416

DR   RCB; RCB0733

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NM-1

AC   CVCL_3074

DR   JCRB; JCRB0155

DR   JCRB; NIHS0232

CC   Characteristics: Estimated life-span is 110 PDL.

CC   Discontinued: JCRB; NIHS0232; true.

OX   NCBI_TaxID=9913; ! Bos taurus

CA   Finite cell line

//

ID   NM-1/E

AC   CVCL_8302

DR   JCRB; JCRB0155.1

CC   Discontinued: JCRB; JCRB0155.1; probable.

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_3074 ! NM-1

CA   Finite cell line

//

ID   NM-1/F

AC   CVCL_8303

DR   JCRB; JCRB0155.2

CC   Discontinued: JCRB; JCRB0155.2; probable.

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_3074 ! NM-1

CA   Finite cell line

//

ID   NM-D4

AC   CVCL_IQ44

SY   K562-D4

RX   Patent=US8283161;

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2605.

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0004 ! K-562

SX   Female

CA   Cancer cell line

//

ID   NM-F9

AC   CVCL_IQ45

SY   K562-F9

RX   Patent=US8283161;

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2606.

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0004 ! K-562

SX   Female

CA   Cancer cell line

//

ID   NM-M2

AC   CVCL_L772

DR   KCLB; 60024

CC   Breed/subspecies: Wistar Furth.

DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_L175 ! TMT-081NM

SX   Female

CA   Cancer cell line

//

ID   NM-M2/TC

AC   CVCL_M053

DR   KCLB; 60026

CC   Breed/subspecies: Wistar Furth.

DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_L772 ! NM-M2

SX   Female

CA   Cancer cell line

//

ID   NM008

AC   CVCL_W755

DR   Cosmic; 929203

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM1007

AC   CVCL_W756

DR   Cosmic; 929207

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM11

AC   CVCL_X014

RX   PubMed=8609053;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C120044; Mouse colon adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0240 ! MC-26

SX   Female

CA   Cancer cell line

//

ID   NM112

AC   CVCL_W757

DR   Cosmic; 929198

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM123

AC   CVCL_W758

SY   Nm123

DR   Cosmic; 929199

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM16

AC   CVCL_W759

DR   Cosmic; 929194

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM176

AC   CVCL_W760

DR   Cosmic; 929200

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM177

AC   CVCL_W761

SY   Nm177

DR   Cosmic; 929195

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM179

AC   CVCL_W762

DR   Cosmic; 929205

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM182

AC   CVCL_W763

DR   Cosmic; 929193

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM2C5

AC   CVCL_B064

SY   NM-2C5

DR   ATCC; CRL-2918

DR   BioSample; SAMN03151834

RX   PubMed=14506175;

WW   http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0417 ! MDA-MB-435

SX   Male

CA   Cancer cell line

//

ID   NM2C5 GFP

AC   CVCL_B065

SY   NM2C5-GFP; NM-2C5-GFP

DR   ATCC; CRL-2919

RX   PubMed=14506175;

WW   http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx

CC   Problematic cell line: Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B064 ! NM2C5

SX   Male

CA   Cancer cell line

//

ID   NM39

AC   CVCL_W764

DR   Cosmic; 929204

DR   Cosmic; 1102378

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM47

AC   CVCL_W765

DR   Cosmic; 929196

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NM78-AM

AC   CVCL_W286

RX   PubMed=20590915;

DI   NCIt; C5915; Oral cavity mucosal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W287 ! NM78-MM

SX   Female

CA   Cancer cell line

//

ID   NM78-MM

AC   CVCL_W287

RX   PubMed=20590915;

CC   Doubling time: 62 hours (at 5th passage), 55 hours (at 21th passage) (PubMed=20590915).

DI   NCIt; C5915; Oral cavity mucosal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W286 ! NM78-AM

SX   Female

CA   Cancer cell line

//

ID   NM87-26Xt

AC   CVCL_1Q39

SY   NM87-26XT

RX   PubMed=8314575;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1Q38 ! GM07965

HI   CVCL_4595 ! UV135

CA   Hybrid cell line

//

ID   NM88

AC   CVCL_W766

SY   Nm88

DR   Cosmic; 929197

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NMB

AC   CVCL_2143

DR   BTO; BTO:0005872

DR   BioSample; SAMN03473470

DR   Cosmic; 717422

DR   Cosmic; 848937

DR   Cosmic; 930073

DR   Cosmic; 1019940

DR   Cosmic; 1109119

DR   Cosmic; 1109368

DR   Cosmic; 1162001

DR   Cosmic; 1167991

DR   Cosmic; 1518072

DR   Cosmic; 1526639

DR   Cosmic; 1543774

DR   Cosmic; 2239465

DR   DSMZ; ACC-657

DR   GEO; GSM692862

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=922665;

RX   PubMed=3000378;

RX   PubMed=6888561;

RX   PubMed=11550280;

RX   PubMed=22213050;

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9,13

ST   D5S818: 11

ST   D7S820: 10

ST   TH01: 7,8

ST   TPOX: 7,9

ST   vWA: 17,18,20

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NMB-7

AC   CVCL_8901

SY   NMB7

DR   BTO; BTO:0003534

DR   Cosmic; 922654

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=7139592;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2143 ! NMB

SX   Female

CA   Cancer cell line

//

ID   NMC-G1

AC   CVCL_1608

SY   NMCG-1; NMCG1; National Medical Center-Glioma 1

DR   BioSample; SAMN03472793

DR   CCLE; NMCG1_CENTRAL_NERVOUS_SYSTEM

DR   CGH-DB; 150-1

DR   ChEMBL-Cells; CHEMBL3308842

DR   ChEMBL-Targets; CHEMBL2366349

DR   Cosmic; 685874

DR   Cosmic; 908449

DR   Cosmic; 1746963

DR   Cosmic; 2302335

DR   Cosmic; 2367540

DR   Cosmic-CLP; 908449

DR   GDSC; 908449

DR   GEO; GSM326197

DR   GEO; GSM887457

DR   GEO; GSM888537

DR   GEO; GSM1670280

DR   IFO; IFO50467

RX   PubMed=8428960;

RX   PubMed=16232199;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,13

ST   D16S539: 10,13

ST   D5S818: 12

ST   D7S820: 8,12

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   nMED1

AC   CVCL_IR47

RX   PubMed=20978004;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   nMED2

AC   CVCL_IR48

RX   PubMed=20978004;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NMFH-1 [JCRB]

AC   CVCL_AT70

DR   JCRB; JCRB1507

CC   Caution: There seems to be two NMFH-1 cell lines, both from myxofibrosarcomas (malignant fibrous histiocytomas). One from Niigata University (Kawashima H. et al) established from a 89 year old male and distributed by RCB, and one from Shimada Y. established from a 43 year old male and distributed by JCRB. The two cell lines have very different STR profiles.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 9,12

ST   D5S818: 10,12

ST   D7S820: 8,11

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 14,20

DI   NCIt; C6496; Myxofibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NMFH-1 [RCB]

AC   CVCL_4661

SY   NMFH1

DR   CLO; CLO_0050023

DR   BioSample; SAMN03471964

DR   Cosmic; 1172182

DR   RCB; RCB2346

RX   PubMed=15173092;

RX   PubMed=16080955;

RX   PubMed=19335880;

RX   PubMed=25760144;

CC   Caution: There seems to be two NMFH-1 cell lines, both from myxofibrosarcomas (malignant fibrous histiocytomas). One from Niigata University (Kawashima H. et al) established from a 89 year old male and distributed by RCB, and one from Shimada Y. established from a 43 year old male and distributed by JCRB. The two cell lines have very different STR profiles.

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 13,14

ST   D13S317: 8,11

ST   D16S539: 12

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 8,10

ST   vWA: 14,18

DI   NCIt; C6496; Myxofibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NMFH-2

AC   CVCL_4W18

SY   NMFH2

DR   GEO; GSM1098532

RX   PubMed=19335880;

DI   NCIt; C6496; Myxofibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NMR-1

AC   CVCL_B912

DR   ISCR; 2229

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=533

CC   From: University of Texas Health Science Center at Houston; Houston; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0159.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   NMR52

AC   CVCL_J707

DR   CLO; CLO_0050339

DR   RCB; RCB2039

CC   Monoclonal antibody target: nLc4Cer.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   NMS-2

AC   CVCL_4662

DR   CLO; CLO_0050138

DR   BioSample; SAMN03471965

DR   Cosmic; 1319814

DR   RCB; RCB2347

RX   PubMed=9849858;

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 12,13

ST   D7S820: 9,12

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 14,19

DI   NCIt; C3798; Malignant peripheral nerve sheath tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L810 ! NMS-2PC

SX   Male

CA   Cancer cell line

//

ID   NMS-2PC

AC   CVCL_L810

RX   PubMed=9849858;

DI   NCIt; C3798; Malignant peripheral nerve sheath tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4662 ! NMS-2

SX   Male

CA   Cancer cell line

//

ID   NMSG 10

AC   CVCL_M832

SY   NMSG10

RX   PubMed=1962790;

RX   PubMed=8927571;

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NMU

AC   CVCL_3563

DR   CLO; CLO_0008183

DR   CLDB; cl3718

DR   ATCC; CRL-1743

DR   BCRC; 60099

RX   PubMed=7118137;

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Cancer cell line

//

ID   NMu2Li

AC   CVCL_S358

DR   ATCC; CRL-6446

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6446; true.

CC   Breed/subspecies: Namru.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   NMu3Li

AC   CVCL_6424

DR   CLO; CLO_0008184

DR   ATCC; CRL-6447

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Breed/subspecies: Namru.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   NMuLi

AC   CVCL_6425

DR   CLO; CLO_0008185

DR   ATCC; CRL-1638

DR   ATCC; CRL-6591

DR   IZSLER; BS CL 164

RX   PubMed=4366196;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6591; true.

CC   Breed/subspecies: Namru.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   NMuMG

AC   CVCL_0075

DR   BTO; BTO:0004183

DR   CLO; CLO_0008186

DR   CLDB; cl3719

DR   ATCC; CRL-1636

DR   BCRC; 60087

DR   ECACC; 94081121

DR   IZSLER; BS CL 188

RX   PubMed=4366196;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-151.html

CC   Breed/subspecies: Namru.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NMuMG-Fucci

AC   CVCL_E069

DR   CLO; CLO_0050967

DR   RCB; RCB2813

RX   PubMed=18267078;

CC   Breed/subspecies: Namru.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0075 ! NMuMG

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NMuMG-Fucci2

AC   CVCL_U135

DR   CLO; CLO_0050968

DR   RCB; RCB2868

CC   Breed/subspecies: Namru.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0075 ! NMuMG

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NMuMG-ST

AC   CVCL_5U35

RX   PubMed=9855001;

CC   Breed/subspecies: Namru.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0075 ! NMuMG

SX   Female

CA   Transformed cell line

//

ID   NN

AC   CVCL_Z600

RX   PubMed=8943096;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Z601 ! NNR

SX   Female

CA   Cancer cell line

//

ID   NN-1

AC   CVCL_Z283

DR   NISES; SK0032

RX   CelloPub=CLPUB00181;

RX   DOI=10.2183/pjab.60.198;

CC   Group: Insect cell line.

OX   NCBI_TaxID=1563985; ! Nephotettix nigropictus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NN-3

AC   CVCL_G674

DR   CLO; CLO_0008187

DR   ATCC; HB-8474

RX   Patent=US4752582;

CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (with L-20 and E-24; recognizes N blood group antigen).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   NN-4

AC   CVCL_G675

DR   CLO; CLO_0008188

DR   ATCC; HB-8473

RX   Patent=US4752582;

CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (with L-20 and E-24; recognizes N blood group antigen).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   NN-5

AC   CVCL_G676

DR   CLO; CLO_0008189

DR   ATCC; HB-8476

RX   Patent=US4752582;

CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (with L-20 and E-24; recognizes N blood group antigen).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   NNR

AC   CVCL_Z601

RX   PubMed=8943096;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Z600 ! NN

SX   Female

CA   Cancer cell line

//

ID   No Per

AC   CVCL_3321

DR   CLO; CLO_0008190

DR   ATCC; CRL-1327

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   NO0001

AC   CVCL_8Y24

DR   ECACC; 02032223

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C35078; Tourette syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   NO36

AC   CVCL_2658

DR   CBA; CBA-0142

DR   Cosmic; 1522764

DR   Cosmic; 1963331

DR   ECACC; 10092312

DR   GEO; GSM796439

RX   PubMed=1703129;

RX   PubMed=21642991;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NOC-S

AC   CVCL_W495

RX   PubMed=2085480;

DI   NCIt; C4878; Lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NOC-Ts

AC   CVCL_W496

RX   PubMed=1958631;

DI   NCIt; C3752; Embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NoCa1

AC   CVCL_HB90

DR   GEO; GSM29783

DR   GEO; GSM29784

DR   GEO; GSM29785

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa10

AC   CVCL_HB99

DR   GEO; GSM29816

DR   GEO; GSM29817

DR   GEO; GSM29819

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa11

AC   CVCL_HC00

DR   GEO; GSM29821

DR   GEO; GSM29822

DR   GEO; GSM29823

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa12

AC   CVCL_HC01

DR   GEO; GSM29824

DR   GEO; GSM29825

DR   GEO; GSM29826

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa13

AC   CVCL_HC02

DR   GEO; GSM29827

DR   GEO; GSM29828

DR   GEO; GSM29829

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa14

AC   CVCL_HC03

DR   GEO; GSM29830

DR   GEO; GSM29831

DR   GEO; GSM29832

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa15

AC   CVCL_HC04

DR   GEO; GSM29833

DR   GEO; GSM29834

DR   GEO; GSM29835

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa2

AC   CVCL_HB91

DR   GEO; GSM29786

DR   GEO; GSM29787

DR   GEO; GSM29788

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa3

AC   CVCL_HB92

DR   GEO; GSM29789

DR   GEO; GSM29790

DR   GEO; GSM29791

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa4

AC   CVCL_HB93

DR   GEO; GSM29792

DR   GEO; GSM29793

DR   GEO; GSM29794

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa5

AC   CVCL_HB94

DR   GEO; GSM29795

DR   GEO; GSM29796

DR   GEO; GSM29797

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa6

AC   CVCL_HB95

DR   GEO; GSM29798

DR   GEO; GSM29799

DR   GEO; GSM29800

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa7

AC   CVCL_HB96

DR   GEO; GSM29801

DR   GEO; GSM29802

DR   GEO; GSM29803

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa8

AC   CVCL_HB97

DR   GEO; GSM29804

DR   GEO; GSM29805

DR   GEO; GSM29806

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NoCa9

AC   CVCL_HB98

DR   GEO; GSM29807

DR   GEO; GSM29814

DR   GEO; GSM29815

RX   PubMed=15096622;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NOCC

AC   CVCL_GQ01

RX   PubMed=27541369;

CC   Doubling time: ~29 hours (PubMed=27541369).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NOD.ESA

AC   CVCL_U868

DR   RCB; AES0118

DR   RCB; RCB2608

CC   Discontinued: RCB; RCB2608; true.

CC   Breed/subspecies: NOD.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   Nody-1

AC   CVCL_L368

RX   PubMed=23196801;

CC   Doubling time: 21.5 hours (PubMed=23196801).

CC   Breed/subspecies: Shiba.

DI   NCIt; C128121; Canine lymphoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   NOE

AC   CVCL_W381

RX   PubMed=17645726;

CC   Doubling time: 15.5 hours (PubMed=17645726).

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NOF137

AC   CVCL_2G71

SY   Normal Ovarian Fibroblast 137

RX   PubMed=17060621;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   NOF150

AC   CVCL_2G72

SY   Normal Ovarian Fibroblast 150

RX   PubMed=17060621;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   NOF151

AC   CVCL_2G73

SY   Normal Ovarian Fibroblast 151

DR   EFO; EFO_0006699

RX   PubMed=17060621;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   NOF151-hTERT

AC   CVCL_2G76

SY   NOF151-hTert

DR   GEO; GSE40266

CC   Transfected with: HGNC; 11730; TERT.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2G73 ! NOF151

SX   Female

CA   Telomerase immortalized cell line

//

ID   NOG8

AC   CVCL_5846

RX   PubMed=3127778;

CC   Breed/subspecies: Namru.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0075 ! NMuMG

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NoGFP-CD16.NK92

AC   CVCL_V429

DR   ATCC; PTA-6967

RX   Patent=US8313943;

CC   Transfected with: HGNC; 3619; FCGR3A (with V-176).

DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2142 ! NK-92

SX   Male

CA   Cancer cell line

//

ID   NOI-90

AC   CVCL_8462

DR   BioSample; SAMN03151906

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a Reh derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1650 ! Reh

SX   Female

CA   Cancer cell line

//

ID   NOK-SI

AC   CVCL_BW57

SY   NOKSI; NOKsi; Normal Oral Keratinocytes-Spontaneously Immortalized

DR   Cosmic; 2296312

RX   PubMed=20463891;

RX   PubMed=25275298;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

ST   Source(s): PubMed=25275298

ST   Amelogenin: X

ST   CSF1PO: 9,11

ST   D13S317: 10,12

ST   D16S539: 9,12

ST   D18S51: 12

ST   D21S11: 28,30.2

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 9,11

ST   D8S1179: 14

ST   FGA: 24

ST   Penta D: 11,13

ST   Penta E: 7,12

ST   TH01: 9.3

ST   TPOX: 11,12

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NOL-3

AC   CVCL_Y587

RX   CelloPub=CLPUB00157;

RX   PubMed=1465024;

RX   PubMed=9737686;

RX   PubMed=9738977;

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   nOLIG1

AC   CVCL_IR51

RX   PubMed=20978004;

DI   NCIt; C3288; Oligodendroglioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NOM9-CT

AC   CVCL_AT83

SY   NOM9-TK; NOM9/TK; Normal oral mucosa 9-CDK4/TERT immortalized

RX   PubMed=20145189;

RX   PubMed=21868764;

CC   Transfected with: HGNC; 1773; CDK4.

CC   Transfected with: HGNC; 11730; TERT.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 11

ST   D5S818: 11,13

ST   D7S820: 11

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Telomerase immortalized cell line

//

ID   NOM9/TKp53

AC   CVCL_AT84

RX   PubMed=21868764;

CC   Transfected with: HGNC; 1773; CDK4.

CC   Transfected with: HGNC; 11730; TERT.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 11

ST   D5S818: 11,13

ST   D7S820: 11

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_AT83 ! NOM9-CT

SX   Male

CA   Telomerase immortalized cell line

//

ID   NOMH-1

AC   CVCL_L038

RX   PubMed=23379414;

CC   Doubling time: 273 hours (PubMed=23379414).

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NOMO-1

AC   CVCL_1609

SY   Nomo-1; NOMO1

DR   BTO; BTO:0005916

DR   BioSample; SAMN01821652

DR   BioSample; SAMN01821737

DR   BioSample; SAMN03473105

DR   CCLE; NOMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308243

DR   ChEMBL-Targets; CHEMBL2366198

DR   Cosmic; 787464

DR   Cosmic; 908451

DR   Cosmic; 975286

DR   Cosmic; 1281342

DR   Cosmic; 1523827

DR   Cosmic; 1524839

DR   Cosmic; 2131550

DR   Cosmic; 2297030

DR   Cosmic; 2306229

DR   Cosmic-CLP; 908451

DR   DSMZ; ACC-542

DR   GDSC; 908451

DR   GEO; GSM236799

DR   GEO; GSM236835

DR   GEO; GSM482496

DR   GEO; GSM887458

DR   GEO; GSM888538

DR   GEO; GSM1374774

DR   GEO; GSM1670283

DR   IFO; IFO50474

RX   PubMed=9738977;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 55 hours (PubMed=25984343); ~35 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,10

ST   D16S539: 9,11

ST   D18S51: 17,22

ST   D21S11: 29,32.2

ST   D3S1358: 15,17

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   D8S1179: 13,14

ST   FGA: 21,22

ST   Penta D: 9,12

ST   Penta E: 15,17

ST   TH01: 6,9

ST   TPOX: 8,12

ST   vWA: 17,18

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NOMO-1/ADM

AC   CVCL_3077

DR   GEO; GSM827275

DR   JCRB; JCRB1069

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1609 ! NOMO-1

SX   Female

CA   Cancer cell line

//

ID   NOMO-1s

AC   CVCL_3078

DR   IFO; IFO50475

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,10

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 8,10

ST   TH01: 6,9

ST   TPOX: 8,12

ST   vWA: 17,18

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1609 ! NOMO-1

SX   Female

CA   Cancer cell line

//

ID   NON,L

AC   CVCL_E795

SY   NON, L

DR   dbMHC; 48989

DR   ECACC; 94082292

DR   IHW; IHW9192

DR   IMGT/HLA; 11734

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl192.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   NOP-1

AC   CVCL_M503

SY   NOP1

RX   CelloPub=CLPUB00090;

RX   PubMed=9737686;

RX   PubMed=9738977;

RX   PubMed=10557056;

RX   PubMed=10936422;

RX   PubMed=11429052;

RX   PubMed=12886255;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NOP-2

AC   CVCL_M502

SY   NOP2

RX   PubMed=1747447;

RX   PubMed=9738977;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NOR-10

AC   CVCL_3939

SY   NOR 10; NOR10; Nor10; Normal fibroblast-10

DR   CLO; CLO_0008191

DR   CLDB; cl3720

DR   CLDB; cl5238

DR   ATCC; CCL-197

DR   BCRC; 60121

DR   ECACC; 90112701

DR   IZSLER; BS CL 114

DR   KCLB; 10197

RX   PubMed=20889;

RX   PubMed=7065527;

CC   Breed/subspecies: C57BL/10.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   NOR-P1

AC   CVCL_4716

DR   BTO; BTO:0003533

DR   CLO; CLO_0050103

DR   BioSample; SAMN03472013

DR   RCB; RCB2139

DR   TKG; TKG 0630

RX   PubMed=10822130;

ST   Source(s): RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 7,10

ST   D13S317: 11

ST   D16S539: 10 (RCB)

ST   D16S539: 9,10 (TKG)

ST   D5S818: 10,11

ST   D7S820: 10,11

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NORIg 7.16.2

AC   CVCL_J853

DR   ECACC; 11060818

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   NOS-1 [Human HNSCC]

AC   CVCL_M837

RX   PubMed=11291288;

RX   PubMed=11337272;

CC   Doubling time: 16.1 hours, at 100th passage (PubMed=11337272).

DI   NCIt; C8171; Lower gingival squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NOS-1 [Human osteosarcoma]

AC   CVCL_1610

SY   NOS1

DR   CLO; CLO_0050812

DR   BioSample; SAMN03472210

DR   ChEMBL-Cells; CHEMBL3308836

DR   ChEMBL-Targets; CHEMBL2366141

DR   Cosmic; 925345

DR   Cosmic-CLP; 925345

DR   GDSC; 925345

DR   GEO; GSM1670284

DR   RCB; RCB1032

RX   PubMed=1449054;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; RCB

ST   Amelogenin: X

ST   CSF1PO: 9,13

ST   D13S317: 9,12

ST   D16S539: 10,12,13

ST   D5S818: 10,12

ST   D7S820: 8,13 (Cosmic-CLP)

ST   D7S820: 8,12,13 (RCB)

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 14,16

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NOS-1.C8

AC   CVCL_T745

RX   PubMed=8100098;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1610 ! NOS-1 [Human osteosarcoma]

SX   Male

CA   Cancer cell line

//

ID   NOS-10

AC   CVCL_4663

SY   NOS10

DR   CLO; CLO_0050013

DR   BioSample; SAMN03471966

DR   RCB; RCB2348

RX   PubMed=15173092;

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,13

ST   D13S317: 12

ST   D16S539: 9,11

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NOS-2

AC   CVCL_3351

SY   NOS2

DR   CLO; CLO_0050811

DR   BioSample; SAMN03472152

DR   RCB; RCB1033

RX   PubMed=1449054;

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9

ST   D5S818: 12

ST   D7S820: 8,11

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NOS1

AC   CVCL_T746

RX   PubMed=12767062;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NOS2

AC   CVCL_T747

SY   NOS-2

DR   BTO; BTO:0004923

RX   PubMed=12767062;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NOS4

AC   CVCL_4464

SY   NOS-4

DR   BTO; BTO:0004924

RX   PubMed=10403549;

RX   PubMed=11865194;

RX   PubMed=12767062;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NOSE-06

AC   CVCL_X010

SY   NOSE06

DR   BioSample; SAMN03151635

RX   PubMed=22710073;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a DOV13 derivative (PubMed=22710073).

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6774 ! DOV13

SX   Female

CA   Cancer cell line

//

ID   NOSE-07

AC   CVCL_X011

SY   NOSE07

DR   BioSample; SAMN03151636

RX   PubMed=22710073;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a DOV13 derivative (PubMed=22710073).

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6774 ! DOV13

SX   Female

CA   Cancer cell line

//

ID   NOTT1

AC   CVCL_A000

SY   NOTT-1; Nott 1; Nott1; UNOTe001-A

DR   hPSCreg; UNOTe001-A

DR   ISCR; 1390

RX   PubMed=20177995;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/nott-1.aspx

CC   From: University of Nottingham; Nottingham; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-07-001, Steering comm. appl. SCSC06-12.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NOTT2

AC   CVCL_A001

SY   NOTT-2; Nott 2; Nott2; UNOTe002-A

DR   hPSCreg; UNOTe002-A

DR   ISCR; 1391

RX   PubMed=20177995;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/nott-2.aspx

CC   From: University of Nottingham; Nottingham; UK.

CC   Registration: UK Stem Cell Bank (UKSCB); R-07-002, Steering comm. appl. SCSC06-31.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NOU-1

AC   CVCL_S912

SY   Nou-1; NOU1; AG13904

DR   CLO; CLO_0022358

DR   Coriell; AG13904

DR   Cosmic; 2030480

RX   PubMed=12419584;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NOV-31

AC   CVCL_DD17

DR   ATCC; CRL-11733

RX   Patent=US5710038;

RX   PubMed=11641787;

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-11733; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Novikoff-Hepatoma

AC   CVCL_1D01

SY   Novikoff Hepatoma; NK

DR   BTO; BTO:0000950

DR   CLS; 500373/p734_Novikoff_Hepatoma

DI   NCIt; C60416; Rat hepatocellular carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   NovrA2

AC   CVCL_4Y50

RX   PubMed=2433772;

RX   PubMed=2845588;

CC   Selected for resistance to: ChEBI; CHEBI:28368; Novobiocin.

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_1915 ! BHK-21 clone 13

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NovrA41

AC   CVCL_4Y51

RX   PubMed=2433772;

CC   Selected for resistance to: ChEBI; CHEBI:28368; Novobiocin.

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_1915 ! BHK-21 clone 13

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NOY1

AC   CVCL_0P30

SY   NOY-1; Nagoya Ovarian Yolk sac tumor cell line clone 1

DR   BTO; BTO:0005874

RX   PubMed=18547965;

RX   PubMed=21150160;

WW   https://www.kerafast.com/product/1280/human-ovarian-yolk-sac-tumor-cell-line-noy1

CC   Doubling time: 28 hours (PubMed=18547965).

DI   NCIt; C8107; Ovarian yolk sac tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0P31 ! NOY2

SX   Female

CA   Cancer cell line

//

ID   NOY1-CR

AC   CVCL_0P32

RX   PubMed=21150160;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C8107; Ovarian yolk sac tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0P30 ! NOY1

SX   Female

CA   Cancer cell line

//

ID   NOY2

AC   CVCL_0P31

SY   Nagoya Ovarian Yolk sac tumor cell line clone 2

RX   PubMed=18547965;

CC   Doubling time: 31 hours (PubMed=18547965).

DI   NCIt; C8107; Ovarian yolk sac tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0P30 ! NOY1

SX   Female

CA   Cancer cell line

//

ID   NOZ

AC   CVCL_3079

SY   NOZC-1

DR   BioSample; SAMN03472480

DR   Cosmic; 1122352

DR   JCRB; JCRB1033

DR   JCRB; NIHS0283

RX   DOI=10.1007/BF02348185;

RX   PubMed=3154020;

CC   Doubling time: 48 hours (JCRB).

CC   Discontinued: JCRB; NIHS0283; true.

CC   Derived from metastatic site: Ascites.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 8,12

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 19

DI   NCIt; C3844; Gallbladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NP cl.120

AC   CVCL_J900

DR   ECACC; 95040312

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   NP cl.25

AC   CVCL_J901

DR   ECACC; 95051114

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   NP-2

AC   CVCL_1R15

SY   NP 2; Case 4

DR   JCRB; JCRB1566

DR   RCB; RCB4498

RX   CelloPub=CLPUB00260;

RX   PubMed=8878451;

RX   PubMed=10551321;

RX   PubMed=18415661;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NP-2/APJ

AC   CVCL_1R19

RX   PubMed=11112502;

CC   Transfected with: HGNC; 339; APLNR.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R15 ! NP-2

SX   Male

CA   Cancer cell line

//

ID   NP-2/CCR3

AC   CVCL_1R20

RX   PubMed=11112502;

CC   Transfected with: HGNC; 1604; CCR3.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R15 ! NP-2

SX   Male

CA   Cancer cell line

//

ID   NP-2/CCR5

AC   CVCL_1R21

SY   NP2/CCR5

RX   PubMed=11112502;

CC   Transfected with: HGNC; 1606; CCR5.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R15 ! NP-2

SX   Male

CA   Cancer cell line

//

ID   NP-2/CCR8

AC   CVCL_1R22

RX   PubMed=11112502;

CC   Transfected with: HGNC; 1609; CCR8.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R15 ! NP-2

SX   Male

CA   Cancer cell line

//

ID   NP-2/CD4

AC   CVCL_1R18

SY   NP2/CD4; NP2-CD4

RX   PubMed=10329384;

RX   PubMed=11112502;

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R15 ! NP-2

SX   Male

CA   Cancer cell line

//

ID   NP-2/CD4/APJ

AC   CVCL_1R25

RX   PubMed=11112502;

CC   Transfected with: HGNC; 339; APLNR.

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R18 ! NP-2/CD4

SX   Male

CA   Cancer cell line

//

ID   NP-2/CD4/CCR3

AC   CVCL_1R26

RX   PubMed=11112502;

CC   Transfected with: HGNC; 1604; CCR3.

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R18 ! NP-2/CD4

SX   Male

CA   Cancer cell line

//

ID   NP-2/CD4/CCR5

AC   CVCL_1R27

SY   NP2/CD4/CCR5; NP2-CD4/CCR5; NP2/CD4/R5

RX   PubMed=11112502;

CC   Transfected with: HGNC; 1606; CCR5.

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R18 ! NP-2/CD4

SX   Male

CA   Cancer cell line

//

ID   NP-2/CD4/CCR8

AC   CVCL_1R28

RX   PubMed=11112502;

CC   Transfected with: HGNC; 1609; CCR8.

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R18 ! NP-2/CD4

SX   Male

CA   Cancer cell line

//

ID   NP-2/CD4/CXCR4

AC   CVCL_1R29

SY   NP2/CD4/CXCR4; NP2-CD4/CXCR4

RX   PubMed=11112502;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 2561; CXCR4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R18 ! NP-2/CD4

SX   Male

CA   Cancer cell line

//

ID   NP-2/CD4/GPR1

AC   CVCL_1R30

RX   PubMed=11112502;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 4463; GPR1.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R18 ! NP-2/CD4

SX   Male

CA   Cancer cell line

//

ID   NP-2/CXCR4

AC   CVCL_1R23

RX   PubMed=11112502;

CC   Transfected with: HGNC; 2561; CXCR4.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R15 ! NP-2

SX   Male

CA   Cancer cell line

//

ID   NP-2/GPR1

AC   CVCL_1R24

RX   PubMed=11112502;

CC   Transfected with: HGNC; 4463; GPR1.

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1R15 ! NP-2

SX   Male

CA   Cancer cell line

//

ID   NP-3

AC   CVCL_1R16

SY   NP 3; Case 2

DR   JCRB; JCRB1567

DR   RCB; RCB4504

RX   CelloPub=CLPUB00260;

RX   PubMed=8878451;

RX   PubMed=10551321;

RX   PubMed=18415661;

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D16S539: 11

ST   D5S818: 9,10

ST   D7S820: 10

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 17,19

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NP-5

AC   CVCL_1R17

SY   NP 5; Case 5; NB4135

DR   JCRB; JCRB1569

DR   RCB; RCB4505

RX   PubMed=8878451;

RX   PubMed=10551321;

RX   PubMed=18415661;

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 9

ST   D16S539: 10,12

ST   D5S818: 13

ST   D7S820: 12,13

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NP-8

AC   CVCL_4W66

SY   NP 8; Case 1

DR   JCRB; JCRB1608

RX   PubMed=8878451;

RX   PubMed=10551321;

RX   PubMed=18415661;

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,11

ST   D16S539: 11

ST   D5S818: 10,12

ST   D7S820: 11,12

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NP11

AC   CVCL_D557

SY   Nonparenchymal 11

RX   PubMed=9648910;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   NP26

AC   CVCL_D558

SY   Nonparenchymal 26

RX   PubMed=9648910;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   NP31

AC   CVCL_D559

SY   Nonparenchymal 31

RX   PubMed=9648910;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   NP32

AC   CVCL_D560

SY   Nonparenchymal 32

RX   PubMed=9648910;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   NP369

AC   CVCL_E796

DR   dbMHC; 48990

DR   ECACC; 94082255

DR   IHW; IHW9155

DR   IMGT/HLA; 11698

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl155.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NP39E6/E7

AC   CVCL_F754

RX   PubMed=12063178;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NP460hTert

AC   CVCL_X205

SY   NP460 hTert; NP460

RX   PubMed=16688717;

RX   PubMed=18196576;

CC   Transfected with: HGNC; 11730; TERT.

ST   Source(s): PubMed=18196576

ST   Amelogenin: X,Y

ST   CSF1PO: 13,14

ST   D13S317: 9,10

ST   D16S539: 11,12

ST   D18S51: 13,21

ST   D19S433: 15,15.2

ST   D21S11: 29,32.2

ST   D2S1338: 20,21

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   D8S1179: 13,14

ST   FGA: 22,25

ST   TH01: 7,10

ST   TPOX: 9,11

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Telomerase immortalized cell line

//

ID   NP69SV40T

AC   CVCL_F755

SY   NP69

DR   GEO; GSM375841

RX   PubMed=12063178;

RX   PubMed=18196576;

RX   PubMed=19724690;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): PubMed=18196576

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 10,12

ST   D16S539: 11,12

ST   D18S51: 13

ST   D19S433: 13,14,14.2

ST   D21S11: 31

ST   D2S1338: 19

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 15,16

ST   FGA: 21

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NPA

AC   CVCL_0467

AS   CVCL_6475

SY   NPA-87; NPA'87; NPA 87; NPA87; NPA87-1; UCLA NPA-87-1; UCLA NPA871

DR   BTO; BTO:0004771

DR   MCCL; MCC:0000365

DR   BioSample; SAMN03151835

DR   Cosmic; 685605

DR   Cosmic; 686727

DR   Cosmic; 849968

DR   Cosmic; 886547

DR   Cosmic; 918183

DR   Cosmic; 928835

DR   Cosmic; 931239

DR   Cosmic; 990533

DR   Cosmic; 1005456

DR   Cosmic; 1021384

DR   Cosmic; 1071908

DR   Cosmic; 1094772

DR   Cosmic; 1132596

DR   Cosmic; 1152122

DR   Cosmic; 1155264

DR   Cosmic; 1155328

DR   Cosmic; 1161613

DR   Cosmic; 1162848

DR   Cosmic; 1176608

DR   Cosmic; 1699416

DR   TOKU-E; 4068

RX   PubMed=8871538;

RX   PubMed=18713817;

RX   PubMed=20143388;

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=18713817, PubMed=20143388, PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.

CC   Derived from metastatic site: Subcutaneous; right buttock.

ST   Source(s): PubMed=18713817; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 9,13

ST   D18S51: 13,17

ST   D21S11: 30

ST   D3S1358: 14,16

ST   D5S818: 11,12

ST   D7S820: 8

ST   D8S1179: 13

ST   FGA: 21

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1395 ! M14

SX   Male

CA   Cancer cell line

//

ID   NPC-BM1

AC   CVCL_6007

RX   PubMed=9595045;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NPC-KT

AC   CVCL_X204

DR   TOKU-E; 4071

RX   PubMed=3008992;

RX   PubMed=6088881;

RX   PubMed=24991015;

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_X200 ! Ad-AH

CA   Hybrid cell line

//

ID   NPC-TW01

AC   CVCL_6008

SY   NPC-TW 01; NPC-tW01; TW 01; TW01; NPC-TW039; NPC-039; NPC-TW-039; NPC-TW 039; TW-039

DR   BTO; BTO:0004895

DR   ChEMBL-Cells; CHEMBL3307329

DR   ChEMBL-Targets; CHEMBL614202

DR   Cosmic; 1193459

DR   GEO; GSM378799

DR   GEO; GSM378800

DR   TOKU-E; 3584

RX   PubMed=2162997;

RX   PubMed=2397471;

RX   PubMed=7685844;

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NPC-TW02

AC   CVCL_6009

SY   NPC-TW 02; TW 02; TW02; NPC-TW076; NPC-076; NPC-TW-076; NPC-TW 076

DR   BTO; BTO:0003961

RX   PubMed=2162997;

RX   PubMed=7685844;

RX   PubMed=21617861;

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NPC-TW03

AC   CVCL_6010

SY   NPC-TW 03; TW 03; TW03

RX   PubMed=7685844;

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NPC-TW04

AC   CVCL_6011

SY   NPC-TW 04; TW 04; TW04

DR   BTO; BTO:0003962

DR   Cosmic; 1193460

RX   PubMed=7685844;

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NPC-TW05

AC   CVCL_6012

SY   NPC-TW 05; NPC.T.W.05; TW 05; TW05

RX   PubMed=7685844;

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NPC-TW06

AC   CVCL_6013

SY   NPC-TW 06; TW 06; TW06

DR   Cosmic; 1193461

RX   PubMed=7685844;

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NPC-TW07

AC   CVCL_6014

SY   NPC-TW 07; TW 07; TW07

RX   PubMed=7685844;

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NPC-TW08

AC   CVCL_6015

SY   NPC-TW 08; TW 08; TW08

RX   PubMed=7685844;

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NPC-TW09

AC   CVCL_6016

SY   NPC-TW 09; TW 09; TW09

RX   PubMed=7685844;

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NPC/HK1

AC   CVCL_7084

SY   HK1; HK-1

DR   BTO; BTO:0004899

DR   Cosmic; 755503

DR   Cosmic; 923772

DR   Cosmic; 1017618

DR   Cosmic; 1300997

RX   PubMed=6259064;

RX   PubMed=12645650;

RX   PubMed=18196576;

ST   Source(s): PubMed=18196576

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 9,11

ST   D18S51: 17

ST   D19S433: 14

ST   D21S11: 28,29

ST   D2S1338: 20,23

ST   D3S1358: 15

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   D8S1179: 11,13

ST   FGA: 26

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 18,19

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NPK

AC   CVCL_9T10

SY   Newborn Pig Kidney

DR   IZSLER; BS CL 24

RX   PubMed=2555655;

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   NPLC/PRF/5

AC   CVCL_B449

SY   N-PLC/PRF/5

DR   BTO; BTO:0002906

RX   PubMed=2827003;

CC   Characteristics: Has lost chromosome Y.

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0485 ! PLC/PRF/5

SX   Male

CA   Cancer cell line

//

ID   NPN 43C9

AC   CVCL_L686

SY   NPN 43C9 (SCRF 43.3); NPN43C9

DR   ATCC; HB-9721

RX   Patent=US5126258;

RX   PubMed=3413482;

CC   Characteristics: Produces a catalytic monoclonal antibody that acts as an amidase.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   NPrEC

AC   CVCL_0061

SY   PrEC; Prostate Epithelial Cell

DR   BTO; BTO:0005301

DR   ChEMBL-Cells; CHEMBL3307346

DR   ChEMBL-Targets; CHEMBL614239

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   NPTh

AC   CVCL_9T11

SY   Newborn Pig Thyroid

DR   IZSLER; BS CL 124

RX   PubMed=8264428;

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   NPTr

AC   CVCL_8376

SY   Newborn Pig Trachea

DR   IZSLER; BS CL 176

RX   PubMed=12505635;

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   NR-1

AC   CVCL_6689

SY   NR1

RX   PubMed=302945;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NR-2

AC   CVCL_6690

SY   NR2

RX   PubMed=302945;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NR-3

AC   CVCL_6691

SY   NR3

RX   PubMed=302945;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NR-4

AC   CVCL_6692

SY   NR4

RX   PubMed=302945;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NR-5

AC   CVCL_6693

SY   NR5

RX   PubMed=302945;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NR-6

AC   CVCL_6694

SY   NR6

DR   BTO; BTO:0001867

RX   PubMed=302945;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NR-6-R

AC   CVCL_6695

SY   NR6R; NR6R-3T3

WW   http://www.unemed.com/wp-content/uploads/2012/07/a0I50000004Hbez-1_0.pdf

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6694 ! NR-6

CA   Spontaneously immortalized cell line

//

ID   NR-7

AC   CVCL_6696

SY   NR7

RX   PubMed=302945;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NR-8

AC   CVCL_6697

SY   NR8

RX   PubMed=302945;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NR6M

AC   CVCL_6698

RX   PubMed=8845302;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6694 ! NR-6

CA   Spontaneously immortalized cell line

//

ID   NR6V

AC   CVCL_6699

RX   PubMed=8845302;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6694 ! NR-6

CA   Spontaneously immortalized cell line

//

ID   NR6W

AC   CVCL_6700

RX   PubMed=8845302;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6694 ! NR-6

CA   Spontaneously immortalized cell line

//

ID   NR8383

AC   CVCL_4396

SY   NR-8383; NR 8383; NR8383.1; AgC11x3A; Normal Rat, August 3, 1983

DR   BTO; BTO:0002907

DR   CLO; CLO_0008193

DR   ATCC; CRL-2192

DR   BCRC; 60423

DR   CCRID; 3131C0001000500009

DR   KCB; KCB 2010189YJ

RX   PubMed=2914814;

RX   PubMed=3497918;

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Spontaneously immortalized cell line

//

ID   NRbM

AC   CVCL_4397

DR   CLO; CLO_0008194

DR   ATCC; CRL-1839

DR   ECACC; 91073008

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   NRCC

AC   CVCL_U280

SY   LoMeT-ccRcc

RX   Patent=CN101550407A;

RX   PubMed=23442546;

RX   PubMed=27993170;

CC   Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C200910.

CC   Doubling time: 35.5 hours (PubMed=23442546).

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NRCE

AC   CVCL_9Y58

SY   New-zealand white Rabbit Corneal Endothelial cells

RX   PubMed=19503740;

CC   Breed/subspecies: New Zealand white.

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NRG

AC   CVCL_5565

DR   CLO; CLO_0051028

DR   JCRB; JCRB1138

DR   RCB; RCB1921

CC   Breed/subspecies: C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_L287 ! KUSA

SX   Female

CA   Adult stem cell

//

ID   NRK

AC   CVCL_3758

SY   Normal Rat Kidney

DR   CLO; CLO_0008195

DR   CLO; CLO_0051425

DR   CLDB; cl3724

DR   CLDB; cl3725

DR   ATCC; CRL-6509

DR   CCRID; 3111C0001CCC000198

DR   CCRID; 3131C0001000500002

DR   CCRID; 3142C0001000000081

DR   ChEMBL-Cells; CHEMBL3307266

DR   ChEMBL-Targets; CHEMBL613518

DR   ECACC; 86032002

DR   KCB; KCB 92014YJ

DR   RCB; RCB0043

DR   TOKU-E; 2772

WW   http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/nrk/nrkcells.html

CC   Breed/subspecies: Osborne-Mendel.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Spontaneously immortalized cell line

//

ID   NRK-49F

AC   CVCL_2144

SY   NRK 49F; NRK49F; NRK clone 49F; Normal Rat Kidney-49F

DR   BTO; BTO:0002409

DR   CLO; CLO_0008196

DR   CLO; CLO_0008197

DR   CLO; CLO_0051426

DR   CLDB; cl3726

DR   CLDB; cl3727

DR   CLDB; cl3728

DR   CLDB; cl3729

DR   CLDB; cl3730

DR   CLDB; cl3731

DR   ATCC; CRL-1570

DR   BCRC; 60084

DR   ChEMBL-Cells; CHEMBL3308395

DR   ChEMBL-Targets; CHEMBL614203

DR   CLS; 500427/p718_NRK-49F

DR   DSMZ; ACC-172

DR   ECACC; 86101301

DR   IZSLER; BS CL 71

DR   IFO; IFO50481

DR   JCRB; JCRB9067

DR   RCB; RCB0112

RX   PubMed=304450;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=NRK-49F

CC   Doubling time: ~30-40 hours (DSMZ).

CC   Breed/subspecies: Osborne-Mendel.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3758 ! NRK

CA   Spontaneously immortalized cell line

//

ID   NRK-4xlambdaN22-3xmEGFP-M9

AC   CVCL_AV97

DR   CLS; 500672/p6173_NRK-4xlambdaN22-3xmEGFP-M9_growing

RX   PubMed=17603490;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Breed/subspecies: Osborne-Mendel.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3758 ! NRK

CA   Spontaneously immortalized cell line

//

ID   NRK-52E

AC   CVCL_0468

SY   NRK 52E; NRK52E; NRK clone 52E; Normal Rat Kidney-52E; NRK-E52

DR   BTO; BTO:0002408

DR   CLO; CLO_0008198

DR   MCCL; MCC:0000366

DR   CLDB; cl3732

DR   CLDB; cl3733

DR   ATCC; CRL-1571

DR   BCRC; 60086

DR   CCRID; 3131C0001000500008

DR   DSMZ; ACC-199

DR   ECACC; 87012902

DR   IFO; IFO50480

DR   TOKU-E; 2774

RX   PubMed=304450;

RX   PubMed=7732277;

CC   Doubling time: ~45 hours (DSMZ).

CC   Breed/subspecies: Osborne-Mendel.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3758 ! NRK

CA   Spontaneously immortalized cell line

//

ID   NRK-EGFP-H2B

AC   CVCL_AV92

DR   CLS; 500724/p6175_NRK-EGFP-H2B

RX   PubMed=17558394;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Breed/subspecies: Osborne-Mendel.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3758 ! NRK

CA   Spontaneously immortalized cell line

//

ID   NRK-EGFP2-Nup50

AC   CVCL_AV93

DR   CLS; 500726/p6185_NRK-EGFP2-Nup50_growing

RX   PubMed=15502822;

CC   Transfected with: RGD; 3191; Npap60.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Breed/subspecies: Osborne-Mendel.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3758 ! NRK

CA   Spontaneously immortalized cell line

//

ID   NRK-EGFP3-Seh1

AC   CVCL_AV94

DR   CLS; 500731/p6187_NRK-EGFP3-Seh1

RX   PubMed=15502822;

CC   Transfected with: RGD; 6490353; Seh1l.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Breed/subspecies: Osborne-Mendel.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3758 ! NRK

CA   Spontaneously immortalized cell line

//

ID   NRK-IBB-DiHcRed1

AC   CVCL_AV95

DR   CLS; 500671/p6180_NRK-IBB-DiHcRed1

RX   PubMed=19804719;

CC   Transfected with: UniProtKB; Q95W85; HcRed.

CC   Breed/subspecies: Osborne-Mendel.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3758 ! NRK

CA   Spontaneously immortalized cell line

//

ID   NRK-Pom121-EGFP3

AC   CVCL_AV96

SY   NRK-Pom121-3EGFP

DR   CLS; 500669/p866_NRK-Pom121-3EGFP

RX   PubMed=15502822;

CC   Transfected with: RGD; 620680; Pom121.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Breed/subspecies: Osborne-Mendel.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3758 ! NRK

CA   Spontaneously immortalized cell line

//

ID   NRm

AC   CVCL_DR18

SY   NRL2

DR   CCRID; 3153C0001000000031

DR   KCB; KCB 85008M

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Sex undetermined

CA   Undefined cell line type

//

ID   NRP-152

AC   CVCL_4869

SY   NRP152

DR   BTO; BTO:0001349

RX   PubMed=8012960;

RX   PubMed=8912849;

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

CC   Transformant: ChEBI; CHEBI:9466; Testosterone propionate.

CC   Breed/subspecies: Lobund-Wistar (L-W).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   NRP-154

AC   CVCL_4870

SY   NRP154

DR   BTO; BTO:0001352

RX   PubMed=8012960;

RX   PubMed=8912849;

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

CC   Transformant: ChEBI; CHEBI:9466; Testosterone propionate.

CC   Breed/subspecies: Lobund-Wistar (L-W).

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   NRS-1

AC   CVCL_4871

DR   CLO; CLO_0050021

DR   BioSample; SAMN03472176

DR   RCB; RCB1188

RX   PubMed=7599791;

RX   PubMed=23882450;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 11,12

ST   D7S820: 8

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 18,20

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NS-1-503

AC   CVCL_J593

RX   PubMed=6869833;

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Cancer cell line

//

ID   NS-10

AC   CVCL_C799

SY   IMHe013-A

DR   hPSCreg; IMHe013-A

DR   ISCR; 1135

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NS-3 [Human colon carcinoma]

AC   CVCL_8377

DR   BioSample; SAMN03151625

DR   JCRB; JCRB1076

DR   JCRB; NIHS0335

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a COLO 201 derivative (PubMed=20143388).

CC   Discontinued: JCRB; JCRB1076; true.

CC   Discontinued: JCRB; NIHS0335; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 10,12

ST   D16S539: 12,13

ST   D5S818: 10,13

ST   D7S820: 9,10

ST   TH01: 8,9

ST   TPOX: 11

ST   vWA: 15

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1987 ! COLO 201

SX   Male

CA   Cancer cell line

//

ID   NS-3 [Human ESC]

AC   CVCL_C800

SY   IMHe001-A

DR   hPSCreg; IMHe001-A

DR   ISCR; 1136

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NS-4

AC   CVCL_C801

SY   IMHe002-A

DR   hPSCreg; IMHe002-A

DR   ISCR; 1137

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NS-5

AC   CVCL_C802

SY   IMHe003-A

DR   hPSCreg; IMHe003-A

DR   ISCR; 1138

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NS-6

AC   CVCL_C803

SY   IMHe004-A

DR   hPSCreg; IMHe004-A

DR   ISCR; 1139

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NS-7

AC   CVCL_C804

SY   IMHe005-A

DR   hPSCreg; IMHe005-A

DR   ISCR; 1140

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NS-8 [Human ESC]

AC   CVCL_C805

SY   IMHe006-A

DR   hPSCreg; IMHe006-A

DR   ISCR; 1141

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NS-8 [Human gastric carcinoma]

AC   CVCL_G372

DR   TKG; TKG 0339

ST   Source(s): TKG

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,12

ST   D16S539: 13

ST   D5S818: 11

ST   D7S820: 10,12

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NS-9

AC   CVCL_C806

SY   IMHe012-A

DR   hPSCreg; IMHe012-A

DR   ISCR; 1142

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NS-Meg

AC   CVCL_S966

SY   NS-MEG

DR   Cosmic; 1012108

RX   PubMed=7719248;

RX   PubMed=16408098;

DI   NCIt; C7965; Adult acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NS0

AC   CVCL_3940

SY   NSO; NS/0; NS/O

DR   BTO; BTO:0004968

DR   CLO; CLO_0008203

DR   CLO; CLO_0008206

DR   CLO; CLO_0050179

DR   CLDB; cl3737

DR   CLDB; cl3738

DR   CLDB; cl3739

DR   ChEMBL-Cells; CHEMBL3307752

DR   ChEMBL-Targets; CHEMBL615003

DR   ECACC; 85110503

DR   IZSLER; BS TCL 48

DR   NCBI_Iran; C142

DR   RCB; RCB0213

DR   TKG; TKG 0594

DR   Wikidata; Q20164415

WW   https://en.wikipedia.org/wiki/NS0_cell

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

SX   Female

CA   Cancer cell line

//

ID   NS0-SFM

AC   CVCL_G345

SY   NSO-SFM; NS0-Serum-Free

DR   ECACC; 03061601

DR   TKG; TKG 0596

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

SX   Female

CA   Cancer cell line

//

ID   NS0-Turbodoma

AC   CVCL_G346

DR   ECACC; 06020202

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

SX   Female

CA   Cancer cell line

//

ID   NS0bcl-2

AC   CVCL_DD16

SY   NSObcl-2; NS0 Bcl-2; NSO-Bcl-2; NSO-bcl2; NS0-bcl2

DR   ATCC; CRL-11705

RX   Patent=US5565337;

RX   PubMed=8202525;

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Transfected with: HGNC; 990; BCL2.

CC   Discontinued: ATCC; CRL-11705; probable.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

SX   Female

CA   Cancer cell line

//

ID   NS1

AC   CVCL_IV58

SY   Nittby-Salford 1

RX   DOI=10.4172/2475-3203.1000101;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C64069; Rat malignant glioma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   NS20Y

AC   CVCL_0469

SY   NS-20Y; NS20-Y

DR   BTO; BTO:0002639

DR   CLO; CLO_0008205

DR   MCCL; MCC:0000367

DR   CLDB; cl3736

DR   DSMZ; ACC-94

DR   ECACC; 08062517

RX   PubMed=4400294;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-236.html

CC   Doubling time: ~30-50 hours (DSMZ).

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4343 ! C-1300

SX   Male

CA   Cancer cell line

//

ID   NS20Y-BU-2

AC   CVCL_4351

DR   ECACC; 08062502

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0469 ! NS20Y

SX   Male

CA   Cancer cell line

//

ID   NS20Y-BU-4

AC   CVCL_4352

DR   ECACC; 08062503

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0469 ! NS20Y

SX   Male

CA   Cancer cell line

//

ID   NS20Y-BU-5

AC   CVCL_4353

DR   ECACC; 08062504

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0469 ! NS20Y

SX   Male

CA   Cancer cell line

//

ID   NS20Y-BU-6

AC   CVCL_4354

DR   ECACC; 08062507

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0469 ! NS20Y

SX   Male

CA   Cancer cell line

//

ID   NS20Y-BU-7

AC   CVCL_4355

DR   ECACC; 08062510

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0469 ! NS20Y

SX   Male

CA   Cancer cell line

//

ID   NS20Y-TG

AC   CVCL_4356

DR   ECACC; 08062512

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: A/J.

DI   NCIt; C21993; Mouse neuroblastoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0469 ! NS20Y

SX   Male

CA   Cancer cell line

//

ID   NSC-34

AC   CVCL_D356

SY   NSC34

DR   BTO; BTO:0004488

RX   PubMed=17896795;

RX   PubMed=25193168;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU140?lob=Cellutions

CC   Omics: Deep proteome analysis.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybrid cell line

//

ID   NSC-H14

AC   CVCL_U174

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/nsc-h14.cmsx

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,13

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 15,16

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9775 ! WA14

SX   Male

CA   Adult stem cell

//

ID   NSC-H14iPSZeng

AC   CVCL_U175

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/nsc-h14ipszeng.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_U174 ! NSC-H14

SX   Male

CA   Adult stem cell

//

ID   NSC-H9

AC   CVCL_U176

RX   PubMed=19774075;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/nsc-h9.cmsx

ST   Source(s): WiCell

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9

ST   D16S539: 12,13

ST   D18S51: 13

ST   D21S11: 21

ST   D3S1358: 13,16

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 8,14

ST   FGA: 26,28

ST   Penta D: 9,13

ST   Penta E: 11,14

ST   TH01: 9.3

ST   TPOX: 10,11

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9773 ! WA09

SX   Female

CA   Adult stem cell

//

ID   NSCLC-N6

AC   CVCL_H623

SY   NSCLCN6

DR   ChEMBL-Cells; CHEMBL3307850

DR   ChEMBL-Targets; CHEMBL614016

RX   PubMed=1776865;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NSCLC-N6 clone C15

AC   CVCL_H624

RX   PubMed=9568077;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H623 ! NSCLC-N6

CA   Cancer cell line

//

ID   NSCLC-N6 clone C65

AC   CVCL_H625

RX   PubMed=9568077;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H623 ! NSCLC-N6

CA   Cancer cell line

//

ID   NSCLC-N6 clone C92

AC   CVCL_H626

RX   PubMed=9568077;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H623 ! NSCLC-N6

CA   Cancer cell line

//

ID   NSCLC-N6 clone C98

AC   CVCL_H627

RX   PubMed=9568077;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H623 ! NSCLC-N6

CA   Cancer cell line

//

ID   NSK

AC   CVCL_8378

SY   Newborn Swine Kidney

DR   IZSLER; BS CL 177

RX   PubMed=12505635;

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   NSK-RC

AC   CVCL_X542

DR   Cosmic; 849383

RX   PubMed=11146448;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NT-1 [Human leukemia]

AC   CVCL_X338

RX   PubMed=25012564;

DI   NCIt; C3519; Atypical chronic myeloid leukemia, BCR-ABL1 negative

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NT-1 [Human tongue SCC]

AC   CVCL_GZ02

RX   DOI=10.3353/omp.9.133;

CC   Doubling time: 26.8 hours (DOI=10.3353/omp.9.133).

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NT-2

AC   CVCL_GZ03

RX   DOI=10.3353/omp.9.133;

CC   Doubling time: 42.4 hours (DOI=10.3353/omp.9.133).

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NT-68

AC   CVCL_9713

RX   PubMed=1320624;

CC   From: Van Valen F.; University of Munster; Germany.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NT-8e

AC   CVCL_E328

RX   PubMed=9310268;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NT-92

AC   CVCL_2145

DR   DSMZ; ACC-639

RX   CelloPub=CLPUB00363;

CC   Doubling time: ~3-4 days (DSMZ).

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

CC   Breed/subspecies: Wistar-AF/Han.

DI   NCIt; C60372; Rat cholangiocarcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   NT-hESC

AC   CVCL_C807

SY   ITSe001-A

DR   hPSCreg; ITSe001-A

RX   PubMed=17112910;

CC   From: Civil Hospital Campus; India.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NT-hESC-1

AC   CVCL_M327

SY   SCNT-hES-1; NT-1; Sooam-hES1; Sooam-hES-1

RX   PubMed=14963337;

RX   PubMed=16410485;

RX   PubMed=24159464;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=14963337) has been retracted due to fraud (see PubMed=16410485).

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016006.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NT-hESC-10

AC   CVCL_M328

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NT-hESC-11

AC   CVCL_M329

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NT-hESC-12

AC   CVCL_M330

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NT-hESC-2

AC   CVCL_M331

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NT-hESC-3

AC   CVCL_M332

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NT-hESC-4

AC   CVCL_M333

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NT-hESC-5

AC   CVCL_M334

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NT-hESC-6

AC   CVCL_M335

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NT-hESC-7

AC   CVCL_M336

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NT-hESC-8

AC   CVCL_M337

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NT-hESC-9

AC   CVCL_M338

RX   PubMed=15905366;

RX   PubMed=16410485;

WW   http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0

CC   Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NT/T-S

AC   CVCL_D886

RX   PubMed=10875873;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   NT00669

AC   CVCL_V377

DR   IMGT/HLA; 14456

RX   PubMed=16948657;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   NT00670

AC   CVCL_V378

DR   IMGT/HLA; 14455

RX   PubMed=16948657;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   NT00671

AC   CVCL_V379

DR   IMGT/HLA; 14453

RX   PubMed=16948657;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   NT00672

AC   CVCL_V380

DR   IMGT/HLA; 14454

RX   PubMed=16948657;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   NT00673

AC   CVCL_V381

DR   IMGT/HLA; 14452

RX   PubMed=16948657;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   NT2-B9

AC   CVCL_4U33

SY   NT2/B9

RX   PubMed=6144603;

RX   PubMed=6694356;

CC   Derived from metastatic site: Lung.

DI   NCIt; C3752; Embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0034 ! NTERA-2

SX   Male

CA   Cancer cell line

//

ID   NT2-D1

AC   CVCL_3407

SY   NT2/D1; NT2D1; Nt2D1; NTERA-2 clone D1; NTERA2-cloneD1; NTERA-2 cl.D1; NTera2 cl.D1; NTERA-2cl.D1; NTera 2/cl.D1; NTERA-2/D1; NTera2/D1; Ntera2/D1; NTERA2-D1; NTera-2D1; NTERA2/D1; NTERA2D1; NTera2D1

DR   BTO; BTO:0000946

DR   CLO; CLO_0008207

DR   EFO; EFO_0005236

DR   CLDB; cl3740

DR   CLDB; cl5088

DR   ATCC; CRL-1973

DR   BCRC; 60356

DR   BCRJ; 0303

DR   ChEMBL-Cells; CHEMBL3307482

DR   ChEMBL-Targets; CHEMBL614206

DR   Cosmic; 687052

DR   Cosmic; 908454

DR   Cosmic; 1995598

DR   Cosmic; 2077191

DR   Cosmic; 2163756

DR   Cosmic-CLP; 908454

DR   ECACC; 01071221

DR   ENCODE; ENCBS374ENC

DR   ENCODE; ENCBS578HFO

DR   ENCODE; ENCBS631LTU

DR   ENCODE; ENCBS810EWQ

DR   GDSC; 908454

DR   GEO; GSM824855

DR   GEO; GSM824856

DR   GEO; GSM1040297

DR   GEO; GSM1040367

DR   GEO; GSM1670285

DR   ICLC; HTL97025

DR   IZSLER; BS TCL 204

RX   PubMed=3293662;

RX   PubMed=6144603;

RX   PubMed=6694356;

RX   PubMed=8411264;

RX   PubMed=23325432;

RX   PubMed=24812411;

RX   PubMed=27397505;

WW   https://en.wikipedia.org/wiki/NTERA-2

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/NT2-D1_protocol.pdf

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-113.html

CC   Part of: ENCODE project common cell types; tier 3.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: H3K9ac ChIP-seq epigenome analysis.

CC   Misspelling: 'NTERA-S-cl-D1' in Cosmic 1995598 and ChEMBL CHEMBL614206 and CHEMBL3307482.

CC   Misspelling: 'NTL-D1' in Cosmic 2077191.

CC   Misspelling: 'NT2101' in PubMed=24812411 and Cosmic 2163756.

CC   Derived from metastatic site: Lung.

ST   Source(s): ATCC; Cosmic-CLP; ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 11,12,13

ST   D5S818: 9,12

ST   D7S820: 10,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C3752; Embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0034 ! NTERA-2

SX   Male

CA   Cancer cell line

//

ID   NT2-D3

AC   CVCL_4U27

SY   NT2/D3; NT2 D3

RX   PubMed=6694356;

CC   Derived from metastatic site: Lung.

DI   NCIt; C3752; Embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0034 ! NTERA-2

SX   Male

CA   Cancer cell line

//

ID   NT2-N

AC   CVCL_7929

SY   NT2N; NTERA-2N; hNT

DR   BTO; BTO:0002574

CC   Derived from metastatic site: Lung.

DI   NCIt; C3752; Embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3407 ! NT2-D1

SX   Male

CA   Cancer cell line

//

ID   NT2-Rho0

AC   CVCL_K047

SY   NT-2 rho(0); NT-2 rho0; NT2 rho0

DR   BTO; BTO:0005075

RX   PubMed=16050988;

CC   Derived from metastatic site: Lung.

DI   NCIt; C3752; Embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0034 ! NTERA-2

SX   Male

CA   Cancer cell line

//

ID   NTERA-2

AC   CVCL_0034

SY   NTera-2; Ntera-2; NTera 2; NTERA2; NTera2; N-Tera-2; NT-2; NT2

DR   BTO; BTO:0000891

DR   CLO; CLO_0008208

DR   EFO; EFO_0002959

DR   BioSample; SAMN03472969

DR   CCRID; 3111C0001CCC000019

DR   ChEMBL-Cells; CHEMBL3308505

DR   ChEMBL-Targets; CHEMBL614205

DR   Cosmic; 821809

DR   Cosmic; 2439936

DR   DSMZ; ACC-527

DR   RSCB; RSCB0150

DR   Wikidata; Q17092091

RX   PubMed=3293662;

RX   PubMed=6694356;

RX   PubMed=16919167;

RX   PubMed=25485619;

WW   https://en.wikipedia.org/wiki/NTERA-2

WW   http://www.proteinatlas.org/learn/cellines

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Lung.

ST   Source(s): DSMZ; PubMed=16919167; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 11,12,13

ST   D18S51: 14

ST   D21S11: 30,31

ST   D3S1358: 16

ST   D5S818: 9,12

ST   D7S820: 10,12

ST   D8S1179: 13,15

ST   FGA: 23

ST   Penta D: 12,13

ST   Penta E: 5,14

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C3752; Embryonal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2777 ! Tera-2

SX   Male

CA   Cancer cell line

//

ID   NTES-2

AC   CVCL_E142

SY   NTES2

RX   PubMed=18253492;

CC   Breed/subspecies: 129.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   Nthy-ori 3-1

AC   CVCL_2659

SY   Nthy ori 3.1; Nthy-ori 3.1; NTHY-ORI3.1; HTori-3.1

DR   BTO; BTO:0004859

DR   CLO; CLO_0008209

DR   CLDB; cl3741

DR   ECACC; 90011609

DR   GEO; GSM827409

RX   PubMed=22087789;

RX   PubMed=21868764;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): ECACC; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 12,13

ST   D5S818: 11

ST   D7S820: 7,12

ST   TH01: 7

ST   TPOX: 9

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4W02 ! HTori-3

SX   Female

CA   Transformed cell line

//

ID   Nthy-ts1

AC   CVCL_2660

SY   N-thy-ts.1; ts.1

DR   CLO; CLO_0008210

DR   CLDB; cl3742

DR   ECACC; 90011610

RX   PubMed=1697930;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Conditionally immortalized cell line

//

ID   NTI-4

AC   CVCL_3080

DR   BioSample; SAMN03471658

DR   JCRB; JCRB0220

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 9,12

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   TH01: 7,8

ST   TPOX: 8

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   NTI-5

AC   CVCL_3081

DR   JCRB; JCRB0222

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 9,12

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   TH01: 7,8

ST   TPOX: 8

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   NTM-5

AC   CVCL_5G34

SY   NTM5; Normal Trabecular Meshwork-5; HTM-5; Human Trabecular Meshwork-5

RX   PubMed=8156826;

RX   PubMed=16303956;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5G32 ! HTM-4

SX   Male

CA   Transformed cell line

//

ID   NTU-G

AC   CVCL_M031

RX   PubMed=8473267;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NTU-LY-1

AC   CVCL_Z964

RX   PubMed=16989856;

CC   Group: Insect cell line.

OX   NCBI_TaxID=78901; ! Lymantria xylina

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NTU-LY-2

AC   CVCL_Z965

RX   PubMed=16989856;

CC   Group: Insect cell line.

OX   NCBI_TaxID=78901; ! Lymantria xylina

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NTU-LY-3

AC   CVCL_Z966

RX   PubMed=16989856;

CC   Group: Insect cell line.

OX   NCBI_TaxID=78901; ! Lymantria xylina

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NTU-LY-4

AC   CVCL_Z967

RX   PubMed=16989856;

CC   Group: Insect cell line.

OX   NCBI_TaxID=78901; ! Lymantria xylina

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NTU-MV

AC   CVCL_Z991

RX   PubMed=17521666;

CC   Group: Insect cell line.

CC   Doubling time: 46.53 hours (in 0% FBS), 33.29 hours (in 4% FBS), 27.76 hours (in 8% FBS), 27.24 hours (in 16% FBS), 37.47 hours (in Sf900 medium) (PubMed=17521666).

OX   NCBI_TaxID=497515; ! Maruca vitrata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NTU-Pn-HF

AC   CVCL_Z329

SY   NTU-PN-HF

RX   DOI=10.1303/aez.2002.171;

CC   Group: Insect cell line.

OX   NCBI_TaxID=497517; ! Perina nuda

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NTU-Pn-HH

AC   CVCL_Z328

SY   NTU-PN-HH; PN-HH

RX   PubMed=8812599;

CC   Group: Insect cell line.

OX   NCBI_TaxID=497517; ! Perina nuda

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NTU-SE

AC   CVCL_Z963

RX   PubMed=22867846;

CC   Group: Insect cell line.

CC   Doubling time: 35.5 hours (PubMed=22867846).

OX   NCBI_TaxID=7107; ! Spodoptera exigua

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NTU-YB

AC   CVCL_Z956

SY   YB

RX   PubMed=19761771;

CC   Group: Insect cell line.

CC   Doubling time: 38.85 hours (in 0% TNM-FH), 31.27 hours (in 5% TNM-FH), 26.87 hours (in 8% TNM-FH), 31.3 hours (in 16% TNM-FH) (PubMed=19761771).

OX   NCBI_TaxID=76203; ! Eurema hecabe

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   NTU1

AC   CVCL_C108

SY   NTUe001-A; National-Taiwan-University 1

DR   BCRC; SC81006

DR   GEO; GSM674604

DR   hPSCreg; NTUe001-A

DR   ISCR; 1649

RX   PubMed=17071820;

CC   From: National Taiwan University; Taiwan.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NTU2

AC   CVCL_C109

SY   NTUe002-A; National-Taiwan-University 2

DR   BCRC; SC81007

DR   hPSCreg; NTUe002-A

DR   ISCR; 1650

RX   PubMed=17071820;

CC   From: National Taiwan University; Taiwan.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NTU3

AC   CVCL_C110

SY   NTUe003-A; National-Taiwan-University 3

DR   BCRC; SC81008

DR   hPSCreg; NTUe003-A

DR   ISCR; 1651

RX   PubMed=17071820;

CC   From: National Taiwan University; Taiwan.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   NTUH-iPSC-01-05

AC   CVCL_GT41

DR   BCRC; SC81034

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NTUH-iPSC-02-02

AC   CVCL_GT30

DR   BCRC; SC81035

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NU 2-26

AC   CVCL_Y104

RX   PubMed=6305379;

DI   NCIt; C3017; Ependymoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NU-AMB-1

AC   CVCL_C249

SY   NU-AmB-1

RX   PubMed=2581902;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NU-DHL-1

AC   CVCL_1876

SY   NUDHL1; NuDHL 1

DR   BioSample; SAMN03473488

DR   CCLE; NUDHL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 850208

DR   Cosmic; 1629931

DR   Cosmic; 2361378

DR   DSMZ; ACC-583

DR   GEO; GSM380139

DR   GEO; GSM380140

DR   GEO; GSM887459

DR   GEO; GSM888539

DR   GEO; GSM1374775

RX   PubMed=2581902;

RX   PubMed=8547074;

RX   PubMed=19278952;

RX   PubMed=22460905;

RX   PubMed=23699601;

RX   PubMed=25355872;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~30-50 hours (DSMZ).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Genome sequenced.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 12,14

ST   D13S317: 10,13

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NU-DUL-1

AC   CVCL_1877

SY   NUDUL1

DR   EFO; EFO_0006700

DR   ATCC; CRL-2969

DR   BioSample; SAMN03473485

DR   CCLE; NUDUL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1629936

DR   Cosmic-CLP; 1330982

DR   DSMZ; ACC-579

DR   GDSC; 1330982

DR   GEO; GSM887460

DR   GEO; GSM888540

DR   GEO; GSM1670286

RX   PubMed=2581902;

RX   PubMed=19278952;

RX   PubMed=22460905;

RX   PubMed=23699601;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~30-36 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: miRNA expression profiling.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,13

ST   D16S539: 11,13

ST   D5S818: 12,14

ST   D7S820: 11,13

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Nu6-1

AC   CVCL_7085

SY   NU6-1; Nu-6-1; Nu 6-1

DR   Cosmic; 877397

DR   Cosmic; 1152492

RX   PubMed=3422461;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7114 ! RH-SLC-L11

SX   Female

CA   Cancer cell line

//

ID   Nu61

AC   CVCL_7086

SY   NU61; nu61; nu61-8-4000

RX   PubMed=14755057;

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=80

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7118 ! SCC-61

SX   Male

CA   Cancer cell line

//

ID   NUB-20

AC   CVCL_5G81

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=2158399;

DI   NCIt; C3716; Primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NUB-6

AC   CVCL_9896

RX   PubMed=3243386;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NUB-7

AC   CVCL_9897

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=3243386;

RX   PubMed=8043511;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NUC-1 [Human choriocarcinoma]

AC   CVCL_M685

RX   PubMed=6579923;

RX   PubMed=11014955;

DI   NCIt; C4646; Gestational choriocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NUC-1 [Mouse urothelial]

AC   CVCL_2146

DR   CLO; CLO_0008211

DR   CLDB; cl3743

DR   DSMZ; ACC-225

RX   PubMed=7687588;

CC   Doubling time: ~24 hours (DSMZ).

CC   Breed/subspecies: C3H/Law.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NUC-5

AC   CVCL_2147

DR   CLO; CLO_0008212

DR   CLDB; cl3744

DR   DSMZ; ACC-226

RX   PubMed=7687588;

CC   Doubling time: ~60-75 hours (DSMZ).

CC   Breed/subspecies: C3H/Law.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   NUGC-2

AC   CVCL_1611

AS   CVCL_8370

SY   NUGC2; NU-GC-2

DR   BTO; BTO:0002596

DR   EFO; EFO_0006701

DR   BioSample; SAMN03472517

DR   BioSample; SAMN03473090

DR   CCLE; NUGC2_STOMACH

DR   CGH-DB; 133-1

DR   Cosmic; 1187287

DR   GEO; GSM887461

DR   GEO; GSM888541

DR   JCRB; JCRB0821

RX   PubMed=1778766;

RX   PubMed=3172586;

RX   PubMed=9290701;

RX   PubMed=15723654;

RX   PubMed=19132987;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 36.1 hours (PubMed=3172586).

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'MUGC-2' in Cosmic 1187287 and PubMed=19132987.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 7,12 (JCRB)

ST   D16S539: 7 (PubMed=25877200)

ST   D18S51: 21

ST   D21S11: 29

ST   D3S1358: 15,16

ST   D5S818: 10,12

ST   D7S820: 11

ST   D8S1179: 13

ST   FGA: 21

ST   Penta D: 12

ST   Penta E: 11

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NUGC-3

AC   CVCL_1612

AS   CVCL_8371

SY   NUGC3; NU-GC-3

DR   BTO; BTO:0002597

DR   EFO; EFO_0006702

DR   BioSample; SAMN03473123

DR   CCLE; NUGC3_STOMACH

DR   CGH-DB; 134-1

DR   ChEMBL-Cells; CHEMBL3307562

DR   ChEMBL-Targets; CHEMBL614208

DR   Cosmic; 801341

DR   Cosmic; 877046

DR   Cosmic; 908455

DR   Cosmic; 918499

DR   Cosmic; 968351

DR   Cosmic; 1187288

DR   Cosmic; 1518256

DR   Cosmic; 1995599

DR   Cosmic; 2484968

DR   Cosmic-CLP; 908455

DR   GDSC; 908455

DR   GEO; GSM827405

DR   GEO; GSM828828

DR   GEO; GSM844666

DR   GEO; GSM887462

DR   GEO; GSM888542

DR   GEO; GSM1374776

DR   GEO; GSM1670287

DR   JCRB; JCRB0822

RX   PubMed=1778766;

RX   PubMed=3172586;

RX   PubMed=9290701;

RX   PubMed=15723654;

RX   PubMed=15767549;

RX   PubMed=19132987;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR45 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 38.2 hours (PubMed=3172586); 32 hours (JCRB).

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'MUGC-3' in Cosmic 1187288 and PubMed=19132987.

CC   Misspelling: 'NVGC3' in Cosmic 801341.

CC   Derived from metastatic site: Brachialis muscle.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 10,11

ST   D16S539: 10,11

ST   D18S51: 18,19

ST   D21S11: 30,31

ST   D3S1358: 16,17

ST   D5S818: 11

ST   D7S820: 8,9

ST   D8S1179: 12,13,16,17

ST   FGA: 17

ST   Penta D: 11

ST   Penta E: 11,18

ST   TH01: 6,8

ST   TPOX: 8,9

ST   vWA: 18

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NUGC-3-Luc

AC   CVCL_4Y07

DR   JCRB; NIHS0731

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Brachialis muscle.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1612 ! NUGC-3

SX   Male

CA   Cancer cell line

//

ID   NUGC-3/5-FU/L

AC   CVCL_L502

SY   NUGC-3/5FU/L; NUGC-3/5-FU; NUGC-3/5FU

RX   PubMed=8609072;

RX   PubMed=10359051;

RX   PubMed=15767549;

CC   Part of: JFCR45 cancer cell line panel.

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

CC   Derived from metastatic site: Brachialis muscle.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1612 ! NUGC-3

SX   Male

CA   Cancer cell line

//

ID   NUGC-4

AC   CVCL_3082

AS   CVCL_8372

SY   NUGC4; NU-GC-4

DR   BTO; BTO:0005917

DR   CLO; CLO_0050789

DR   EFO; EFO_0006703

DR   BioSample; SAMN01821711

DR   BioSample; SAMN03473124

DR   CCLE; NUGC4_STOMACH

DR   CGH-DB; 135-1

DR   ChEMBL-Cells; CHEMBL3307267

DR   ChEMBL-Targets; CHEMBL613519

DR   Cosmic; 1187289

DR   Cosmic; 1329186

DR   Cosmic; 1460702

DR   Cosmic; 1518257

DR   Cosmic; 1890473

DR   Cosmic; 2009530

DR   Cosmic; 2484971

DR   Cosmic-CLP; 1298357

DR   GDSC; 1298357

DR   GEO; GSM827575

DR   GEO; GSM844667

DR   GEO; GSM887463

DR   GEO; GSM888543

DR   GEO; GSM1374777

DR   GEO; GSM1670288

DR   JCRB; JCRB0834

DR   RCB; RCB1939

DR   TKG; TKG 0449

RX   PubMed=1778766;

RX   PubMed=3172586;

RX   PubMed=9290701;

RX   PubMed=15723654;

RX   PubMed=19132987;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 29.9 hours (PubMed=3172586).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'MUGC-4' in Cosmic 1187289 and PubMed=19132987.

CC   Derived from metastatic site: Paragastric lymph node.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 9

ST   D18S51: 16,19

ST   D21S11: 30.3,31

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 11

ST   D8S1179: 12

ST   FGA: 23,26

ST   Penta D: 9,12

ST   Penta E: 13,15

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 14,18

DI   NCIt; C5250; Signet ring cell gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NUH2

AC   CVCL_N272

SY   NUH-2

DR   ATCC; HB-9762

RX   Patent=US5227160;

RX   PubMed=2509467;

CC   Monoclonal antibody target: UniProtKB; P04626; Disialogangliosides with binary 2-3 sialosyllactosamine structure.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   NUL1

AC   CVCL_R788

SY   NUL 1

RX   PubMed=3001399;

RX   PubMed=3409226;

RX   PubMed=4067735;

RX   PubMed=6713549;

CC   Transformant: ChEBI; CHEBI:17967; Urethane.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21762; Adenoma of the mouse pulmonary system

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   NUL1 clone B3

AC   CVCL_5U97

SY   NUL1 B3; NULB3; B3

RX   PubMed=2152771;

RX   PubMed=2177605;

RX   PubMed=3409226;

RX   PubMed=9347924;

CC   Transformant: ChEBI; CHEBI:17967; Urethane.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21762; Adenoma of the mouse pulmonary system

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_R788 ! NUL1

CA   Cancer cell line

//

ID   NUL1 clone B5

AC   CVCL_5U98

SY   NUL1 B5; NULB5; b5

RX   PubMed=2152771;

RX   PubMed=2177605;

RX   PubMed=3409226;

RX   PubMed=9347924;

CC   Transformant: ChEBI; CHEBI:17967; Urethane.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21762; Adenoma of the mouse pulmonary system

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_R788 ! NUL1

CA   Cancer cell line

//

ID   NuLi-1

AC   CVCL_C455

SY   Normal Lung, University of Iowa-1

DR   ATCC; CRL-4011

DR   BioSample; SAMN03471719

RX   PubMed=12676769;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 10,12

ST   D16S539: 8,13

ST   D5S818: 11,13

ST   D7S820: 12,13

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NuLi-2

AC   CVCL_S915

SY   Normal Lung, University of Iowa-2

RX   PubMed=12676769;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   NuLi-3

AC   CVCL_C456

SY   Normal Lung, University of Iowa-3

DR   ATCC; CRL-4012

DR   BioSample; SAMN03471720

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

CC   Discontinued: ATCC; CRL-4012; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 10,11

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   NULLI-SCC1

AC   CVCL_3408

DR   CLO; CLO_0008213

DR   CLDB; cl3745

DR   CLDB; cl7206

DR   ATCC; CRL-1566

DR   ICLC; ATL06001

CC   Breed/subspecies: 129/Sv.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   Nur-1

AC   CVCL_1Q60

RX   PubMed=25627346;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NUTLC-1

AC   CVCL_L423

RX   PubMed=8025020;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NUTLC-2

AC   CVCL_L424

RX   PubMed=1339008;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NUTLC-3

AC   CVCL_L425

RX   PubMed=8025020;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NUTLC-4

AC   CVCL_L426

RX   PubMed=1339008;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NUTLC-5

AC   CVCL_L427

RX   PubMed=1339008;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NUTOS

AC   CVCL_D658

RX   PubMed=20712710;

DI   NCIt; C3749; Alveolar rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NuTu-19

AC   CVCL_HA28

SY   NUTU-19; NuTu 19

RX   PubMed=8168110;

RX   PubMed=8828419;

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C129858; Adenocarcinoma of the rat ovary

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Cancer cell line

//

ID   NUZ

AC   CVCL_V411

SY   NUZ-1

DR   Cosmic; 877472

DR   Cosmic; 1152546

RX   CelloPub=CLPUB00091;

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NW-16

AC   CVCL_5219

SY   NW16

DR   BTO; BTO:0003055

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0513 ! Rat2

CA   Spontaneously immortalized cell line

//

ID   NW0004

AC   CVCL_8Y25

DR   ECACC; 03041506

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2989; DiGeorge syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   NW0005

AC   CVCL_8Y26

DR   ECACC; 03041507

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2989; DiGeorge syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   NW0006

AC   CVCL_8Y27

DR   ECACC; 03110420

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   NW145

AC   CVCL_2148

SY   NW-145; NW 145; NW-MEL-145; NW-Mel-145; EST57

DR   Cosmic; 972264

DR   Cosmic; 1047648

DR   Cosmic; 2163798

DR   ESTDAB; ESTDAB-057

DR   GEO; GSM156014

RX   PubMed=17260012;

CC   Omics: Array-based CGH.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D3S1358: 14,15

ST   D5S818: 11

ST   D7S820: 10

ST   FGA: 20

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NW145/E7

AC   CVCL_C538

SY   NW-145/E7; NW145 clone E7

DR   Cosmic; 972259

DR   ESTDAB; ESTDAB-058

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D3S1358: 14,15

ST   D5S818: 11

ST   D7S820: 10

ST   FGA: 20

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2148 ! NW145

SX   Male

CA   Cancer cell line

//

ID   NW1539

AC   CVCL_S590

SY   NW-1539; NW-MEL-1539; NW-Mel-1539

DR   BTO; BTO:0005427

RX   PubMed=12747757;

RX   PubMed=15087389;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NW38

AC   CVCL_S591

SY   NW-38; NW-MEL-38

RX   PubMed=9432985;

RX   PubMed=12747757;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NW450

AC   CVCL_S592

SY   MW-450; NW-MEL-450; NW-Mel-450

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NW624

AC   CVCL_S589

SY   NW-624; NW-Mel-624

DR   BTO; BTO:0005428

RX   PubMed=15087389;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NW726

AC   CVCL_S593

SY   NW-726; NW-Mel-726

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NW745

AC   CVCL_S594

SY   NW-745; NW-Mel-745

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NWR A

AC   CVCL_R793

RX   PubMed=21892153;

OX   NCBI_TaxID=9807; ! Ceratotherium simum

OI   CVCL_R794 ! NWR B

OI   CVCL_R795 ! NWR C

SX   Female

CA   Induced pluripotent stem cell

//

ID   NWR B

AC   CVCL_R794

RX   PubMed=21892153;

OX   NCBI_TaxID=9807; ! Ceratotherium simum

OI   CVCL_R793 ! NWR A

OI   CVCL_R795 ! NWR C

SX   Female

CA   Induced pluripotent stem cell

//

ID   NWR C

AC   CVCL_R795

RX   PubMed=21892153;

OX   NCBI_TaxID=9807; ! Ceratotherium simum

OI   CVCL_R793 ! NWR A

OI   CVCL_R794 ! NWR B

SX   Female

CA   Induced pluripotent stem cell

//

ID   NWT-21

AC   CVCL_D206

SY   NWT21

RX   PubMed=15050915;

CC   Transfected with: HGNC; 5465; IGF1R.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   NY

AC   CVCL_1613

DR   BioSample; SAMN03471633

DR   ChEMBL-Cells; CHEMBL3308123

DR   ChEMBL-Targets; CHEMBL1075552

DR   Cosmic; 910849

DR   Cosmic-CLP; 910849

DR   GDSC; 910849

DR   GEO; GSM320822

DR   GEO; GSM827276

DR   GEO; GSM1670289

DR   JCRB; JCRB0614

RX   PubMed=6596455;

RX   PubMed=9290701;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 10,13

ST   D5S818: 13

ST   D7S820: 11

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NYAES-PR4A

AC   CVCL_Z961

RX   DOI=10.1016/0022-2011(88)90135-8;

CC   Group: Insect cell line.

OX   NCBI_TaxID=64459; ! Pieris rapae

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Nyalim

AC   CVCL_0D20

RX   PubMed=25711304;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Nyalimx

AC   CVCL_0D21

RX   PubMed=25711304;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0D20 ! Nyalim

SX   Male

CA   Cancer cell line

//

ID   Nyevu

AC   CVCL_IU24

RX   PubMed=178913;

RX   PubMed=4364259;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NYGM

AC   CVCL_9278

RX   PubMed=15859160;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NYH/187/162

AC   CVCL_0B24

SY   NYH/187

RX   PubMed=10416608;

RX   PubMed=12044890;

CC   Selected for resistance to: ChEBI; CHEBI:50223; (+)-dexrazoxane (Cardioxane; ICRF-187).

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8207 ! GLC-2

SX   Male

CA   Cancer cell line

//

ID   NYH/187/165

AC   CVCL_0B25

RX   PubMed=12044890;

CC   Selected for resistance to: ChEBI; CHEBI:50223; (+)-dexrazoxane (Cardioxane; ICRF-187).

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8207 ! GLC-2

SX   Male

CA   Cancer cell line

//

ID   NYH/CAM

AC   CVCL_0B26

RX   PubMed=9062409;

CC   Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8207 ! GLC-2

SX   Male

CA   Cancer cell line

//

ID   NYH/CIS

AC   CVCL_0B27

RX   PubMed=9062409;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8207 ! GLC-2

SX   Male

CA   Cancer cell line

//

ID   NYH/TPT

AC   CVCL_0B28

RX   PubMed=7640225;

RX   PubMed=9062409;

CC   Selected for resistance to: ChEBI; CHEBI:63632; Topotecan.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8207 ! GLC-2

SX   Male

CA   Cancer cell line

//

ID   NYH/VM

AC   CVCL_0B29

SY   OC-NYH/VM

RX   PubMed=8390259;

RX   PubMed=9062409;

CC   Selected for resistance to: ChEBI; CHEBI:75988; Teniposide (VM-26).

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8207 ! GLC-2

SX   Male

CA   Cancer cell line

//

ID   NYSCF-10005-1044-1044-Skin-mR-iPSC

AC   CVCL_AB86

WW   http://shared.eagle-i.net/i/00000149-1589-b8ee-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1046-1046-Skin-mR-iPSC

AC   CVCL_AB87

WW   http://shared.eagle-i.net/i/00000149-15ac-a13a-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1047-1047-Skin-mR-iPSC

AC   CVCL_AB88

WW   http://shared.eagle-i.net/i/00000149-15b4-bf9c-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1048-1048-Skin-mR-iPSC

AC   CVCL_AB89

WW   http://shared.eagle-i.net/i/00000149-15b7-4014-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1049-1049-Skin-mR-iPSC

AC   CVCL_AB90

WW   http://shared.eagle-i.net/i/00000149-15bb-9f8f-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1050-1050-Skin-mR-iPSC

AC   CVCL_AB91

WW   http://shared.eagle-i.net/i/00000149-16b8-157f-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1051-1051-Skin-mR-iPSC

AC   CVCL_AB92

WW   http://shared.eagle-i.net/i/00000149-16ba-b3a9-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1058-1058-Skin-mR-iPSC

AC   CVCL_AB93

WW   http://shared.eagle-i.net/i/00000149-16bb-aa74-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1059-1059-Skin-mR-iPSC

AC   CVCL_AB94

WW   http://shared.eagle-i.net/i/00000149-16bc-b251-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1062-1062-Skin-mR-iPSC

AC   CVCL_AB95

WW   http://shared.eagle-i.net/i/00000149-16bd-c475-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1063-1063-Skin-mR-iPSC

AC   CVCL_AB96

WW   http://shared.eagle-i.net/i/00000149-16be-c4ce-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1064-1064-Skin-mR-iPSC

AC   CVCL_AB97

WW   http://shared.eagle-i.net/i/00000149-16c0-1779-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1065-1065-Skin-mR-iPSC

AC   CVCL_AB98

WW   http://shared.eagle-i.net/i/00000149-16c0-d7d3-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1067-1067-Skin-mR-iPSC

AC   CVCL_AB99

WW   http://shared.eagle-i.net/i/00000149-16c1-bd44-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1069-1069-Skin-mR-iPSC

AC   CVCL_AC00

WW   http://shared.eagle-i.net/i/00000149-16c2-8040-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1070-1070-Skin-mR-iPSC

AC   CVCL_AC01

WW   http://shared.eagle-i.net/i/00000149-16c3-655f-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1071-1071-Skin-mR-iPS

AC   CVCL_AC02

WW   http://shared.eagle-i.net/i/00000149-16c4-9fcf-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1073-1073-Skin-mR-iPS

AC   CVCL_AC03

WW   http://shared.eagle-i.net/i/00000149-16c5-ba23-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1076-1076-Skin-mR-iPS

AC   CVCL_AC04

WW   http://shared.eagle-i.net/i/00000149-16c7-60dd-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1081-1081-Skin-mR-iPS

AC   CVCL_AC05

WW   http://shared.eagle-i.net/i/00000149-16c8-c97a-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1082-1082-Skin-mR-iPS

AC   CVCL_AC06

WW   http://shared.eagle-i.net/i/00000149-16c9-c937-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-1085-1085-Skin-mR-iPS

AC   CVCL_AC07

WW   http://shared.eagle-i.net/i/00000149-16cb-01a0-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-117-117-Skin-sv-iPSC

AC   CVCL_AC08

WW   http://shared.eagle-i.net/i/00000149-16cf-7e9b-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-118-118-Skin-mR-iPSC

AC   CVCL_AC09

WW   http://shared.eagle-i.net/i/00000149-14ff-9aeb-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-128-128-Skin-mR-iPSC

AC   CVCL_AC10

WW   http://shared.eagle-i.net/i/00000149-1504-e92c-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-141-141-Skin-mR-iPSC

AC   CVCL_AC11

WW   http://shared.eagle-i.net/i/00000149-1508-d6c9-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-177-177-Skin-mR-iPSC

AC   CVCL_AC12

WW   http://shared.eagle-i.net/i/00000149-150c-48f8-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-186-186-Skin-mR-iPSC

AC   CVCL_AC13

WW   http://shared.eagle-i.net/i/00000149-150f-20d1-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-370-370-Skin-mR-iPSC

AC   CVCL_AC14

WW   http://shared.eagle-i.net/i/00000146-8fac-486f-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-375-375-Skin-mR-iPSC

AC   CVCL_AC15

WW   http://shared.eagle-i.net/i/00000146-8fac-6553-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-384-384-Skin-mR-iPSC

AC   CVCL_AC16

WW   http://shared.eagle-i.net/i/00000146-8fac-7e96-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-392-392-Skin-mR-iPSC

AC   CVCL_AC17

WW   http://shared.eagle-i.net/i/00000146-8fac-96e6-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-401-401-Skin-mR-iPSC

AC   CVCL_AC18

WW   http://shared.eagle-i.net/i/00000149-1438-36f8-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-405-405-Skin-mR-iPSC

AC   CVCL_AC19

WW   http://shared.eagle-i.net/i/00000149-14d4-7c92-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-406-406-Skin-mR-iPSC

AC   CVCL_AC20

WW   http://shared.eagle-i.net/i/00000146-8fac-a910-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-411-411-Skin-mR-iPSC

AC   CVCL_AC21

WW   http://shared.eagle-i.net/i/00000149-14dd-bf9c-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-415-415-Skin-mR-iPSC

AC   CVCL_AC22

WW   http://shared.eagle-i.net/i/00000146-8fac-cdfa-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-417-417-Skin-mR-iPSC

AC   CVCL_AC23

WW   http://shared.eagle-i.net/i/00000146-8fac-e152-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-425-425-Skin-mR-iPSC

AC   CVCL_AC24

WW   http://shared.eagle-i.net/i/00000146-8fad-0819-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-432-432-Skin-mR-iPSC

AC   CVCL_AC25

WW   http://shared.eagle-i.net/i/00000149-1511-c177-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-433-433-Skin-mR-iPSC

AC   CVCL_AC26

WW   http://shared.eagle-i.net/i/00000146-8fad-1dd6-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-434-434-Skin-mR-iPSC

AC   CVCL_AC27

WW   http://shared.eagle-i.net/i/00000146-8fad-3004-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-437-437-Skin-mR-iPSC

AC   CVCL_AC28

WW   http://shared.eagle-i.net/i/00000146-8fad-4688-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-438-438-Skin-mR-iPSC

AC   CVCL_AC29

WW   http://shared.eagle-i.net/i/00000146-8fad-5a0a-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-459-459-Skin-mR-iPSC

AC   CVCL_AC30

WW   http://shared.eagle-i.net/i/00000149-1515-22c6-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-460-460-Skin-mR-iPSC

AC   CVCL_AC31

WW   http://shared.eagle-i.net/i/00000149-1519-62e0-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-465-465-Skin-mR-iPSC

AC   CVCL_AC32

WW   http://shared.eagle-i.net/i/00000149-1522-4d9e-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-469-469-Skin-mR-iPSC

AC   CVCL_AC33

WW   http://shared.eagle-i.net/i/00000149-1525-db6e-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-470-470-Skin-mR-iPSC

AC   CVCL_AC34

WW   http://shared.eagle-i.net/i/00000149-1528-e8e2-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-476-476-Skin-mR-iPSC

AC   CVCL_AC35

WW   http://shared.eagle-i.net/i/00000146-8fad-6f9b-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-478-478-Skin-mR-iPSC

AC   CVCL_AC36

WW   http://shared.eagle-i.net/i/00000149-152f-4bba-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-491-491-Skin-mR-iPSC

AC   CVCL_AC37

WW   http://shared.eagle-i.net/i/00000149-1531-a557-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-555-555-Skin-mR-iPSC

AC   CVCL_AC38

WW   http://shared.eagle-i.net/i/00000149-1533-72f5-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-558-558-Skin-mR-iPSC

AC   CVCL_AC39

WW   http://shared.eagle-i.net/i/00000146-8fad-8234-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-562-562-Skin-mR-iPSC

AC   CVCL_AC40

WW   http://shared.eagle-i.net/i/00000149-14e7-ef13-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-566-566-Skin-mR-iPSC

AC   CVCL_AC41

WW   http://shared.eagle-i.net/i/00000146-8fad-a940-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-568-568-Skin-mR-iPSC

AC   CVCL_AC42

WW   http://shared.eagle-i.net/i/00000146-8fad-ba06-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-569-569-Skin-mR-iPSC

AC   CVCL_AC43

WW   http://shared.eagle-i.net/i/00000146-8fad-d153-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-570-570-Skin-mR-iPSC

AC   CVCL_AC44

WW   http://shared.eagle-i.net/i/00000149-1535-9606-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-580-580-Skin-mR-iPSC

AC   CVCL_AC45

WW   http://shared.eagle-i.net/i/00000146-8fad-e1fa-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-582-582-Skin-mR-iPSC

AC   CVCL_AC46

WW   http://shared.eagle-i.net/i/00000146-8fad-fa5f-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-583-583-Skin-mR-iPSC

AC   CVCL_AC47

WW   http://shared.eagle-i.net/i/00000149-1538-7ddb-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-585-585-Skin-mR-iPSC

AC   CVCL_AC48

WW   http://shared.eagle-i.net/i/00000146-8fae-254c-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-590-590-Skin-mR-iPSC

AC   CVCL_AC49

WW   http://shared.eagle-i.net/i/00000146-8fae-3875-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-592-592-Skin-mR-iPSC

AC   CVCL_AC50

WW   http://shared.eagle-i.net/i/00000146-8fae-5113-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-596-596-Skin-mR-iPSC

AC   CVCL_AC51

WW   http://shared.eagle-i.net/i/00000146-8fae-6308-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-597-597-Skin-mR-iPSC

AC   CVCL_AC52

WW   http://shared.eagle-i.net/i/00000146-8fae-7850-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-598-598-Skin-mR-iPSC

AC   CVCL_AC53

WW   http://shared.eagle-i.net/i/00000146-8fae-8a5a-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-605-605-Skin-mR-iPSC

AC   CVCL_AC54

WW   http://shared.eagle-i.net/i/00000146-8fae-9a6b-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-611-611-Skin-mR-iPSC

AC   CVCL_AC55

WW   http://shared.eagle-i.net/i/00000146-8fae-b2da-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-617-617-Skin-mR-iPSC

AC   CVCL_AC56

WW   http://shared.eagle-i.net/i/00000146-8fae-c91e-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-623-623-Skin-mR-iPSC

AC   CVCL_AC57

WW   http://shared.eagle-i.net/i/00000146-8fae-dbb3-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-632-632-Skin-mR-iPSC

AC   CVCL_AC58

WW   http://shared.eagle-i.net/i/00000146-8fae-f258-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-635-635-Skin-mR-iPSC

AC   CVCL_AC59

WW   http://shared.eagle-i.net/i/00000149-153a-a6d3-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-636-636-Skin-mR-iPSC

AC   CVCL_AC60

WW   http://shared.eagle-i.net/i/00000146-8faf-0616-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-642-642-Skin-mR-iPSC

AC   CVCL_AC61

WW   http://shared.eagle-i.net/i/00000146-8faf-1bd4-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-644-644-Skin-mR-iPSC

AC   CVCL_AC62

WW   http://shared.eagle-i.net/i/00000146-8faf-32dd-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-645-645-Skin-mR-iPSC

AC   CVCL_AC63

WW   http://shared.eagle-i.net/i/00000149-14ed-db90-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-648-648-Skin-mR-iPSC

AC   CVCL_AC64

WW   http://shared.eagle-i.net/i/00000146-8faf-4481-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-650-650-Skin-mR-iPSC

AC   CVCL_AC65

WW   http://shared.eagle-i.net/i/00000146-8faf-5be3-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-660-660-Skin-mR-iPSC

AC   CVCL_AC66

WW   http://shared.eagle-i.net/i/00000146-8faf-80c8-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-661-661-Skin-mR-iPSC

AC   CVCL_AC67

WW   http://shared.eagle-i.net/i/00000146-8faf-986c-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-669-669-Skin-mR-iPSC

AC   CVCL_AC68

WW   http://shared.eagle-i.net/i/00000149-153c-3493-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-675-675-Skin-mR-iPSC

AC   CVCL_AC69

WW   http://shared.eagle-i.net/i/00000149-153d-9395-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-684-684-Skin-mR-iPSC

AC   CVCL_AC70

WW   http://shared.eagle-i.net/i/00000149-153f-2010-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-686-686-Skin-mR-iPSC

AC   CVCL_AC71

WW   http://shared.eagle-i.net/i/00000149-1541-0610-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-689-689-Skin-mR-iPSC

AC   CVCL_AC72

WW   http://shared.eagle-i.net/i/00000149-1542-caee-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-694-694-Skin-mR-iPSC

AC   CVCL_AC73

WW   http://shared.eagle-i.net/i/00000146-8faf-a92c-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-699-699-Skin-mR-iPSC

AC   CVCL_AC74

WW   http://shared.eagle-i.net/i/00000146-8faf-c16d-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-700-700-Skin-mR-iPSC

AC   CVCL_AC75

WW   http://shared.eagle-i.net/i/00000149-1544-392b-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-702-702-Skin-mR-iPSC

AC   CVCL_AC76

WW   http://shared.eagle-i.net/i/00000149-1546-1c4c-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-705-705-Skin-mR-iPSC

AC   CVCL_AC77

WW   http://shared.eagle-i.net/i/00000149-1547-73a7-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-709-709-Skin-mR-iPSC

AC   CVCL_AC78

WW   http://shared.eagle-i.net/i/00000149-1549-5fd0-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-716-716-Skin-mR-iPSC

AC   CVCL_AC79

WW   http://shared.eagle-i.net/i/00000149-154a-aea0-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-733-733-Skin-mR-iPSC

AC   CVCL_AC80

WW   http://shared.eagle-i.net/i/00000149-154c-7ab1-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-739-739-Skin-mR-iPSC

AC   CVCL_AC81

WW   http://shared.eagle-i.net/i/00000149-1550-6026-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-743-743-Skin-mR-iPSC

AC   CVCL_AC82

WW   http://shared.eagle-i.net/i/00000149-1552-0510-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-750-750-Skin-mR-iPSC

AC   CVCL_AC83

WW   http://shared.eagle-i.net/i/00000149-1553-5fce-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-752-752-Skin-mR-iPSC

AC   CVCL_AC84

WW   http://shared.eagle-i.net/i/00000149-1554-9653-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-767-767-Skin-mR-iPSC

AC   CVCL_AC85

WW   http://shared.eagle-i.net/i/00000149-1558-1c7a-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-773-773-Skin-mR-iPSC

AC   CVCL_AC86

WW   http://shared.eagle-i.net/i/00000149-155a-440e-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-780-780-Skin-mR-iPSC

AC   CVCL_AC87

WW   http://shared.eagle-i.net/i/00000149-155d-0461-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-794-794-Skin-mR-iPSC

AC   CVCL_AC88

WW   http://shared.eagle-i.net/i/00000149-155e-971f-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-808-808-Skin-mR-iPSC

AC   CVCL_AC89

WW   http://shared.eagle-i.net/i/00000149-1560-0151-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-818-818-Skin-mR-iPSC

AC   CVCL_AC90

WW   http://shared.eagle-i.net/i/00000149-1561-5579-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-819-819-Skin-mR-iPSC

AC   CVCL_AC91

WW   http://shared.eagle-i.net/i/00000149-1562-6309-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-824-824-Skin-mR-iPSC

AC   CVCL_AC92

WW   http://shared.eagle-i.net/i/00000149-1563-a316-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-825-825-Skin-mR-iPSC

AC   CVCL_AC93

WW   http://shared.eagle-i.net/i/00000149-1564-be42-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-830-830-Skin-mR-iPSC

AC   CVCL_AC94

WW   http://shared.eagle-i.net/i/00000149-1567-e2ff-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-835-835-Skin-mR-iPSC

AC   CVCL_AC95

WW   http://shared.eagle-i.net/i/00000149-156f-7f7d-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-841-841-Skin-mR-iPSC

AC   CVCL_AC96

WW   http://shared.eagle-i.net/i/00000149-1571-7e8f-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-845-845-Skin-mR-iPSC

AC   CVCL_AC97

WW   http://shared.eagle-i.net/i/00000149-1575-2de6-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-861-861-Skin-mR-iPSC

AC   CVCL_AC98

WW   http://shared.eagle-i.net/i/00000149-1577-5392-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-876-876-Skin-mR-iPSC

AC   CVCL_AC99

WW   http://shared.eagle-i.net/i/00000149-157a-3a37-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-882-882-Skin-mR-iPSC

AC   CVCL_AD00

WW   http://shared.eagle-i.net/i/00000149-157b-6ee9-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-885-885-Skin-mR-iPSC

AC   CVCL_AD01

WW   http://shared.eagle-i.net/i/00000149-157c-f80b-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-888-888-Skin-mR-iPSC

AC   CVCL_AD02

WW   http://shared.eagle-i.net/i/00000149-157f-8bba-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-900-900-Skin-mR-iPSC

AC   CVCL_AD03

WW   http://shared.eagle-i.net/i/00000149-14f6-7a2d-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-10005-901-901-Skin-mR-iPSC

AC   CVCL_AD04

WW   http://shared.eagle-i.net/i/00000149-1587-1fa8-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1000-ASC2-Dura-SV-iPSC1

AC   CVCL_AD05

WW   http://shared.eagle-i.net/i/00000146-8fc9-99b9-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C84909; Multiple system atrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD06 ! NYSCF-AD-1000-ASC2-Skin-SV-iPSC1

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1000-ASC2-Skin-SV-iPSC1

AC   CVCL_AD06

WW   http://shared.eagle-i.net/i/00000146-8fc9-da69-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C84909; Multiple system atrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD05 ! NYSCF-AD-1000-ASC2-Dura-SV-iPSC1

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1001-ASC7-Dura-SV-iPSC1

AC   CVCL_AD07

WW   http://shared.eagle-i.net/i/00000146-8fca-1655-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1007-ASC19-Dura-SV-iPSC1

AC   CVCL_AD08

WW   http://shared.eagle-i.net/i/00000146-8fca-6832-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1011-ASC27-Dura-SV-iPSC1

AC   CVCL_AD09

WW   http://shared.eagle-i.net/i/00000146-8fca-bb53-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD10 ! NYSCF-AD-1011-ASC27-Dura-SV-iPSC2

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1011-ASC27-Dura-SV-iPSC2

AC   CVCL_AD10

WW   http://shared.eagle-i.net/i/00000146-8fca-d15d-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD09 ! NYSCF-AD-1011-ASC27-Dura-SV-iPSC1

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1012-ASC30-Dura-SV-iPSC1

AC   CVCL_AD11

WW   http://shared.eagle-i.net/i/00000146-8fcb-0c5a-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1013-AG06842-Skin-RV-IPSC1

AC   CVCL_AD12

SY   6842A

RX   PubMed=24416243;

WW   http://shared.eagle-i.net/i/00000146-8fb0-7800-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H777 ! AG06842

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1015-AG07671-Skin-RV-IPSC1

AC   CVCL_AD13

SY   7671C

RX   PubMed=24416243;

WW   http://shared.eagle-i.net/i/00000146-8fb1-3e14-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C123412; Familial Alzheimer's disease, type 3

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4P39 ! AG07671

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1016-AG07768-Skin-RV-IPSC1

AC   CVCL_AD14

SY   7768C

RX   PubMed=24416243;

WW   http://shared.eagle-i.net/i/00000146-8fb1-f5a7-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C123412; Familial Alzheimer's disease, type 3

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_T877 ! AG07768

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1019-AG07889-Skin-RV-IPSC1

AC   CVCL_AD15

RX   PubMed=24416243;

WW   http://shared.eagle-i.net/i/00000146-8fb4-2dbe-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4K02 ! AG07889

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-AD-1021-AG08446-Skin-RV-IPSC1

AC   CVCL_AD16

RX   PubMed=24416243;

WW   http://shared.eagle-i.net/i/00000146-8fb4-b595-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4K58 ! AG08446

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1016-1016-Skin-RV-IPSC1

AC   CVCL_AD91

RX   PubMed=21979046;

WW   http://shared.eagle-i.net/i/00000146-8fb8-b8a7-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1018-1018-Skin-RV-IPSC11

AC   CVCL_AD17

WW   http://shared.eagle-i.net/i/00000146-8fb8-faff-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1019-1019-Skin-MR-iPSC1

AC   CVCL_AD18

WW   http://shared.eagle-i.net/i/00000149-1959-bf1b-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD19 ! NYSCF-DE-1019-1019-Skin-RV-iPSC1

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1019-1019-Skin-RV-iPSC1

AC   CVCL_AD19

WW   http://shared.eagle-i.net/i/00000146-8fb9-ba25-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD18 ! NYSCF-DE-1019-1019-Skin-MR-iPSC1

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1020-1020-Skin-MR-iPSC1

AC   CVCL_AD20

WW   http://shared.eagle-i.net/i/00000149-1961-a95c-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1024-1024-Skin-MR-iPSC1

AC   CVCL_AD21

WW   http://shared.eagle-i.net/i/00000149-1962-ef68-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD22 ! NYSCF-DE-1024-1024-Skin-RV-iPSC1

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1024-1024-Skin-RV-iPSC1

AC   CVCL_AD22

WW   http://shared.eagle-i.net/i/00000146-8fbb-4930-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD21 ! NYSCF-DE-1024-1024-Skin-MR-iPSC1

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1028-1028-Skin-MR-iPSC1

AC   CVCL_AD23

WW   http://shared.eagle-i.net/i/00000149-1964-6cb5-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1034-1034-Skin-RV-IPSC1

AC   CVCL_AD92

RX   PubMed=21979046;

WW   http://shared.eagle-i.net/i/00000146-8fbd-3cba-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD93 ! NYSCF-DE-1034-1034-Skin-SV-IPSC1

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1034-1034-Skin-SV-IPSC1

AC   CVCL_AD93

RX   PubMed=21979046;

WW   http://shared.eagle-i.net/i/00000146-8fcf-864f-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD92 ! NYSCF-DE-1034-1034-Skin-RV-IPSC1

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1035-1035-Skin-MR-iPSC1

AC   CVCL_AD24

WW   http://shared.eagle-i.net/i/00000149-1965-8348-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1039-1039-Skin-MR-iPSC1

AC   CVCL_AD25

WW   http://shared.eagle-i.net/i/00000149-1966-777e-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1044-1044-Skin-MR-iPSC1

AC   CVCL_AD26

WW   http://shared.eagle-i.net/i/00000149-1967-6482-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1045-1045-Skin-MR-iPSC1

AC   CVCL_AD27

WW   http://shared.eagle-i.net/i/00000149-1968-7a94-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1046-1046-Skin-MR-iPSC1

AC   CVCL_AD28

WW   http://shared.eagle-i.net/i/00000149-1969-18a3-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1048-1048-Skin-MR-iPSC1

AC   CVCL_AD29

WW   http://shared.eagle-i.net/i/00000149-1969-cad7-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1051-1051-Skin-MR-iPSC1

AC   CVCL_AD30

WW   http://shared.eagle-i.net/i/00000149-196a-824f-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1052-1052-Skin-MR-iPSC1

AC   CVCL_AD31

WW   http://shared.eagle-i.net/i/00000149-196b-8a1e-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1057-1057-Skin-MR-iPSC1

AC   CVCL_AD32

WW   http://shared.eagle-i.net/i/00000149-1972-e252-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1060-1060-Skin-MR-iPSC1

AC   CVCL_AD33

WW   http://shared.eagle-i.net/i/00000149-1973-94ef-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1064-1064-Skin-MR-iPSC1

AC   CVCL_AD34

WW   http://shared.eagle-i.net/i/00000149-1974-6ab2-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1086-1086-Skin-MR-iPSC1

AC   CVCL_AD35

WW   http://shared.eagle-i.net/i/00000149-1975-2f83-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1091-1091-Skin-MR-iPSC1

AC   CVCL_AD36

WW   http://shared.eagle-i.net/i/00000149-1976-2e12-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1109-1109-Skin-MR-iPSC1

AC   CVCL_AD37

WW   http://shared.eagle-i.net/i/00000149-1977-1000-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1113-1113-Skin-MR-iPSC1

AC   CVCL_AD38

WW   http://shared.eagle-i.net/i/00000149-1978-15d2-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-DE-1158-1158-Skin-MR-iPSC1

AC   CVCL_AD39

WW   http://shared.eagle-i.net/i/00000149-1951-3c56-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C2986; Type 1 diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1000-10006-101-Skin-mi-iPSC1

AC   CVCL_AD40

WW   http://shared.eagle-i.net/i/00000146-8faa-81f1-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1001-10006-102-Skin-mi-iPSC4

AC   CVCL_AD41

SY   iPSC102

RX   PubMed=25254339;

WW   http://shared.eagle-i.net/i/00000146-8faa-c4a4-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1002-10006-103-Skin-mi-iPSC4

AC   CVCL_AD42

WW   http://shared.eagle-i.net/i/00000146-8fab-0348-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1003-10006-104-Skin-mi-iPSC1

AC   CVCL_AD43

SY   iPSC104

RX   PubMed=25254339;

WW   http://shared.eagle-i.net/i/00000146-8fab-14b3-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1004-10006-105-Skin-mi-iPSC1

AC   CVCL_AD44

WW   http://shared.eagle-i.net/i/00000146-8fab-2b7a-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1005-10006-106-Skin-mi-iPSC1

AC   CVCL_AD45

WW   http://shared.eagle-i.net/i/00000146-8fab-3c65-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1006-10006-107-Skin-mi-iPSC1

AC   CVCL_AD46

SY   iPSC107

RX   PubMed=25254339;

WW   http://shared.eagle-i.net/i/00000146-8fab-53c7-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1007-10006-108-Skin-mi-iPSC1

AC   CVCL_AD47

WW   http://shared.eagle-i.net/i/00000146-8fab-8c7e-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1008-10006-109-Skin-mi-iPSC1

AC   CVCL_AD48

SY   iPSC109

RX   PubMed=25254339;

WW   http://shared.eagle-i.net/i/00000146-8fab-a483-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1011-10006-112-Skin-mi-iPSC1

AC   CVCL_AD49

WW   http://shared.eagle-i.net/i/00000146-8fab-dd7c-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1017-10006-113-Skin-mi-iPSC1

AC   CVCL_AD50

WW   http://shared.eagle-i.net/i/00000149-1920-31fb-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-MS-1019-10006-115-Skin-mi-iPSC1

AC   CVCL_AD51

WW   http://shared.eagle-i.net/i/00000149-1926-bebe-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C3243; Multiple sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Induced pluripotent stem cell

//

ID   NYSCF-PD-1030-10001.130.01-Skin-SV-iPSC7

AC   CVCL_AD52

WW   http://shared.eagle-i.net/i/00000146-8fd8-4a86-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC2

AC   CVCL_AD53

WW   http://shared.eagle-i.net/i/00000146-8fda-9b0c-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD54 ! NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC5

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC5

AC   CVCL_AD54

WW   http://shared.eagle-i.net/i/00000146-8fda-d117-b0a0-8e9480000000

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD53 ! NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC2

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC4

AC   CVCL_AD55

WW   http://shared.eagle-i.net/i/00000149-1936-8413-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD56 ! NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC5

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC5

AC   CVCL_AD56

WW   http://shared.eagle-i.net/i/00000149-1937-4432-6df5-792d80000000

CC   From: New York Stem Cell Foundation; New York; USA.

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AD55 ! NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC4

SX   Male

CA   Induced pluripotent stem cell

//

ID   NYSCF1

AC   CVCL_AD94

RX   PubMed=21979046;

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NYSCF2

AC   CVCL_AX70

RX   PubMed=26982723;

CC   From: New York Stem Cell Foundation; New York; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   NYU08-175

AC   CVCL_T592

RX   PubMed=22404973;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NYU09-085

AC   CVCL_T593

RX   PubMed=22404973;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NYU09-203

AC   CVCL_T594

RX   PubMed=22404973;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NYU10-040

AC   CVCL_T595

RX   PubMed=22404973;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NYU10-230

AC   CVCL_T596

RX   PubMed=22404973;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NYUES1

AC   CVCL_B869

SY   NYUES 1

DR   ISCR; 793

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=180

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0045.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   NYUES10

AC   CVCL_B876

DR   ISCR; 1895

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=683

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0240.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NYUES11

AC   CVCL_B877

DR   ISCR; 1896

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=640

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0236.

DI   NCIt; C116344; Trisomy 14

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NYUES12

AC   CVCL_B878

DR   ISCR; 1897

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=638

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0235.

DI   NCIt; C37865; Trisomy 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   NYUES13

AC   CVCL_M246

DR   ISCR; 2281

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=641

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0237.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   NYUES2

AC   CVCL_B870

SY   NYUES 2

DR   ISCR; 794

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=181

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0046.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   NYUES3

AC   CVCL_B871

SY   NYUES 3

DR   ISCR; 795

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=182

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0047.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NYUES4

AC   CVCL_B872

SY   NYUES 4

DR   ISCR; 796

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=183

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0048.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   NYUES5

AC   CVCL_B873

SY   NYUES 5

DR   ISCR; 797

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=184

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0049.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   NYUES6

AC   CVCL_B874

SY   NYUES 6

DR   ISCR; 798

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=185

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0050.

DI   NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NYUES7

AC   CVCL_B875

SY   NYUES 7

DR   ISCR; 799

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=186

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0051.

DI   NCIt; C36100; BRCA1 syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   NYUES8

AC   CVCL_B879

DR   ISCR; 1898

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=681

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0238.

DI   NCIt; C85239; Zellweger syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   NYUES9

AC   CVCL_B880

DR   ISCR; 1899

RX   PubMed=22204497;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=682

CC   From: New York University School of Medicine; New York; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0239.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   NZM1

AC   CVCL_D815

SY   NZM01; NZM001

DR   Cosmic; 2007642

DR   Cosmic; 2141929

RX   PubMed=7999427;

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=23658559;

RX   PubMed=24455489;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Obturator lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D823 ! NZM2

SX   Male

CA   Cancer cell line

//

ID   NZM10

AC   CVCL_D816

DR   Cosmic; 1660296

DR   Cosmic; 2007650

RX   PubMed=11216673;

RX   PubMed=22475322;

RX   PubMed=23658559;

CC   Derived from metastatic site: Lung.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM100

AC   CVCL_0B53

DR   Cosmic; 2141924

RX   PubMed=23755070;

RX   PubMed=24455489;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM101

AC   CVCL_0D60

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM102

AC   CVCL_0D61

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM103

AC   CVCL_0D62

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM104

AC   CVCL_0D63

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM105

AC   CVCL_0D64

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM106

AC   CVCL_0D65

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM11

AC   CVCL_D817

SY   NZM011

DR   Cosmic; 2007651

DR   Cosmic; 2141926

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=23658559;

RX   PubMed=23755070;

RX   PubMed=24455489;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Subcutaneous lesion.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM12

AC   CVCL_D818

DR   Cosmic; 1660300

RX   CelloPub=CLPUB00227;

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=22475322;

RX   PubMed=23755070;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Small intestine.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM13

AC   CVCL_D819

DR   Cosmic; 2007652

RX   CelloPub=CLPUB00227;

RX   PubMed=11216673;

RX   PubMed=23658559;

RX   PubMed=23755070;

CC   Derived from metastatic site: Neck nodule.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NZM14

AC   CVCL_D820

DR   Cosmic; 2007653

RX   PubMed=11216673;

RX   PubMed=23658559;

CC   Derived from metastatic site: Thigh skeletal muscle.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM15

AC   CVCL_D821

DR   Cosmic; 1660297

DR   Cosmic; 2007654

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=22475322;

RX   PubMed=23658559;

RX   PubMed=23755070;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Subcutaneous neck nodule.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM16

AC   CVCL_S436

RX   CelloPub=CLPUB00227;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM17

AC   CVCL_S437

SY   NZM017; NZM 017

DR   Cosmic; 2007655

DR   Cosmic; 2141931

RX   CelloPub=CLPUB00227;

RX   PubMed=23658559;

RX   PubMed=23755070;

RX   PubMed=24455489;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM18

AC   CVCL_S438

RX   CelloPub=CLPUB00227;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM19

AC   CVCL_D822

DR   Cosmic; 2007656

RX   CelloPub=CLPUB00227;

RX   PubMed=20041153;

RX   PubMed=23658559;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM2

AC   CVCL_D823

SY   NZM02

DR   Cosmic; 2007643

RX   CelloPub=CLPUB00227;

RX   PubMed=7999427;

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=23658559;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Deep iliac lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D815 ! NZM1

SX   Male

CA   Cancer cell line

//

ID   NZM20

AC   CVCL_D824

SY   NZM020

DR   Cosmic; 2007657

DR   Cosmic; 2141927

RX   PubMed=20041153;

RX   PubMed=23658559;

RX   PubMed=23755070;

RX   PubMed=24455489;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM21

AC   CVCL_S435

DR   Cosmic; 2007658

RX   CelloPub=CLPUB00227;

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM22

AC   CVCL_D825

DR   Cosmic; 2007659

RX   CelloPub=CLPUB00227;

RX   PubMed=20041153;

RX   PubMed=23658559;

RX   PubMed=23755070;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM23

AC   CVCL_D826

DR   Cosmic; 2007660

RX   PubMed=20041153;

RX   PubMed=23658559;

RX   PubMed=23755070;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM24

AC   CVCL_D827

DR   Cosmic; 2007661

RX   CelloPub=CLPUB00227;

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S430 ! NZM25

CA   Cancer cell line

//

ID   NZM25

AC   CVCL_S430

RX   CelloPub=CLPUB00227;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D827 ! NZM24

CA   Cancer cell line

//

ID   NZM26

AC   CVCL_S431

RX   CelloPub=CLPUB00227;

RX   PubMed=23755070;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM27

AC   CVCL_S432

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM28

AC   CVCL_S433

DR   Cosmic; 2007662

RX   CelloPub=CLPUB00227;

RX   PubMed=23658559;

RX   PubMed=23755070;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM29

AC   CVCL_S434

DR   Cosmic; 2007663

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM3

AC   CVCL_D828

SY   NZM03; NZM003

DR   Cosmic; 1660299

DR   Cosmic; 2007644

DR   Cosmic; 2406331

RX   CelloPub=CLPUB00227;

RX   PubMed=7999427;

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=22475322;

RX   PubMed=23658559;

RX   PubMed=23755070;

RX   PubMed=24455489;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Cervical lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM30

AC   CVCL_D829

SY   NZM030

DR   Cosmic; 1660292

DR   Cosmic; 2007664

DR   Cosmic; 2406334

RX   CelloPub=CLPUB00227;

RX   PubMed=22475322;

RX   PubMed=23658559;

RX   PubMed=24455489;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM31

AC   CVCL_S439

DR   Cosmic; 2007665

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM32

AC   CVCL_0D28

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM33

AC   CVCL_S440

DR   Cosmic; 2007666

RX   CelloPub=CLPUB00227;

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM34

AC   CVCL_D830

SY   NZM034

DR   Cosmic; 1660290

DR   Cosmic; 2007667

DR   Cosmic; 2406335

RX   CelloPub=CLPUB00227;

RX   PubMed=22475322;

RX   PubMed=23658559;

RX   PubMed=24455489;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM35

AC   CVCL_S427

DR   Cosmic; 2007668

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM36

AC   CVCL_S428

DR   Cosmic; 2007669

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM37

AC   CVCL_S449

DR   Cosmic; 2007670

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM38

AC   CVCL_S450

DR   Cosmic; 2007671

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM39

AC   CVCL_S429

DR   Cosmic; 2007672

RX   PubMed=23658559;

RX   PubMed=23755070;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM4

AC   CVCL_D831

SY   NZM04; NZM004

DR   Cosmic; 2007645

DR   Cosmic; 2141925

RX   CelloPub=CLPUB00227;

RX   PubMed=7999427;

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=23658559;

RX   PubMed=23755070;

RX   PubMed=24455489;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM40

AC   CVCL_D832

SY   NZM040; NZM 040

DR   Cosmic; 1660293

DR   Cosmic; 2007673

DR   Cosmic; 2406332

RX   PubMed=20041153;

RX   PubMed=22475322;

RX   PubMed=23658559;

RX   PubMed=23755070;

RX   PubMed=24455489;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM41

AC   CVCL_S426

DR   Cosmic; 2007674

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM42

AC   CVCL_D833

DR   Cosmic; 1660298

RX   PubMed=20041153;

RX   PubMed=22475322;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S423 ! NZM48

CA   Cancer cell line

//

ID   NZM43

AC   CVCL_D834

DR   Cosmic; 1660291

DR   Cosmic; 2007675

RX   PubMed=22475322;

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM44

AC   CVCL_S425

DR   Cosmic; 2007676

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM45

AC   CVCL_D835

DR   Cosmic; 2007677

RX   PubMed=20041153;

RX   PubMed=23658559;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM46

AC   CVCL_D836

SY   NZM046

DR   Cosmic; 1660294

DR   Cosmic; 2007678

DR   Cosmic; 2406336

RX   PubMed=20041153;

RX   PubMed=22475322;

RX   PubMed=23658559;

RX   PubMed=24455489;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM47

AC   CVCL_S424

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM48

AC   CVCL_S423

DR   Cosmic; 2007679

RX   PubMed=23658559;

RX   PubMed=23755070;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D833 ! NZM42

CA   Cancer cell line

//

ID   NZM49

AC   CVCL_S422

DR   Cosmic; 2007680

RX   PubMed=23658559;

RX   PubMed=23755070;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM5

AC   CVCL_D837

SY   NZM05

DR   Cosmic; 2007646

RX   CelloPub=CLPUB00227;

RX   PubMed=7999427;

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=23658559;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM50

AC   CVCL_S421

RX   PubMed=23755070;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM51

AC   CVCL_S420

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM52

AC   CVCL_D838

DR   Cosmic; 1660295

RX   PubMed=20041153;

RX   PubMed=22475322;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM53

AC   CVCL_D839

RX   PubMed=20041153;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM54

AC   CVCL_0D29

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM55

AC   CVCL_S419

SY   NZM055

DR   Cosmic; 2007681

DR   Cosmic; 2141921

RX   PubMed=23658559;

RX   PubMed=24455489;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM56

AC   CVCL_S418

DR   Cosmic; 2007682

RX   CelloPub=CLPUB00227;

RX   PubMed=23658559;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM57

AC   CVCL_D840

RX   PubMed=20041153;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM58

AC   CVCL_D841

DR   Cosmic; 2007683

RX   PubMed=20041153;

RX   PubMed=23658559;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM59

AC   CVCL_0B54

RX   PubMed=23755070;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM6

AC   CVCL_D842

SY   NZM06; NZM006

DR   Cosmic; 1660289

DR   Cosmic; 2007647

DR   Cosmic; 2406333

RX   CelloPub=CLPUB00227;

RX   PubMed=7999427;

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=22475322;

RX   PubMed=23658559;

RX   PubMed=24455489;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Small intestine.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NZM60

AC   CVCL_S416

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM61

AC   CVCL_S417

SY   NZM061

DR   Cosmic; 2007684

DR   Cosmic; 2141922

RX   PubMed=23658559;

RX   PubMed=24455489;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM62

AC   CVCL_0D26

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0D27 ! NZM64

CA   Cancer cell line

//

ID   NZM63

AC   CVCL_S441

SY   NZM063

DR   Cosmic; 2007685

DR   Cosmic; 2141932

RX   PubMed=23658559;

RX   PubMed=24455489;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM64

AC   CVCL_0D27

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0D26 ! NZM62

CA   Cancer cell line

//

ID   NZM65

AC   CVCL_0D30

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM66

AC   CVCL_0D31

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM67

AC   CVCL_0D32

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM68

AC   CVCL_0D33

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM69

AC   CVCL_0D34

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM7

AC   CVCL_D843

SY   NZM07; NZM007

DR   Cosmic; 2007648

DR   Cosmic; 2141920

RX   PubMed=7999427;

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=23658559;

RX   PubMed=23755070;

RX   PubMed=24455489;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Cervical lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM7.2

AC   CVCL_D844

SY   NZM07.2

RX   PubMed=11216673;

RX   PubMed=20041153;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Cervical lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D843 ! NZM7

SX   Male

CA   Cancer cell line

//

ID   NZM7.4

AC   CVCL_D845

SY   NZM07.4

RX   PubMed=11216673;

RX   PubMed=20041153;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Cervical lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D843 ! NZM7

SX   Male

CA   Cancer cell line

//

ID   NZM70

AC   CVCL_0D35

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM71

AC   CVCL_0C85

RX   PubMed=23755070;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM72

AC   CVCL_0D36

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM73

AC   CVCL_0D37

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM74

AC   CVCL_0D38

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM75

AC   CVCL_0D39

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM76

AC   CVCL_0B51

SY   NZM076

DR   Cosmic; 2141928

RX   PubMed=24455489;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM77

AC   CVCL_0D40

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM78

AC   CVCL_0D41

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM79

AC   CVCL_0D42

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM8

AC   CVCL_D846

SY   NZM08

RX   PubMed=7718330;

RX   PubMed=11216673;

CC   Miscellaneous: Cell line has been lost.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM80

AC   CVCL_0D43

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM81

AC   CVCL_0D44

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM82

AC   CVCL_0B55

RX   PubMed=23755070;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM83

AC   CVCL_0D45

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM84

AC   CVCL_0D46

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM85

AC   CVCL_0B56

RX   PubMed=23755070;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM86

AC   CVCL_0B52

SY   NZM086

DR   Cosmic; 2141923

RX   PubMed=23755070;

RX   PubMed=24455489;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM87

AC   CVCL_0D47

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM88

AC   CVCL_0D48

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM89

AC   CVCL_0D49

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM9

AC   CVCL_D847

SY   NZM09; NZM009

DR   Cosmic; 2007649

DR   Cosmic; 2141930

RX   CelloPub=CLPUB00227;

RX   PubMed=11216673;

RX   PubMed=20041153;

RX   PubMed=23658559;

RX   PubMed=23755070;

RX   PubMed=24455489;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NZM90

AC   CVCL_0D50

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM91

AC   CVCL_0D51

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM92

AC   CVCL_0D52

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM93

AC   CVCL_0D53

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM94

AC   CVCL_0D54

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM95

AC   CVCL_0D55

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM96

AC   CVCL_0D56

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM97

AC   CVCL_0D57

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM98

AC   CVCL_0D58

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZM99

AC   CVCL_0D59

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NZOV1

AC   CVCL_D811

SY   NZ-OV1

RX   PubMed=7718330;

RX   PubMed=21912889;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NZOV10

AC   CVCL_D814

RX   PubMed=21912889;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NZOV11

AC   CVCL_D810

RX   PubMed=21912889;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NZOV2

AC   CVCL_D812

RX   PubMed=21912889;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NZOV8

AC   CVCL_D813

RX   PubMed=21912889;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NZP-12

AC   CVCL_3759

SY   National Zoological Park-12

DR   CLO; CLO_0008216

DR   ATCC; CRL-1921

OX   NCBI_TaxID=71111; ! Crossarchus obscurus

CA   Finite cell line

//

ID   NZP-29

AC   CVCL_3760

SY   National Zoological Park-29

DR   CLO; CLO_0008217

DR   ATCC; CRL-1925

OX   NCBI_TaxID=59534; ! Oryx dammah

CA   Finite cell line

//

ID   NZP-36

AC   CVCL_3761

SY   National Zoological Park-36

DR   CLO; CLO_0008218

DR   ATCC; CRL-1922

OX   NCBI_TaxID=9790; ! Equus burchelli

CA   Finite cell line

//

ID   NZP-46

AC   CVCL_6340

SY   National Zoological Park-46

DR   ATCC; CRL-1926

OX   NCBI_TaxID=64678; ! Callosciurus notatus

CA   Finite cell line

//

ID   NZP-53

AC   CVCL_V311

SY   National Zoological Park-53

DR   ATCC; CRL-1920

CC   Discontinued: ATCC; CRL-1920; true.

OX   NCBI_TaxID=9646; ! Ailuropoda melanoleuca

CA   Finite cell line

//

ID   NZP-60

AC   CVCL_3762

SY   National Zoological Park-60

DR   CLO; CLO_0008220

DR   ATCC; CRL-1924

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9482; ! Callithrix argentata

CA   Finite cell line

//

ID   O-342

AC   CVCL_5847

DR   CLS; 500305/p662_O-342

RX   PubMed=1744159;

RX   PubMed=2121738;

CC   Doubling time: ~24 hours (PubMed=1744159).

CC   Breed/subspecies: BDIX.

DI   NCIt; C129858; Adenocarcinoma of the rat ovary

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Cancer cell line

//

ID   O-342/DDP

AC   CVCL_5J47

RX   PubMed=1744159;

RX   PubMed=2121738;

CC   Doubling time: ~24 hours (PubMed=1744159).

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Breed/subspecies: BDIX.

DI   NCIt; C129858; Adenocarcinoma of the rat ovary

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_5847 ! O-342

SX   Female

CA   Cancer cell line

//

ID   O24B

AC   CVCL_W083

DR   Cosmic; 1522767

DR   GEO; GSM726280

RX   PubMed=21642991;

CC   Omics: SNP array analysis.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   O9-1

AC   CVCL_GS42

DR   Millipore; SCC049

RX   PubMed=22889333;

CC   Characteristics: Neural crest cell line capable of differentiating into four cell types: osteoblasts, chondrocytes, smooth muscle cells, and glial cells.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   OA1

AC   CVCL_3763

DR   CLO; CLO_0008224

DR   CLDB; cl3754

DR   ATCC; CRL-6538

DR   IZSLER; BS CL 109

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Female

CA   Finite cell line

//

ID   OA2.Sk

AC   CVCL_S362

DR   ATCC; CRL-6539

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6539; true.

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Sex undetermined

CA   Finite cell line

//

ID   OA3.Bm

AC   CVCL_S363

DR   ATCC; CRL-6540

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6540; true.

OX   NCBI_TaxID=9940; ! Ovis aries

OI   CVCL_R786 ! OA3.Lu

OI   CVCL_3764 ! OA3.Ts

SX   Male

CA   Finite cell line

//

ID   OA3.Lu

AC   CVCL_R786

DR   ATCC; CRL-6545

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6545; true.

OX   NCBI_TaxID=9940; ! Ovis aries

OI   CVCL_S363 ! OA3.Bm

OI   CVCL_3764 ! OA3.Ts

SX   Male

CA   Finite cell line

//

ID   OA3.Ts

AC   CVCL_3764

SY   OAT-T3

DR   CLO; CLO_0008225

DR   ATCC; CRL-6546

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX   NCBI_TaxID=9940; ! Ovis aries

OI   CVCL_S363 ! OA3.Bm

OI   CVCL_R786 ! OA3.Lu

SX   Male

CA   Finite cell line

//

ID   OA4.Bm

AC   CVCL_3765

DR   CLO; CLO_0008226

DR   ATCC; CRL-6547

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6547; true.

OX   NCBI_TaxID=9940; ! Ovis aries

OI   CVCL_R785 ! OA4.K

OI   CVCL_6426 ! OA4.K/S1

OI   CVCL_S364 ! OA4.Tes

SX   Male

CA   Finite cell line

//

ID   OA4.K

AC   CVCL_R785

DR   ATCC; CRL-6548

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6548; true.

OX   NCBI_TaxID=9940; ! Ovis aries

OI   CVCL_3765 ! OA4.Bm

OI   CVCL_6426 ! OA4.K/S1

OI   CVCL_S364 ! OA4.Tes

SX   Male

CA   Finite cell line

//

ID   OA4.K/S1

AC   CVCL_6426

DR   CLO; CLO_0008227

DR   ATCC; CRL-6549

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX   NCBI_TaxID=9940; ! Ovis aries

OI   CVCL_3765 ! OA4.Bm

OI   CVCL_R785 ! OA4.K

OI   CVCL_S364 ! OA4.Tes

SX   Male

CA   Finite cell line

//

ID   OA4.Tes

AC   CVCL_S364

DR   ATCC; CRL-6550

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6550; true.

OX   NCBI_TaxID=9940; ! Ovis aries

OI   CVCL_3765 ! OA4.Bm

OI   CVCL_R785 ! OA4.K

OI   CVCL_6426 ! OA4.K/S1

SX   Male

CA   Finite cell line

//

ID   OACM4.1 C

AC   CVCL_2249

SY   OAC-M4.1 C

RX   PubMed=11407472;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4025; Esophageal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1843 ! OACP4 C

SX   Male

CA   Cancer cell line

//

ID   OACM5.1 C

AC   CVCL_1842

SY   OAC-M5.1 C; OAC-M5.1; OACM5-1; OACM5.1; OACM5_1

DR   BioSample; SAMN03473445

DR   Cosmic; 1599344

DR   Cosmic-CLP; 1503363

DR   DSMZ; ACC-696

DR   ECACC; 11012006

DR   GDSC; 1503363

DR   GEO; GSM1670290

RX   PubMed=11407472;

RX   PubMed=20075370;

RX   PubMed=23795680;

RX   PubMed=27397505;

CC   Doubling time: ~48 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Cosmic-CLP; DSMZ; ECACC

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D5S818: 11,12

ST   D7S820: 8 (Cosmic-CLP; DSMZ)

ST   D7S820: 8.2 (ECACC)

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 19,20

DI   NCIt; C4025; Esophageal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OACP4 C

AC   CVCL_1843

SY   OAC-P4C; OACP4C; OACp4C

DR   BioSample; SAMN03473391

DR   Cosmic; 1599345

DR   Cosmic-CLP; 1503362

DR   DSMZ; ACC-704

DR   ECACC; 11012005

DR   GDSC; 1503362

DR   GEO; GSM1670291

RX   PubMed=11407472;

RX   PubMed=20075370;

RX   PubMed=23795680;

RX   PubMed=27397505;

CC   Doubling time: ~35-50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Misspelling: 'OACP4CE' in PubMed=23795680.

ST   Source(s): Cosmic-CLP; DSMZ; ECACC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 12

ST   D5S818: 9

ST   D7S820: 9,11

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4025; Esophageal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2249 ! OACM4.1 C

SX   Male

CA   Cancer cell line

//

ID   OAD2

AC   CVCL_Z080

RX   PubMed=12569360;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OANC1

AC   CVCL_W891

DR   Cosmic; 2030752

RX   PubMed=24077944;

DI   NCIt; C7027; Barrett adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OAT-1975

AC   CVCL_X185

SY   OAT 75; Oat 75; Oat-75

RX   PubMed=195719;

CC   Doubling time: 24 hours (PubMed=195719).

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OAW28

AC   CVCL_1614

SY   OAW-28; OAW 28

DR   CLO; CLO_0008228

DR   EFO; EFO_0006704

DR   CLDB; cl3756

DR   BioSample; SAMN03472477

DR   CCLE; OAW28_OVARY

DR   ChEMBL-Cells; CHEMBL3308479

DR   ChEMBL-Targets; CHEMBL1075553

DR   Cosmic; 946360

DR   Cosmic; 1707570

DR   Cosmic-CLP; 946360

DR   ECACC; 85101601

DR   GDSC; 946360

DR   GEO; GSM659383

DR   GEO; GSM827435

DR   GEO; GSM887464

DR   GEO; GSM888544

DR   GEO; GSM1374778

DR   GEO; GSM1670292

RX   PubMed=2653399;

RX   PubMed=8795574;

RX   PubMed=22460905;

RX   PubMed=23415752;

RX   PubMed=23839242;

RX   PubMed=25230021;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'OWA28' in Cosmic 1707570.

CC   Derived from metastatic site: Ascites.

ST   Source(s): Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 13

ST   D18S51: 12,14

ST   D19S433: 13

ST   D21S11: 29

ST   D2S1338: 20,23

ST   D3S1358: 14,18

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 11,15

ST   FGA: 21,24

ST   Penta D: 9

ST   Penta E: 7

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17,19

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OAW42

AC   CVCL_1615

SY   OAW-42; OAW 42

DR   CLO; CLO_0008229

DR   EFO; EFO_0006705

DR   CLDB; cl3757

DR   BioSample; SAMN03472455

DR   CCLE; OAW42_OVARY

DR   ChEMBL-Cells; CHEMBL3308397

DR   ChEMBL-Targets; CHEMBL1075554

DR   CLS; 300304/p577_OAW-42

DR   Cosmic; 688103

DR   Cosmic; 910548

DR   Cosmic; 1609537

DR   Cosmic; 1707560

DR   Cosmic-CLP; 910548

DR   ECACC; 85073102

DR   GDSC; 910548

DR   GEO; GSM313710

DR   GEO; GSM659384

DR   GEO; GSM827350

DR   GEO; GSM887465

DR   GEO; GSM888545

DR   GEO; GSM1374779

DR   GEO; GSM1670293

RX   PubMed=2653399;

RX   PubMed=8795574;

RX   PubMed=11414198;

RX   PubMed=22460905;

RX   PubMed=23415752;

RX   PubMed=23839242;

RX   PubMed=25230021;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Doubling time: 40 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): CLS; Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 12,13

ST   D18S51: 16,21

ST   D19S433: 13,14

ST   D21S11: 26

ST   D2S1338: 17

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 8

ST   D8S1179: 13

ST   FGA: 22,25

ST   Penta D: 10

ST   Penta E: 12

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 15,16 (CLS; Cosmic-CLP; ECACC; PubMed=25877200)

ST   vWA: 14,16 (PubMed=25230021)

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OAW42-A

AC   CVCL_W125

RX   PubMed=8100138;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C5228; Ovarian cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1615 ! OAW42

SX   Female

CA   Cancer cell line

//

ID   ob 17

AC   CVCL_S603

SY   OB 17; ob17; Ob17

RX   PubMed=216011;

RX   PubMed=6352350;

CC   Doubling time: 12.5 hours (in 10% fetal calf serum), 19 hours (in 1% fetal calf serum) (PubMed=216011).

CC   Breed/subspecies: C57BL/6J ob/ob.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   OB-6

AC   CVCL_D626

DR   TOKU-E; 4092

RX   PubMed=10412038;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   Ob1754

AC   CVCL_S606

RX   PubMed=3800927;

CC   Breed/subspecies: C57BL/6J ob/ob.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S603 ! ob 17

CA   Spontaneously immortalized cell line

//

ID   Ob1771

AC   CVCL_0476

SY   OB1771; Ob 1771

DR   MCCL; MCC:0000374

RX   PubMed=3800927;

RX   PubMed=3814078;

CC   Breed/subspecies: C57BL/6J ob/ob.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S603 ! ob 17

CA   Spontaneously immortalized cell line

//

ID   ob17MT

AC   CVCL_S604

SY   Ob17MT; ob17MT1

RX   PubMed=6089203;

CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).

CC   Breed/subspecies: C57BL/6J ob/ob.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S603 ! ob 17

CA   Transformed cell line

//

ID   ob17PY

AC   CVCL_S605

SY   Ob17PY; ob17PY1

RX   PubMed=6089203;

CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).

CC   Breed/subspecies: C57BL/6J ob/ob.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S603 ! ob 17

CA   Transformed cell line

//

ID   Oba-BL

AC   CVCL_W931

SY   OBA-BL; OBA BL; OBA

RX   PubMed=2824665;

RX   PubMed=2898508;

RX   PubMed=2943927;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OBC13

AC   CVCL_9W25

RX   PubMed=2307979;

CC   Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: v-Myc.

CC   Breed/subspecies: C57BL/6 x CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OBCK6

AC   CVCL_U886

RX   PubMed=2246327;

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Spontaneously immortalized cell line

//

ID   OBGF400

AC   CVCL_AS93

RX   PubMed=18358537;

RX   PubMed=19937495;

CC   Transfected with: HGNC; 11730; TERT.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Female

CA   Telomerase immortalized cell line

//

ID   OBL21

AC   CVCL_9W26

SY   OBL-21

RX   PubMed=2307979;

CC   Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: v-Myc.

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OBL21A

AC   CVCL_9W27

SY   OBL21a; OBL 21A

RX   PubMed=2307979;

CC   Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: v-Myc.

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_9W26 ! OBL21

CA   Transformed cell line

//

ID   OBL24

AC   CVCL_9W28

RX   PubMed=2307979;

CC   Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: v-Myc.

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OC 314

AC   CVCL_1616

SY   OC-314; OC314

DR   CLO; CLO_0008231

DR   CCLE; OC314_OVARY

DR   ChEMBL-Cells; CHEMBL3308244

DR   ChEMBL-Targets; CHEMBL2366288

DR   Cosmic; 909257

DR   Cosmic-CLP; 909257

DR   GDSC; 909257

DR   GEO; GSM459736

DR   GEO; GSM887466

DR   GEO; GSM888546

DR   GEO; GSM1670294

DR   ICLC; HTL98015

RX   PubMed=8690298;

RX   PubMed=15677628;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Instable (MSI-high) (PubMed=15677628; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ICLC; HTL98015; true.

CC   Derived from metastatic site: Ascites.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,9

ST   D16S539: 10,11,12

ST   D5S818: 10,12

ST   D7S820: 11

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 15,19

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OC 315

AC   CVCL_1617

SY   OC-315; OC315

DR   CLO; CLO_0008232

DR   CCLE; OC315_OVARY

DR   GEO; GSM459737

DR   ICLC; HTL98013

RX   PubMed=8690298;

RX   PubMed=15677628;

CC   Problematic cell line: Possibly contaminated. May be identical to OC 314 (CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Instable (MSI-high) (PubMed=15677628).

CC   Discontinued: ICLC; HTL98013; true.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OC 316

AC   CVCL_1618

SY   OC-316; OC316

DR   CLO; CLO_0008233

DR   CCLE; OC316_OVARY

DR   GEO; GSM887467

DR   GEO; GSM888547

DR   ICLC; HTL98014

RX   PubMed=8690298;

RX   PubMed=15677628;

RX   PubMed=22460905;

RX   PubMed=23415752;

RX   PubMed=23839242;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Problematic cell line: Possibly contaminated. May be identical to OC 314 (CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-high) (PubMed=15677628).

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ICLC; HTL98014; true.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OC-109

AC   CVCL_GT33

RX   PubMed=7947929;

RX   PubMed=7959295;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OC-109-VGH

AC   CVCL_GT34

DR   BCRC; 60601

RX   CelloPub=CLPUB00352;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OC-117-VGH

AC   CVCL_GT35

SY   VGH-OC-117

DR   BCRC; 60602

RX   PubMed=10592434;

RX   PubMed=16138714;

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OC-238

AC   CVCL_GT36

RX   PubMed=7947929;

RX   PubMed=7959295;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OC-3-VGH

AC   CVCL_GT37

DR   BCRC; 60599

RX   PubMed=3455323;

CC   Doubling time: 48 hours (BCRC).

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OC-7-NU

AC   CVCL_GT38

RX   PubMed=7947929;

RX   PubMed=7959295;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OC-89-VGH

AC   CVCL_GT39

SY   VGH-OC-89

RX   CelloPub=CLPUB00350;

RX   PubMed=10592434;

DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OC-k1

AC   CVCL_D799

RX   PubMed=10562438;

RX   PubMed=12382283;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   OC-k2

AC   CVCL_D800

RX   PubMed=10562438;

RX   PubMed=12382283;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   OC-k3

AC   CVCL_D801

SY   OCk3

RX   PubMed=10562438;

RX   PubMed=12382283;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   OC-k4

AC   CVCL_D802

RX   PubMed=10562438;

RX   PubMed=12382283;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   OC/CDE 14

AC   CVCL_U975

RX   PubMed=7679995;

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   OC/CDE 22

AC   CVCL_U976

SY   OC/CDE-22; OC/CDE22

DR   BTO; BTO:0002198

RX   PubMed=7526039;

RX   PubMed=7532542;

RX   PubMed=7679995;

RX   PubMed=11751433;

RX   PubMed=12075625;

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   OC/CDE 6

AC   CVCL_U977

SY   OC/CDE6

RX   PubMed=7526039;

RX   PubMed=7532542;

RX   PubMed=7679995;

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   OC10B

AC   CVCL_6G52

RX   PubMed=9495512;

CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   OC15

AC   CVCL_0E97

SY   OC 15

RX   PubMed=988033;

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_5572 ! OTT6050

SX   Male

CA   Cancer cell line

//

ID   Oc2T(VX7)

AC   CVCL_S376

SY   OC 2T

DR   ATCC; CRL-6594

RX   PubMed=6500159;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6594; true.

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

HI   CVCL_3470 ! Vx7

CA   Cancer cell line

//

ID   OC3

AC   CVCL_D859

SY   OC-3

DR   BTO; BTO:0004006

RX   PubMed=14720193;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Oc4T/cc

AC   CVCL_T725

SY   Oc 4T

DR   ATCC; CRL-6501

RX   PubMed=6500159;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6501; true.

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

HI   CVCL_3470 ! Vx7

CA   Cancer cell line

//

ID   OCC/PI

AC   CVCL_EG06

SY   OCC/Permanent I

RX   PubMed=27356577;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCC/PII

AC   CVCL_EG07

SY   OCC/Permanent II

RX   PubMed=27356577;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCC1

AC   CVCL_C829

SY   OCC-1

RX   PubMed=2354825;

RX   PubMed=23415752;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCCC33

AC   CVCL_EI99

DR   Cosmic; 1493899

RX   PubMed=21381030;

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCD

AC   CVCL_5848

DR   CLS; 400417/p2781_OCD

CC   Breed/subspecies: NMRI.

DI   NCIt; C22964; Osteochondroma of the mouse skeletal system

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   OCI-AML1

AC   CVCL_5228

SY   OCI/AML1; OCI/AML-1; OCI-AML-1; OCIAML1

DR   Cosmic; 787465

DR   Cosmic; 975287

DR   Cosmic; 1281343

DR   Cosmic; 1319544

DR   Cosmic; 2306230

DR   DSMZ; ACC-726

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: ~3-4 days (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 12,13

ST   D16S539: 11

ST   D5S818: 11,13

ST   D7S820: 10

ST   TH01: 8,9.3

ST   TPOX: 11

ST   vWA: 16,18

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-AML1a

AC   CVCL_5225

SY   OCI/AML1a; OCI/AML-1a

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=OCI%2fAML1a

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5228 ! OCI-AML1

SX   Female

CA   Cancer cell line

//

ID   OCI-AML2

AC   CVCL_1619

SY   OCI AML2; OCI-AML-2; OCI/AML-2; OCIAML2; AML-2

DR   BTO; BTO:0004619

DR   CLO; CLO_0008235

DR   EFO; EFO_0006706

DR   CLDB; cl3760

DR   CLDB; cl7059

DR   BioSample; SAMN03473106

DR   BCRJ; 0383

DR   CCLE; OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308300

DR   ChEMBL-Targets; CHEMBL2366220

DR   Cosmic; 787466

DR   Cosmic; 910947

DR   Cosmic; 975288

DR   Cosmic; 1012109

DR   Cosmic; 1281344

DR   Cosmic; 1319545

DR   Cosmic; 1582386

DR   Cosmic; 2131551

DR   Cosmic; 2306231

DR   Cosmic-CLP; 910947

DR   DSMZ; ACC-99

DR   GDSC; 910947

DR   GEO; GSM482511

DR   GEO; GSM887468

DR   GEO; GSM888548

DR   GEO; GSM1374780

DR   GEO; GSM1670295

DR   ICLC; HTL01010

RX   PubMed=15843827;

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: 30 hours (PubMed=25984343); ~30-50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D18S51: 14

ST   D21S11: 29

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 12

ST   D8S1179: 12,15

ST   FGA: 19,24

ST   Penta D: 12

ST   Penta E: 12,14

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 14,17

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCI-AML3

AC   CVCL_1844

SY   OCI AML3; OCI-AML-3; OCI/AML-3; OCI/AML3; OCIAML3

DR   BTO; BTO:0004620

DR   EFO; EFO_0006289

DR   BioSample; SAMN03473107

DR   CCLE; OCIAML3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 787467

DR   Cosmic; 975289

DR   Cosmic; 1012110

DR   Cosmic; 1127258

DR   Cosmic; 1245831

DR   Cosmic; 1319546

DR   Cosmic; 1557602

DR   Cosmic; 1582387

DR   Cosmic; 1696140

DR   Cosmic; 1779129

DR   Cosmic; 2131552

DR   Cosmic; 2306232

DR   Cosmic-CLP; 1290455

DR   DSMZ; ACC-582

DR   GDSC; 1290455

DR   GEO; GSM482512

DR   GEO; GSM887469

DR   GEO; GSM888549

DR   GEO; GSM1670296

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: 28 hours (PubMed=25984343); ~35-40 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,13

ST   D16S539: 11,13

ST   D18S51: 12,18

ST   D21S11: 29,30

ST   D3S1358: 16

ST   D5S818: 11,13

ST   D7S820: 9,10

ST   D8S1179: 10,12

ST   FGA: 22

ST   Penta D: 12,13

ST   Penta E: 11,13

ST   TH01: 8,10

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCI-AML4

AC   CVCL_5224

SY   OCI AML4; OCI-AML-4; OCI/AML-4; OCIAML4

DR   Cosmic; 787468

DR   Cosmic; 975290

DR   Cosmic; 1281345

DR   Cosmic; 1319547

DR   Cosmic; 2306233

DR   DSMZ; ACC-729

RX   PubMed=1715961;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: ~24-30 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 11

ST   D5S818: 11,12

ST   D7S820: 12

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 14,17

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-AML5

AC   CVCL_1620

SY   OCI AML5; OCI-AML-5; OCI/AML-5; OCIAML5

DR   BTO; BTO:0004621

DR   CLO; CLO_0008236

DR   EFO; EFO_0006707

DR   BioSample; SAMN03472968

DR   BioSample; SAMN03473389

DR   CCLE; OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 787469

DR   Cosmic; 975291

DR   Cosmic; 1012111

DR   Cosmic; 1281346

DR   Cosmic; 1319548

DR   Cosmic; 2131553

DR   Cosmic; 2306234

DR   Cosmic-CLP; 1330983

DR   DSMZ; ACC-247

DR   GDSC; 1330983

DR   GEO; GSM887470

DR   GEO; GSM888550

DR   GEO; GSM1374781

DR   GEO; GSM1374782

DR   GEO; GSM1670297

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: 28 hours (PubMed=25984343); ~30-50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,14

ST   D16S539: 11,13

ST   D18S51: 15,17

ST   D21S11: 28,32.2

ST   D3S1358: 18

ST   D5S818: 12,13

ST   D7S820: 11,12

ST   D8S1179: 13,14

ST   FGA: 19,24

ST   Penta D: 9

ST   Penta E: 13,18

ST   TH01: 7,9.3 (Cosmic-CLP; DSMZ)

ST   TH01: 9.3 (PubMed=25877200)

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCI-AML6

AC   CVCL_5226

SY   OCI AML6; OCI-AML-6; OCI/AML-6; OCI/AML6; OCIAML6

DR   Cosmic; 787470

DR   Cosmic; 975292

DR   Cosmic; 1281347

DR   DSMZ; ACC-730

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: ~3-5 days (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,13

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 12

ST   TH01: 7,9.3

ST   TPOX: 10,11

ST   vWA: 17

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-AML6.2

AC   CVCL_5227

SY   OCI AML6.2; OCI-AML-6.2; OCI/AML-6.2

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5226 ! OCI-AML6

SX   Female

CA   Cancer cell line

//

ID   OCI-C1p

AC   CVCL_DH02

DR   GEO; GSM1001406

DR   GEO; GSM1001443

DR   GEO; GSM1001467

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 10,12

ST   TH01: 7,9.3

ST   TPOX: 9,11

ST   vWA: 16,17

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-C2p

AC   CVCL_DH03

DR   GEO; GSM1001415

DR   GEO; GSM1001452

DR   GEO; GSM1001462

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 8,13

ST   D5S818: 10,12

ST   D7S820: 9,11

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-C3x

AC   CVCL_DH04

DR   GEO; GSM1001399

DR   GEO; GSM1001436

DR   GEO; GSM1001459

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-C4p

AC   CVCL_DH05

DR   GEO; GSM1001397

DR   GEO; GSM1001434

RX   PubMed=26080861;

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 12

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-C5x

AC   CVCL_DH06

DR   GEO; GSM1001396

DR   GEO; GSM1001433

DR   GEO; GSM1001495

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 10,11,12

ST   D16S539: 10,11,12

ST   D5S818: 10,11

ST   D7S820: 8,12

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 18,22

DI   NCIt; C40078; Ovarian clear cell adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-CSp

AC   CVCL_DH07

DR   GEO; GSM1001416

DR   GEO; GSM1001453

RX   PubMed=26080861;

CC   Omics: Transcriptome analysis.

DI   NCIt; C9192; Ovarian carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-D1p

AC   CVCL_DH08

DR   GEO; GSM1001408

DR   GEO; GSM1001445

DR   GEO; GSM1001458

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C8106; Ovarian dysgerminoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-E1p

AC   CVCL_DH09

DR   GEO; GSM1001400

DR   GEO; GSM1001437

DR   GEO; GSM1001463

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 14,19

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-E2p

AC   CVCL_DH10

DR   GEO; GSM1001402

DR   GEO; GSM1001439

RX   PubMed=26080861;

CC   Omics: Transcriptome analysis.

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-E3x

AC   CVCL_DH11

DR   GEO; GSM1001411

DR   GEO; GSM1001448

DR   GEO; GSM1001468

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,10

ST   D16S539: 11

ST   D5S818: 12,13

ST   D7S820: 8,9

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-EP1p

AC   CVCL_DH12

DR   GEO; GSM1001407

DR   GEO; GSM1001444

DR   GEO; GSM1001464

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 11,14

ST   D16S539: 9,11

ST   D5S818: 16,17

ST   D7S820: 10,13

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 16,19

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-Ly1

AC   CVCL_1879

SY   OCI-LY1; OCI-LY-1; OCI-Ly-1; Oci-Ly-1; OCI-Ly01; OCI Ly1; Ly1; LY1

DR   EFO; EFO_0005907

DR   Cosmic; 1134602

DR   Cosmic; 1295512

DR   Cosmic; 1329091

DR   Cosmic; 1517641

DR   Cosmic; 1541900

DR   Cosmic; 1629932

DR   Cosmic; 1636682

DR   Cosmic; 1945183

DR   Cosmic; 2276318

DR   DSMZ; ACC-722

DR   ENCODE; ENCBS397COL

DR   ENCODE; ENCBS729LWO

DR   ENCODE; ENCBS899DSB

DR   ENCODE; ENCBS945KYE

DR   GEO; GSM1957

DR   GEO; GSM380130

DR   GEO; GSM552450

DR   GEO; GSM1059803

DR   GEO; GSM1374783

RX   PubMed=3567358;

RX   PubMed=10676951;

RX   PubMed=11807979;

RX   PubMed=19278952;

RX   PubMed=19358282;

RX   PubMed=23292937;

RX   PubMed=23699601;

WW   http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Genome sequenced.

CC   Omics: H3K9ac ChIP-seq epigenome analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 11

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCI-Ly10

AC   CVCL_8795

SY   OCI-LY10; OCI-LY-10; OCILY-10; OCI Ly10; OCILY10; Ly10; LY10

DR   EFO; EFO_0006708

DR   BioSample; SAMN03470849

DR   CCLE; OCILY10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1134604

DR   Cosmic; 1329095

DR   Cosmic; 1486585

DR   Cosmic; 1487547

DR   Cosmic; 1517650

DR   Cosmic; 1541905

DR   Cosmic; 1550338

DR   Cosmic; 1945184

DR   Cosmic; 2139542

DR   Cosmic; 2276333

DR   Cosmic; 2437310

DR   GEO; GSM1956

DR   GEO; GSM2015

DR   GEO; GSM2071

DR   GEO; GSM552455

DR   GEO; GSM1059800

DR   GEO; GSM1374784

DR   GEO; GSM1890029

DR   GEO; GSM1890030

DR   GEO; GSM1890031

DR   GEO; GSM1890032

DR   Lonza; 944

RX   PubMed=3567358;

RX   PubMed=10676951;

RX   PubMed=23292937;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 13

ST   D18S51: 14,18

ST   D21S11: 29

ST   D3S1358: 16

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   D8S1179: 13,14

ST   FGA: 20

ST   Penta D: 9

ST   Penta E: 14,17

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-Ly11

AC   CVCL_M071

SY   OCI-LY11

RX   PubMed=3567358;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-Ly12

AC   CVCL_8796

SY   OCI-LY12; OCI-LY-12; OCI Ly12; Ly12

DR   GEO; GSM1990

RX   PubMed=3567358;

RX   PubMed=10676951;

RX   PubMed=11807979;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Omics: Transcriptome analysis.

DI   NCIt; C27810; Malignant non-Hodgkin's lymphoma, cleaved cell

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCI-Ly13.1

AC   CVCL_M072

SY   OCI-LY13.1

RX   PubMed=3567358;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8797 ! OCI-Ly13.2

SX   Female

CA   Cancer cell line

//

ID   OCI-Ly13.2

AC   CVCL_8797

SY   OCI-LY13.2; OCI-LY-13.2; OCI Ly13.2; Ly13.2

DR   GEO; GSM1989

RX   PubMed=3567358;

RX   PubMed=10676951;

RX   PubMed=11807979;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Omics: Transcriptome analysis.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M072 ! OCI-Ly13.1

SX   Female

CA   Cancer cell line

//

ID   OCI-Ly14

AC   CVCL_M073

SY   OCI-LY14

RX   PubMed=3567358;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-Ly15

AC   CVCL_M074

SY   OCI-LY15

RX   PubMed=3567358;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C7873; Adult immunoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-Ly16

AC   CVCL_M076

SY   OCI-LY16

RX   PubMed=3567358;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Miscellaneous: Cell line has been lost (PubMed=3567358).

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-Ly17

AC   CVCL_8798

SY   OCI-LY17; OCI-LY-17; OCI-Ly 17; OCI Ly17; Ly17

RX   PubMed=1493476;

RX   PubMed=11807979;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C3466; T-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCI-Ly18

AC   CVCL_1880

SY   OCI-LY18; OCI-LY-18; Ly18; LY18

DR   BioSample; SAMN03473448

DR   Cosmic; 1517651

DR   Cosmic; 1541906

DR   Cosmic; 1636683

DR   Cosmic; 2276334

DR   DSMZ; ACC-699

DR   GEO; GSM380131

DR   GEO; GSM552456

DR   GEO; GSM1374785

RX   PubMed=1311715;

RX   PubMed=11807979;

RX   PubMed=19278952;

WW   http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: ~30-40 hours (DSMZ).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'OCI-LZ18' in BioSample SAMN03473448.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10,12

ST   D16S539: 11,13

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 15,19

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCI-Ly19

AC   CVCL_1878

SY   OCI-LY19; OCI-LY-19; OCI Ly19; OCILY-19; OCILY19; Ly19; LY19

DR   EFO; EFO_0006709

DR   BioSample; SAMN03471654

DR   CCLE; OCILY19_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1079258

DR   Cosmic; 1086340

DR   Cosmic; 1295509

DR   Cosmic; 1329093

DR   Cosmic; 1629933

DR   Cosmic; 1945185

DR   Cosmic; 2276335

DR   Cosmic-CLP; 1330984

DR   DSMZ; ACC-528

DR   GDSC; 1330984

DR   GEO; GSM380132

DR   GEO; GSM552460

DR   GEO; GSM887471

DR   GEO; GSM888551

DR   GEO; GSM1374786

DR   GEO; GSM1670298

RX   PubMed=19278952;

RX   PubMed=22460905;

RX   PubMed=23292937;

RX   PubMed=23699601;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: ~40 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 12

ST   D18S51: 14

ST   D21S11: 30

ST   D3S1358: 15,16

ST   D5S818: 9,11

ST   D7S820: 12

ST   D8S1179: 14,15

ST   FGA: 20,23

ST   Penta D: 12,13

ST   Penta E: 12,15

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 16

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-Ly2

AC   CVCL_8799

SY   OCI-LY2; OCI-LY-2; OCI-Ly-2; OCI-Ly02; Ly2; LY2

DR   Cosmic; 1176630

DR   GEO; GSM1059810

RX   PubMed=3567358;

RX   PubMed=11807979;

RX   PubMed=19358282;

WW   http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCI-Ly3

AC   CVCL_8800

SY   OCI-LY3; OCI-LY-3; Oci-Ly-3; OCILY-3; OCI-Ly03; OCI Ly3; OCILY3; Ly3; LY3

DR   EFO; EFO_0006710

DR   CCLE; OCILY3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1290019

DR   Cosmic; 1329094

DR   Cosmic; 1486584

DR   Cosmic; 1487544

DR   Cosmic; 1517647

DR   Cosmic; 1541901

DR   Cosmic; 1548654

DR   Cosmic; 1550337

DR   Cosmic; 1945198

DR   Cosmic; 2276329

DR   Cosmic; 2437309

DR   DSMZ; ACC-761

DR   ENCODE; ENCBS018GXW

DR   ENCODE; ENCBS757GPD

DR   GEO; GSM2023

DR   GEO; GSM1963

DR   GEO; GSM380133

DR   GEO; GSM552451

DR   GEO; GSM887472

DR   GEO; GSM888552

DR   GEO; GSM1059799

DR   GEO; GSM1374787

DR   GEO; GSM1890025

DR   GEO; GSM1890026

DR   GEO; GSM1890027

DR   GEO; GSM1890028

DR   Lonza; 945

RX   PubMed=3567358;

RX   PubMed=10676951;

RX   PubMed=11807979;

RX   PubMed=19278952;

RX   PubMed=22460905;

RX   PubMed=23292937;

RX   PubMed=23699601;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: ~24 hours (DSMZ).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Genome sequenced.

CC   Omics: H3K9ac ChIP-seq epigenome analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Caution: A cell line, now termed GNE-587170 (CVCL_AT69), was mistakenly distributed by OCI to a number of groups under the designation OCI-Ly-3, the origin of that cell line is now known.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 7,9.3

ST   TPOX: 8,12

ST   vWA: 17

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCI-Ly4

AC   CVCL_8801

SY   OCI-LY4; OCI-LY-4; Ly4; LY4

DR   Cosmic; 1517648

DR   Cosmic; 1541902

DR   Cosmic; 1636684

DR   Cosmic; 2276330

DR   GEO; GSM380134

DR   GEO; GSM552452

DR   GEO; GSM1374788

RX   PubMed=3567358;

RX   PubMed=11807979;

RX   PubMed=19278952;

WW   http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Transcriptome analysis.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-Ly5

AC   CVCL_M075

SY   OCI-LY5

RX   PubMed=3567358;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C7540; Small lymphocytic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-Ly6

AC   CVCL_8802

SY   OCI-LY6; OCI-LY-6; Ly6

RX   PubMed=3567358;

WW   http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-Ly7

AC   CVCL_1881

SY   OCI-LY7; OCI-LY-7; OCI-Ly-7; Oci-Ly-7; OCI-Ly07; OCILY7; Ly7; LY7

DR   EFO; EFO_0006711

DR   BioSample; SAMN03473439

DR   Cosmic; 1329092

DR   Cosmic; 1517649

DR   Cosmic; 1541903

DR   Cosmic; 1629934

DR   Cosmic; 1945199

DR   Cosmic; 2276331

DR   Cosmic-CLP; 1659819

DR   DSMZ; ACC-688

DR   ENCODE; ENCBS006VZG

DR   ENCODE; ENCBS040MJM

DR   ENCODE; ENCBS121JKZ

DR   ENCODE; ENCBS141AMI

DR   ENCODE; ENCBS304FAI

DR   ENCODE; ENCBS581USS

DR   ENCODE; ENCBS699NWP

DR   ENCODE; ENCBS865AAA

DR   ENCODE; ENCBS866AAA

DR   ENCODE; ENCBS886BJZ

DR   GDSC; 1659819

DR   GEO; GSM380135

DR   GEO; GSM552453

DR   GEO; GSM1059809

DR   GEO; GSM1374789

RX   PubMed=3567358;

RX   PubMed=11807979;

RX   PubMed=19278952;

RX   PubMed=19358282;

RX   PubMed=23292937;

RX   PubMed=23699601;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: ~20-24 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Genome sequenced.

CC   Omics: H3K9ac ChIP-seq epigenome analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 15,18

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCI-Ly8

AC   CVCL_8803

SY   OCI-LY8; OCI-LY-8; OCI-Ly-8; OCLY8; Ly8; LY8

DR   Cosmic; 1134603

DR   Cosmic; 1517603

DR   Cosmic; 1541904

DR   Cosmic; 1945186

DR   Cosmic; 2276332

DR   Cosmic; 2297007

DR   GEO; GSM116023

DR   GEO; GSM380136

DR   GEO; GSM552454

DR   GEO; GSM1374790

RX   PubMed=3567358;

RX   PubMed=7849311;

RX   PubMed=11807979;

RX   PubMed=16960149;

RX   PubMed=19278952;

RX   PubMed=19358282;

RX   PubMed=23292937;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Transcriptome analysis.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-M1

AC   CVCL_2149

SY   OCI M1; OCIM1

DR   BTO; BTO:0004622

DR   EFO; EFO_0006712

DR   BioSample; SAMN03473108

DR   CCLE; OCIM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 787471

DR   Cosmic; 924043

DR   Cosmic; 975293

DR   Cosmic; 1281348

DR   Cosmic; 2131554

DR   Cosmic; 2306235

DR   Cosmic-CLP; 1330985

DR   DSMZ; ACC-529

DR   GDSC; 1330985

DR   GEO; GSM887473

DR   GEO; GSM888553

DR   GEO; GSM1374791

DR   GEO; GSM1670299

RX   PubMed=3166384;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: ~30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12,14

ST   D13S317: 11,12

ST   D16S539: 9

ST   D18S51: 16

ST   D21S11: 31.2,33.2

ST   D3S1358: 17,18

ST   D5S818: 11

ST   D7S820: 10

ST   D8S1179: 13

ST   FGA: 18,24

ST   Penta D: 6,11

ST   Penta E: 10,11

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-M1p

AC   CVCL_DH13

DR   GEO; GSM1001395

DR   GEO; GSM1001432

DR   GEO; GSM1001465

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 16,17

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 18

DI   NCIt; C5243; Ovarian mucinous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-M2

AC   CVCL_2150

SY   OCI M2; OCIM2

DR   BTO; BTO:0004623

DR   EFO; EFO_0006713

DR   BioSample; SAMN03473109

DR   Cosmic; 787472

DR   Cosmic; 924044

DR   Cosmic; 975294

DR   Cosmic; 1012112

DR   Cosmic; 1245830

DR   Cosmic; 1281349

DR   Cosmic; 1465962

DR   Cosmic; 2306236

DR   DSMZ; ACC-619

DR   GEO; GSM1374792

RX   PubMed=3166384;

RX   PubMed=16408098;

RX   PubMed=25485619;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Doubling time: ~36 hours (DSMZ).

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,14

ST   D16S539: 11

ST   D18S51: 16,20

ST   D21S11: 29

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   D8S1179: 10,13

ST   FGA: 21

ST   Penta D: 9

ST   Penta E: 10,12

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-My1

AC   CVCL_E338

SY   OCI-MY1; OCI-My 1; OCIMy1

DR   Cosmic; 2081400

DR   Cosmic; 2367265

DR   GEO; GSM1374793

RX   PubMed=1912582;

RX   PubMed=10936422;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-My2

AC   CVCL_E337

SY   OCI-MY2; OCI-My 2; OCIMy2

RX   PubMed=1912582;

RX   PubMed=10936422;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-My3

AC   CVCL_E336

SY   OCI-MY3; OCI-My 3; OCIMy3

RX   PubMed=1912582;

RX   PubMed=10936422;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-My4

AC   CVCL_E334

SY   OCI-MY4; OCI-My 4; OCIMy4

RX   PubMed=1912582;

RX   PubMed=10936422;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-My5

AC   CVCL_E332

SY   OCI-MY5; OCI-My 5; OCIMy5; MY5

DR   Cosmic; 720791

DR   Cosmic; 2081401

DR   Cosmic; 2302416

DR   Cosmic; 2367261

DR   GEO; GSM1374794

RX   PubMed=1912582;

RX   PubMed=8943038;

RX   PubMed=10936422;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-My6

AC   CVCL_E335

SY   OCI-MY6; OCI-My 6; OCIMy6

RX   PubMed=1912582;

RX   PubMed=10936422;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-My7

AC   CVCL_E333

SY   OCI-MY7; OCI-My 7; OCIMy7

DR   Cosmic; 2081402

DR   Cosmic; 2367266

RX   PubMed=1912582;

RX   PubMed=10936422;

CC   From: Ontario Cancer Institute (OCI); Toronto; Canada.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCI-P1a

AC   CVCL_DH14

DR   GEO; GSM1001410

DR   GEO; GSM1001447

DR   GEO; GSM1001470

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,13

ST   D16S539: 12,14

ST   D5S818: 11,13

ST   D7S820: 11,12

ST   TH01: 9.3

ST   TPOX: 11,12

ST   vWA: 16,20

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-P2a

AC   CVCL_DH15

DR   GEO; GSM1001401

DR   GEO; GSM1001438

DR   GEO; GSM1001466

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-P3a

AC   CVCL_DH16

DR   GEO; GSM1001413

DR   GEO; GSM1001450

RX   PubMed=26080861;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-P4p

AC   CVCL_DH17

DR   GEO; GSM1001405

DR   GEO; GSM1001442

DR   GEO; GSM1001469

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-P5x

AC   CVCL_DH18

DR   GEO; GSM1001414

DR   GEO; GSM1001451

DR   GEO; GSM1001457

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 10,12

ST   D7S820: 12

ST   TH01: 6

ST   TPOX: 9,11

ST   vWA: 14,17

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-P6p

AC   CVCL_DH19

DR   GEO; GSM1001412

DR   GEO; GSM1001449

RX   PubMed=26080861;

CC   Omics: Transcriptome analysis.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-P7a

AC   CVCL_DH20

DR   GEO; GSM1001409

DR   GEO; GSM1001446

DR   GEO; GSM1001460

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 8,14

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 6,10

ST   TPOX: 9,11

ST   vWA: 15,18

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-P8p

AC   CVCL_DH21

DR   GEO; GSM1001431

DR   GEO; GSM1001456

RX   PubMed=26080861;

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 9

ST   D5S818: 11,13

ST   D7S820: 9,10

ST   TH01: 7,9.3

ST   TPOX: 9,11

ST   vWA: 15,17

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCI-P9a1

AC   CVCL_DH22

DR   GEO; GSM1001403

DR   GEO; GSM1001440

DR   GEO; GSM1001461

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,13

ST   D16S539: 9

ST   D5S818: 11

ST   D7S820: 9,14

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,19

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DH23 ! OCI-P9a2

SX   Female

CA   Cancer cell line

//

ID   OCI-P9a2

AC   CVCL_DH23

DR   GEO; GSM1001418

DR   GEO; GSM1001455

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DH22 ! OCI-P9a1

SX   Female

CA   Cancer cell line

//

ID   OCI-U1a

AC   CVCL_DH24

DR   GEO; GSM1001404

DR   GEO; GSM1001441

DR   GEO; GSM1001494

RX   PubMed=26080861;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): PubMed=26080861

ST   Amelogenin: X

ST   CSF1PO: 10,14

ST   D13S317: 8,10

ST   D16S539: 12,13

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C9192; Ovarian carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCL-1

AC   CVCL_6701

DR   BTO; BTO:0004802

RX   PubMed=6420051;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCL-3

AC   CVCL_6702

DR   BTO; BTO:0004840

RX   PubMed=19501511;

CC   Miscellaneous: Not listed anywhere else than in the paper listed by BTO (PubMed=19501511).

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCM-1

AC   CVCL_6934

SY   OCM1; Ocm1; Ocular Choroidal Melanoma-1

DR   BTO; BTO:0002736

DR   Cosmic; 848327

DR   Cosmic; 899892

DR   Cosmic; 916139

DR   Cosmic; 986617

DR   Cosmic; 1320368

DR   Cosmic; 1628408

DR   GEO; GSM276733

RX   PubMed=2722439;

RX   PubMed=8621261;

RX   PubMed=9154388;

RX   PubMed=15714118;

RX   PubMed=16772116;

RX   PubMed=17487557;

RX   PubMed=18689700;

RX   PubMed=22236444;

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=18689700;

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 9

ST   D18S51: 13,18

ST   D21S11: 30

ST   D3S1358: 14,16

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 21

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3448 ! MuM-2C

SX   Female

CA   Cancer cell line

//

ID   OCM-1A

AC   CVCL_6935

SY   OCM1A; OCM1a

DR   CCRID; 3111C0001CCC000234

DR   Cosmic; 1247863

DR   GEO; GSM1082693

RX   PubMed=15299072;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6934 ! OCM-1

SX   Female

CA   Cancer cell line

//

ID   OCM-2

AC   CVCL_6936

SY   OCM2; Ocular Choroidal Melanoma-2

RX   PubMed=2722439;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCM-3

AC   CVCL_6937

SY   OCM3; Ocm3; ocm-3

DR   Cosmic; 916142

DR   Cosmic; 1320369

DR   Cosmic; 1628409

DR   Cosmic; 2163831

DR   ESTDAB; ESTDAB-129

RX   PubMed=16772116;

RX   PubMed=18689700;

RX   PubMed=22236444;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Was originally thought to originate from an uveal melanoma.

CC   From: Kan-Mitchell J.; Wayne State University; Detroit; USA.

ST   Source(s): ESTDAB; PubMed=18689700;

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D18S51: 12,16

ST   D21S11: 28,29

ST   D3S1358: 16,18

ST   D5S818: 11,13

ST   D7S820: 10

ST   D8S1179: 13

ST   FGA: 19

ST   TH01: 7

ST   TPOX: 8,12

ST   vWA: 16,19

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0526 ! SK-MEL-28

SX   Male

CA   Cancer cell line

//

ID   OCM-8

AC   CVCL_6938

SY   OCM8; Ocm8; ocm-8

DR   Cosmic; 1320370

DR   Cosmic; 1628410

DR   ESTDAB; ESTDAB-130

RX   PubMed=16772116;

RX   PubMed=18689700;

RX   PubMed=22236444;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Was originally thought to originate from an uveal melanoma.

CC   From: Kan-Mitchell J.; Wayne State University; Detroit; USA.

ST   Source(s): ESTDAB; PubMed=18689700;

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D18S51: 12,16

ST   D21S11: 28,29

ST   D3S1358: 16,18

ST   D5S818: 11,13

ST   D7S820: 10

ST   D8S1179: 13

ST   FGA: 19

ST   TH01: 7

ST   TPOX: 8,12

ST   vWA: 16,19

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0526 ! SK-MEL-28

SX   Male

CA   Cancer cell line

//

ID   OCPC-2-VGH

AC   CVCL_GT40

SY   VGH-OCPC-2

DR   BCRC; 60603

RX   CelloPub=CLPUB00351;

RX   PubMed=10592434;

DI   NCIt; C7278; Ovarian papillary cystadenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCRG9

AC   CVCL_C395

DR   RCB; AES0152

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Breed/subspecies: 129/Ola.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   OCUB-1

AC   CVCL_L114

RX   PubMed=7873497;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCUB-F

AC   CVCL_3352

SY   OCUB-1F; OCUBF

DR   CLO; CLO_0051610

DR   BioSample; SAMN03472189

DR   Cosmic; 997934

DR   Cosmic; 1046937

DR   Cosmic; 1289404

DR   GEO; GSM217593

DR   GEO; GSM459705

DR   GEO; GSM1661986

DR   RCB; RCB0882

RX   PubMed=7873497;

RX   PubMed=15677628;

RX   PubMed=23601657;

CC   Microsatellite instability: Instable (MSI) (PubMed=15677628).

CC   Omics: miRNA expression profiling.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 10

ST   D7S820: 9,13

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L114 ! OCUB-1

SX   Female

CA   Cancer cell line

//

ID   OCUB-M

AC   CVCL_1621

SY   OCUB-1M

DR   CLO; CLO_0051609

DR   BioSample; SAMN03472188

DR   ChEMBL-Cells; CHEMBL3308245

DR   ChEMBL-Targets; CHEMBL2366121

DR   Cosmic; 909256

DR   Cosmic-CLP; 909256

DR   GDSC; 909256

DR   GEO; GSM217594

DR   GEO; GSM1661987

DR   GEO; GSM1670300

DR   RCB; RCB0881

RX   PubMed=7873497;

RX   PubMed=15677628;

RX   PubMed=27397505;

CC   Microsatellite instability: Instable (MSI-low) (PubMed=15677628; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): Cosmic-CLP; RCB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 10

ST   D7S820: 9,13

ST   TH01: 9

ST   TPOX: 7,8

ST   vWA: 18

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L114 ! OCUB-1

SX   Female

CA   Cancer cell line

//

ID   OCUCh-LM1

AC   CVCL_L091

SY   Osaka City University Cholangiocarcinoma-Liver Metastasis 1

RX   CelloPub=CLPUB00275;

RX   PubMed=7880737;

CC   Doubling time: 31 hours (PubMed=7880737).

CC   Derived from metastatic site: Liver.

DI   NCIt; C4436; Cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCUCh-LM1-H1

AC   CVCL_L092

RX   PubMed=7880737;

CC   Derived from metastatic site: Liver.

DI   NCIt; C4436; Cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L091 ! OCUCh-LM1

SX   Male

CA   Cancer cell line

//

ID   OCUG-1

AC   CVCL_3083

SY   Osaka City University Gallblader-1

DR   BioSample; SAMN03471651

DR   GEO; GSM827176

DR   JCRB; JCRB0191

RX   PubMed=21533512;

CC   Doubling time: 47.1 hours (PubMed=21533512).

CC   Derived from metastatic site: Peritoneal effusion.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 9,13

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C3844; Gallbladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCUM-1

AC   CVCL_3084

SY   OCUM1

DR   BTO; BTO:0005918

DR   EFO; EFO_0006714

DR   BioSample; SAMN03471652

DR   BioSample; SAMN03473049

DR   CCLE; OCUM1_STOMACH

DR   CGH-DB; 131-1

DR   Cosmic; 1889265

DR   Cosmic; 2009531

DR   Cosmic; 2443794

DR   Cosmic; 2484967

DR   Cosmic-CLP; 1298358

DR   GDSC; 1298358

DR   GEO; GSM827576

DR   GEO; GSM887474

DR   GEO; GSM888554

DR   GEO; GSM1374795

DR   GEO; GSM1670301

DR   JCRB; JCRB0192

RX   PubMed=1961183;

RX   PubMed=15723654;

RX   PubMed=21115893;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 33.2 hours (PubMed=1961183).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10,11

ST   D16S539: 11

ST   D18S51: 12,13

ST   D21S11: 30

ST   D3S1358: 17

ST   D5S818: 9,10

ST   D7S820: 12

ST   D8S1179: 11,12

ST   FGA: 19,23

ST   Penta D: 12,13

ST   Penta E: 12,19

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 14,17 (Cosmic-CLP; PubMed=25877200)

ST   vWA: 14,16,17 (JCRB)

DI   NCIt; C5250; Signet ring cell gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCUM-11

AC   CVCL_8379

RX   PubMed=15546507;

CC   Doubling time: 11.3 hours (PubMed=15546507).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCUM-12

AC   CVCL_8380

DR   Cosmic; 2009532

RX   PubMed=20145613;

RX   PubMed=21115893;

CC   Doubling time: 13.4 hours, at 190th passage (PubMed=20145613).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCUM-12/Hypo

AC   CVCL_8381

RX   PubMed=20145613;

RX   PubMed=21965748;

CC   Characteristics: Hypoxia-resistant.

CC   Doubling time: 24.9 hours, at 10th passage (PubMed=20145613).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8380 ! OCUM-12

SX   Male

CA   Cancer cell line

//

ID   OCUM-2D

AC   CVCL_8382

RX   PubMed=7577468;

RX   PubMed=21115893;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8383 ! OCUM-2M

SX   Female

CA   Cancer cell line

//

ID   OCUM-2M

AC   CVCL_8383

DR   Cosmic; 2009533

RX   PubMed=7577468;

RX   PubMed=11221876;

RX   PubMed=21115893;

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8382 ! OCUM-2D

SX   Female

CA   Cancer cell line

//

ID   OCUM-2M/5-FU

AC   CVCL_IV67

SY   OCUM-2M/5FU

RX   PubMed=20393015;

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8383 ! OCUM-2M

SX   Female

CA   Cancer cell line

//

ID   OCUM-2M/DDP

AC   CVCL_8384

RX   PubMed=9137537;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8383 ! OCUM-2M

SX   Female

CA   Cancer cell line

//

ID   OCUM-2M/GEM

AC   CVCL_IV68

RX   PubMed=20393015;

CC   Selected for resistance to: ChEBI; CHEBI:175901; Gemcitabine (Gemzar).

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8383 ! OCUM-2M

SX   Female

CA   Cancer cell line

//

ID   OCUM-2M/OXA

AC   CVCL_IV69

RX   PubMed=20393015;

RX   PubMed=27157913;

CC   Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8383 ! OCUM-2M

SX   Female

CA   Cancer cell line

//

ID   OCUM-2M/PTX

AC   CVCL_IV70

RX   PubMed=20393015;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8383 ! OCUM-2M

SX   Female

CA   Cancer cell line

//

ID   OCUM-2M/SN38

AC   CVCL_IV71

RX   PubMed=20393015;

RX   PubMed=21997136;

CC   Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8383 ! OCUM-2M

SX   Female

CA   Cancer cell line

//

ID   OCUM-2MD3

AC   CVCL_8385

SY   OCUM-2 MD3; OCUM2-MD3

RX   PubMed=8912536;

RX   PubMed=11221876;

RX   PubMed=21115893;

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8383 ! OCUM-2M

SX   Female

CA   Cancer cell line

//

ID   OCUM-2MLN

AC   CVCL_8386

SY   OCUM-2M LN

RX   PubMed=9626818;

RX   PubMed=11221876;

RX   PubMed=21115893;

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8383 ! OCUM-2M

SX   Female

CA   Cancer cell line

//

ID   OCUM-6

AC   CVCL_8387

DR   BioSample; SAMN03151875

RX   PubMed=11605005;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OCUM-11 derivative (PubMed=20143388).

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8379 ! OCUM-11

SX   Female

CA   Cancer cell line

//

ID   OCUM-7

AC   CVCL_8388

RX   PubMed=15254696;

CC   Characteristics: Has lost chromosome Y.

CC   Doubling time: 23 hours, at 25th passage (PubMed=15254696).

CC   Microsatellite instability: Instable (MSI-high) (PubMed=15254696).

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCUM-8

AC   CVCL_8389

RX   PubMed=15546507;

CC   Doubling time: 13.4 hours (PubMed=15546507).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCUM-8/5-FU

AC   CVCL_IG91

RX   PubMed=21997136;

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8389 ! OCUM-8

SX   Female

CA   Cancer cell line

//

ID   OCUM-8/GEM

AC   CVCL_II63

RX   PubMed=21997136;

CC   Selected for resistance to: ChEBI; CHEBI:175901; Gemcitabine (Gemzar).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8389 ! OCUM-8

SX   Female

CA   Cancer cell line

//

ID   OCUM-8/OXA

AC   CVCL_IL00

RX   PubMed=21997136;

RX   PubMed=27157913;

CC   Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8389 ! OCUM-8

SX   Female

CA   Cancer cell line

//

ID   OCUM-8/PTX

AC   CVCL_IP78

RX   PubMed=21997136;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8389 ! OCUM-8

SX   Female

CA   Cancer cell line

//

ID   OCUM-8/SN38

AC   CVCL_IV66

RX   PubMed=21997136;

CC   Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8389 ! OCUM-8

SX   Female

CA   Cancer cell line

//

ID   OCUM-9

AC   CVCL_8390

RX   PubMed=21115893;

DI   NCIt; C9159; Diffuse gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCUP-A1

AC   CVCL_CW20

RX   PubMed=27067801;

CC   Doubling time: 20.6 +- 1.2 hours (PubMed=27067801).

DI   NCIt; C5722; Undifferentiated pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCUP-A2

AC   CVCL_CW21

RX   PubMed=27067801;

CC   Doubling time: 20.6 +- 1.4 hours (PubMed=27067801).

DI   NCIt; C5722; Undifferentiated pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OCUT-1

AC   CVCL_6017

SY   Ocut-1; OCUT1

DR   BTO; BTO:0004846

DR   Cosmic; 1152123

DR   Cosmic; 1239960

DR   Cosmic; 1280045

DR   Cosmic; 1507372

DR   Cosmic; 1533548

DR   Cosmic; 1536125

DR   Cosmic; 1889003

DR   Cosmic; 2054107

DR   Cosmic; 2319852

RX   PubMed=12210034;

RX   PubMed=23833040;

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCUT-2

AC   CVCL_9814

SY   OCUT2

DR   BTO; BTO:0005143

DR   Cosmic; 1507373

DR   Cosmic; 1533549

DR   Cosmic; 1536126

DR   Cosmic; 1889004

RX   PubMed=15785737;

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OCUT-2C

AC   CVCL_W915

SY   OCUT2C

DR   Cosmic; 2054108

RX   PubMed=23833040;

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9814 ! OCUT-2

SX   Female

CA   Cancer cell line

//

ID   OCUU-1

AC   CVCL_HF21

SY   OCUU1; Osaka City University Urology-1

RX   PubMed=14534724;

RX   PubMed=15604581;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCUU-2

AC   CVCL_HF22

SY   Osaka City University Urology-2

RX   PubMed=14534724;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCUU-3

AC   CVCL_HF23

SY   OCUU3; Osaka City University Urology-3

RX   PubMed=15604581;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCUU-4

AC   CVCL_HF24

SY   OCUU4; Osaka City University Urology-4

RX   PubMed=14534724;

RX   PubMed=15604581;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCUU-5

AC   CVCL_HF25

SY   OCUU5; Osaka City University Urology-5

RX   PubMed=14534724;

RX   PubMed=15604581;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OCUU-6

AC   CVCL_M615

SY   Osaka City University Urology-6

RX   PubMed=15859154;

CC   Doubling time: 26 hours (PubMed=15859154).

DI   NCIt; C2946; Chondrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OD-3

AC   CVCL_G237

SY   OD3

DR   CLO; CLO_0008237

DR   ATCC; HB-10204

RX   Patent=US5604107;

CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   ODA

AC   CVCL_0G09

SY   Oda

RX   PubMed=9738977;

RX   PubMed=10557056;

RX   PubMed=11429052;

RX   PubMed=12886255;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Odense-3

AC   CVCL_B019

SY   Odense3; OD3; SDUe001-A

DR   hPSCreg; SDUe001-A

DR   ISCR; 1773

RX   PubMed=18393673;

CC   From: University of Southern Denmark; Denmark.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Odense-4

AC   CVCL_B018

SY   Odense4; SDUe006-A

DR   hPSCreg; SDUe006-A

CC   From: University of Southern Denmark; Denmark.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Odf2-deficient F9 cells

AC   CVCL_T374

DR   CLO; CLO_0050540

DR   RCB; RCB2808

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0259 ! F9

SX   Male

CA   Cancer cell line

//

ID   Odour

AC   CVCL_W935

DR   Cosmic; 931130

RX   PubMed=170370;

RX   PubMed=9473234;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OE

AC   CVCL_J350

SY   Okayama Endometrium

DR   BioSample; SAMN03151749

RX   PubMed=1246601;

RX   PubMed=4946504;

RX   PubMed=5169552;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   OE-E6/E7

AC   CVCL_F597

DR   BTO; BTO:0003067

RX   PubMed=11468776;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   OE19

AC   CVCL_1622

SY   OE-19; JROECL19; JROECL 19; OEC19

DR   CLO; CLO_0008238

DR   EFO; EFO_0002308

DR   CLDB; cl3761

DR   BioSample; SAMN03471032

DR   CCLE; OE19_OESOPHAGUS

DR   ChEMBL-Cells; CHEMBL3308462

DR   ChEMBL-Targets; CHEMBL1075555

DR   Cosmic; 871232

DR   Cosmic; 910079

DR   Cosmic; 978854

DR   Cosmic; 997860

DR   Cosmic; 1175878

DR   Cosmic; 1599342

DR   Cosmic; 1618819

DR   Cosmic; 1995600

DR   Cosmic-CLP; 910079

DR   DSMZ; ACC-700

DR   ECACC; 96071721

DR   GDSC; 910079

DR   GEO; GSM827301

DR   GEO; GSM887475

DR   GEO; GSM888555

DR   GEO; GSM1264050

DR   GEO; GSM1264051

DR   GEO; GSM1264052

DR   GEO; GSM1264053

DR   GEO; GSM1264054

DR   GEO; GSM1264092

DR   GEO; GSM1264093

DR   GEO; GSM1264094

DR   GEO; GSM1264095

DR   GEO; GSM1264096

DR   GEO; GSM1670302

DR   IGRhCellID; OE19

RX   PubMed=9010035;

RX   PubMed=16364037;

RX   PubMed=20075370;

RX   PubMed=22460905;

RX   PubMed=23795680;

RX   PubMed=24083764;

RX   PubMed=25070024;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 9,11

ST   D16S539: 12,13

ST   D18S51: 12

ST   D19S433: 13

ST   D21S11: 30

ST   D2S1338: 18,19

ST   D3S1358: 15,18

ST   D5S818: 11,14

ST   D7S820: 8

ST   D8S1179: 13,15

ST   FGA: 23,26

ST   Penta D: 9

ST   Penta E: 5,8

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 16,17 (Cosmic-CLP; ECACC)

ST   vWA: 16,17,18 (DSMZ; PubMed=25877200)

DI   NCIt; C4025; Esophageal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OE21

AC   CVCL_2661

SY   OE-21; JROECL21

DR   BTO; BTO:0004489

DR   CLO; CLO_0008239

DR   EFO; EFO_0002309

DR   CLDB; cl5089

DR   BioSample; SAMN03472891

DR   CCLE; OE21_OESOPHAGUS

DR   Cosmic; 1339912

DR   Cosmic; 1995601

DR   Cosmic; 2009522

DR   Cosmic-CLP; 1298359

DR   ECACC; 96062201

DR   GDSC; 1298359

DR   GEO; GSM827300

DR   GEO; GSM888556

DR   GEO; GSM1374796

DR   GEO; GSM1374797

DR   GEO; GSM1670303

DR   IGRhCellID; OE21

RX   PubMed=9010035;

RX   PubMed=16364037;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X (Cosmic-CLP)

ST   Amelogenin: X,Y (ECACC; PubMed=25877200)

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 12,13 (Cosmic-CLP; PubMed=25877200)

ST   D16S539: 13 (ECACC)

ST   D18S51: 19

ST   D19S433: 15.2

ST   D21S11: 30,31

ST   D2S1338: 17,19

ST   D3S1358: 17

ST   D5S818: 13 (Cosmic-CLP)

ST   D5S818: 12,13 (ECACC; PubMed=25877200)

ST   D7S820: 11,12

ST   D8S1179: 12

ST   FGA: 20

ST   Penta D: 11,12

ST   Penta E: 12

ST   TH01: 7,8 (Cosmic-CLP)

ST   TH01: 8 (ECACC; PubMed=25877200)

ST   TPOX: 8,11

ST   vWA: 15,16 (Cosmic-CLP)

ST   vWA: 16,17 (ECACC; PubMed=25877200)

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OE33

AC   CVCL_0471

SY   OE-33; JROECL33; JROECL 33; OEC33

DR   BTO; BTO:0003541

DR   CLO; CLO_0008240

DR   EFO; EFO_0002310

DR   MCCL; MCC:0000369

DR   CLDB; cl3762

DR   BioSample; SAMN03472890

DR   BioSample; SAMN03473392

DR   CCLE; OE33_OESOPHAGUS

DR   ChEMBL-Cells; CHEMBL3308776

DR   ChEMBL-Targets; CHEMBL1075556

DR   Cosmic; 871233

DR   Cosmic; 910549

DR   Cosmic; 978855

DR   Cosmic; 997861

DR   Cosmic; 1175877

DR   Cosmic; 1599343

DR   Cosmic; 1618820

DR   Cosmic-CLP; 910549

DR   DSMZ; ACC-706

DR   ECACC; 96070808

DR   GDSC; 910549

DR   GEO; GSM827306

DR   GEO; GSM887476

DR   GEO; GSM888557

DR   GEO; GSM1670304

DR   IGRhCellID; OE33

RX   PubMed=9010035;

RX   PubMed=20075370;

RX   PubMed=22460905;

RX   PubMed=23795680;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.addexbio.com/productdetail?pid=115

WW   http://www.addexbio.com/productdetail?pid=121

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 33 hours (PubMed=25984343); ~30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11 (Cosmic-CLP; DSMZ)

ST   CSF1PO: 10 (ECACC; PubMed=25877200)

ST   D13S317: 14

ST   D16S539: 12

ST   D18S51: 12

ST   D19S433: 12,15,16

ST   D21S11: 29,31.2

ST   D2S1338: 17,19,20

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 9,10

ST   D8S1179: 10,12

ST   FGA: 23

ST   Penta D: 9,11

ST   Penta E: 12,18

ST   TH01: 7,8 (Cosmic-CLP; ECACC; PubMed=25877200)

ST   TH01: 7 (DSMZ)

ST   TPOX: 8,11

ST   vWA: 17 (Cosmic-CLP; DSMZ; ECACC)

ST   vWA: 14,17 (PubMed=25877200)

DI   NCIt; C7027; Barrett adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OE47

AC   CVCL_4627

SY   OE-47; JROECL47

DR   CLO; CLO_0008241

DR   CLDB; cl3763

DR   Cosmic; 997862

DR   ECACC; 96061336

RX   PubMed=9010035;

RX   PubMed=23795680;

CC   Discontinued: ECACC; 96061336; probable.

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OE50

AC   CVCL_4628

SY   OE-50; JROECL50

DR   CLO; CLO_0008242

DR   CLDB; cl3764

DR   Cosmic; 997863

DR   ECACC; 96061337

RX   PubMed=9010035;

RX   PubMed=23795680;

CC   Discontinued: ECACC; 96061337; probable.

DI   NCIt; C4025; Esophageal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OECM-1

AC   CVCL_6782

SY   OECM1; OEC-M1

DR   BTO; BTO:0003964

RX   PubMed=8083436;

RX   PubMed=9877329;

RX   PubMed=15466821;

RX   PubMed=24825747;

CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24825747; obtained by personal communication of Yuan T-.C.

ST   Source(s): PubMed=24825747

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 10

ST   D16S539: 10,12

ST   D18S51: 16

ST   D19S433: 13,14

ST   D21S11: 29,32.2

ST   D2S1338: 18,23

ST   D3S1358: 15,18

ST   D5S818: 10,11

ST   D7S820: 8,11

ST   D8S1179: 15

ST   FGA: 22,28

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OEE-III

AC   CVCL_A764

DR   Cosmic; 1590844

RX   PubMed=12089864;

RX   PubMed=22038905;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C46099; Hereditary thyroid gland medullary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OELE

AC   CVCL_IW56

DR   CCLE; OELE_OVARY

RX   PubMed=25984343;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 48 hours (PubMed=25984343).

CC   Omics: shRNA library screening.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   Oex2054SV.4

AC   CVCL_DQ96

RX   PubMed=27346197;

DI   NCIt; C34864; Hereditary optic atrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   OF

AC   CVCL_M621

DR   BioSample; SAMN03151750

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   OF4374

AC   CVCL_6F49

RX   PubMed=12441130;

OX   NCBI_TaxID=9888; ! Muntiacus muntjak

HI   CVCL_6F46 ! F4374

SX   Female

CA   Finite cell line

//

ID   OFCOL II

AC   CVCL_HA27

DR   BCRJ; 0192

RX   PubMed=18754721;

RX   PubMed=23146572;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   OFP8

AC   CVCL_L234

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L235 ! OKP8

SX   Sex undetermined

CA   Finite cell line

//

ID   Ogg1 KO MEF

AC   CVCL_6E74

DR   Ximbio; 151846

RX   PubMed=10557315;

CC   Knockout cell: Method=KO mouse; MGI; MGI:1097693; Ogg1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   OGU1

AC   CVCL_4664

DR   CLO; CLO_0050008

DR   BioSample; SAMN03471968

DR   RCB; RCB2351

RX   PubMed=25846106;

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 12,13

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 14

DI   NCIt; C6915; Primary effusion lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ogun

AC   CVCL_V742

SY   OGUN; P4-Ogun

DR   CGH-DB; 9203-4

RX   PubMed=4321974;

RX   PubMed=5786183;

RX   PubMed=6018567;

RX   PubMed=6060209;

CC   Characteristics: EBV-negative.

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OH-1

AC   CVCL_A765

SY   OH1; O-H-1

DR   Cosmic; 953984

RX   PubMed=6108156;

RX   PubMed=6120760;

RX   PubMed=6264474;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OH-2 [Human lung carcinoma]

AC   CVCL_X427

DR   Cosmic; 953986

RX   PubMed=6304739;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OH-2 [Human plasma cell myeloma]

AC   CVCL_5442

RX   PubMed=8062895;

RX   PubMed=10936422;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=OH-2

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OH-3

AC   CVCL_A766

SY   OH3

DR   Cosmic; 953982

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OH931

AC   CVCL_M833

RX   PubMed=9109944;

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OHH1.K

AC   CVCL_4546

DR   CLO; CLO_0008243

DR   CLDB; cl3765

DR   ATCC; CRL-6193

DR   BCRC; 60281

DR   IZSLER; BS CL 123

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX   NCBI_TaxID=9872; ! Odocoileus hemionus

OI   CVCL_4547 ! OHH1.Li

OI   CVCL_4548 ! OHH1.Lu

OI   CVCL_S205 ! OHH1.Sp

SX   Male

CA   Finite cell line

//

ID   OHH1.Li

AC   CVCL_4547

DR   CLO; CLO_0008244

DR   ATCC; CRL-6194

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

OX   NCBI_TaxID=9872; ! Odocoileus hemionus

OI   CVCL_4546 ! OHH1.K

OI   CVCL_4548 ! OHH1.Lu

OI   CVCL_S205 ! OHH1.Sp

SX   Male

CA   Finite cell line

//

ID   OHH1.Lu

AC   CVCL_4548

SY   OHH1.LU

DR   CLO; CLO_0008245

DR   ATCC; CRL-6195

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6195; true.

OX   NCBI_TaxID=9872; ! Odocoileus hemionus

OI   CVCL_4546 ! OHH1.K

OI   CVCL_4547 ! OHH1.Li

OI   CVCL_S205 ! OHH1.Sp

SX   Male

CA   Finite cell line

//

ID   OHH1.Sp

AC   CVCL_S205

DR   ATCC; CRL-6196

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6196; true.

OX   NCBI_TaxID=9872; ! Odocoileus hemionus

OI   CVCL_4546 ! OHH1.K

OI   CVCL_4547 ! OHH1.Li

OI   CVCL_4548 ! OHH1.Lu

SX   Male

CA   Finite cell line

//

ID   OHK [Human primary effusion lymphoma]

AC   CVCL_W730

RX   PubMed=11841405;

DI   NCIt; C6915; Primary effusion lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OHK [Human ovarian tumor]

AC   CVCL_W731

RX   CelloPub=CLPUB00136;

CC   Doubling time: 38.4 hours (CelloPub=CLPUB00136).

DI   NCIt; C4270; Malignant ovarian Brenner tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OHN-GM

AC   CVCL_A662

DR   Cosmic; 787473

DR   Cosmic; 975295

DR   Cosmic; 1281350

RX   PubMed=9266938;

DI   NCIt; C8252; Therapy-related acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OHP101.B11.1

AC   CVCL_J481

SY   OHP 101.B11.1

DR   JCRB; JCRB1316.2

RX   PubMed=3312820;

CC   Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OHP138.H8.1

AC   CVCL_J482

SY   OHP 138.H8.1

DR   JCRB; JCRB1316.3

RX   PubMed=3312820;

CC   Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OHP1E9.3.1

AC   CVCL_J483

SY   OHP 1E9.3.1; 1E9

DR   JCRB; JCRB1316.4

RX   PubMed=3312820;

CC   Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OHP4B2.2.3

AC   CVCL_J484

SY   OHP 4B2.2.3; 4B2

DR   JCRB; JCRB1316.5

RX   PubMed=3312820;

CC   Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OHP57.G6.1

AC   CVCL_J485

SY   OHP 57.G6.1

DR   JCRB; JCRB1316.1

RX   PubMed=3312820;

CC   Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OHP7D7.2.3

AC   CVCL_J486

SY   OHP 7D7.2.3; 7D7

DR   JCRB; JCRB1316.6

RX   PubMed=3312820;

CC   Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OHR

AC   CVCL_F503

DR   Cosmic; 1358200

RX   DOI=10.14930/jsma1939.51.429;

RX   PubMed=2562091;

DI   NCIt; C3728; Hepatoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OHS

AC   CVCL_B450

SY   OHSX; OHS-50

DR   Cosmic; 1529909

DR   GEO; GSM879220

DR   GEO; GSM1676308

DR   GEO; GSM1701642

RX   PubMed=3459716;

RX   PubMed=8198963;

RX   PubMed=19787792;

RX   PubMed=21519327;

RX   PubMed=26351324;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OHS-4

AC   CVCL_R724

SY   OHS4

RX   PubMed=1860886;

CC   Doubling time: 39 hours (PubMed=1860886).

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B450 ! OHS

SX   Male

CA   Cancer cell line

//

ID   OHSTMAM-4

AC   CVCL_D244

RX   DOI=10.1016/0165-4608(96)85254-X;

RX   PubMed=21556597;

CC   Derived from metastatic site: Submandibular mass.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OHTA

AC   CVCL_4665

DR   RCB; RCB0545

CC   Breed/subspecies: ICR.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   OIH-1

AC   CVCL_4872

DR   CLO; CLO_0050990

DR   BioSample; SAMN03472124

DR   RCB; RCB1290

RX   PubMed=9631582;

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8

ST   D16S539: 10,12

ST   D5S818: 13

ST   D7S820: 11

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C3247; Myelodysplastic syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OK

AC   CVCL_0472

SY   Opossum Kidney; OK-WT

DR   BTO; BTO:0003069

DR   CLO; CLO_0008246

DR   MCCL; MCC:0000370

DR   CLDB; cl3766

DR   ATCC; CRL-1840

DR   CCRID; 3131C0001000400020

DR   CLS; 606465/p702_OK

DR   ECACC; 91021202

DR   KCB; KCB 200824YJ

DR   TOKU-E; 2794

DR   Wikidata; Q25326634

RX   PubMed=566717;

RX   PubMed=1802405;

WW   https://en.wikipedia.org/wiki/OK_cells

WW   http://fluoview.magnet.fsu.edu/gallery/cells/ok/okcells.html

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-497.html

CC   Doubling time: 18 hours (PubMed=566717).

OX   NCBI_TaxID=9267; ! Didelphis virginiana

SX   Female

CA   Spontaneously immortalized cell line

//

ID   OK [Sheep]

AC   CVCL_X339

SY   Ovine Kidney

DR   ATCC; CRL-6551

RX   PubMed=5587551;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6551; true.

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   OK-92

AC   CVCL_A767

SY   OK92

DR   Cosmic; 1118795

RX   PubMed=15069686;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OK7A

AC   CVCL_W411

SY   OK7a; OK-7A

RX   PubMed=7503230;

RX   PubMed=7681260;

OX   NCBI_TaxID=9267; ! Didelphis virginiana

HI   CVCL_0472 ! OK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   OKa-C-1

AC   CVCL_3085

DR   JCRB; JCRB1343

DR   JCRB; NIHS0544

RX   PubMed=8641981;

CC   Doubling time: 95 hours (PubMed=8641981).

CC   Discontinued: JCRB; NIHS0544; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 10

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Okajima

AC   CVCL_9815

SY   OKAJIMA

DR   EFO; EFO_0006715

DR   BioSample; SAMN03470905

DR   CGH-DB; 123-1

DR   CGH-DB; 9025-4

DR   Cosmic; 926117

DR   Cosmic; 1001656

DR   Cosmic; 1518258

DR   Cosmic; 2443795

RX   PubMed=3962675;

RX   PubMed=15723654;

RX   PubMed=24807215;

RX   PubMed=25485619;

CC   Doubling time: 36-40 hours (PubMed=3962675).

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9

ST   D16S539: 9,11

ST   D18S51: 15,18

ST   D19S433: 14.2

ST   D21S11: 29,30

ST   D2S1338: 17,24

ST   D3S1358: 17,18

ST   D5S818: 11

ST   D7S820: 8,12

ST   D8S1179: 14,15

ST   FGA: 19,25

ST   Penta D: 9,12

ST   Penta E: 17,21

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OKB

AC   CVCL_D041

SY   OK/B; Opossum Kidney clone B

RX   PubMed=2539748;

OX   NCBI_TaxID=9267; ! Didelphis virginiana

HI   CVCL_0472 ! OK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   OKB2

AC   CVCL_L219

SY   OK-B2

RX   PubMed=1708735;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L220 ! OKF4

OI   CVCL_L221 ! OKP4

SX   Male

CA   Finite cell line

//

ID   OKB3

AC   CVCL_L239

SY   OK-B3

RX   PubMed=1708735;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   OKB4

AC   CVCL_L240

SY   OK-B4

RX   PubMed=1708735;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   OKB8

AC   CVCL_L228

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   OKF4

AC   CVCL_L220

SY   OK-F4

DR   GEO; GSM1431137

RX   PubMed=1708735;

RX   PubMed=10648628;

RX   PubMed=25169794;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L219 ! OKB2

OI   CVCL_L221 ! OKP4

SX   Male

CA   Finite cell line

//

ID   OKF4/E6E7

AC   CVCL_L226

SY   OKF4 E6E7

DR   GEO; GSM1431132

RX   PubMed=25169794;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L220 ! OKF4

SX   Male

CA   Transformed cell line

//

ID   OKF4/TERT-1

AC   CVCL_L227

SY   OKF4 TERT

DR   GEO; GSM1431131

RX   PubMed=10648628;

RX   PubMed=25169794;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

CC   Transfected with: HGNC; 11730; TERT.

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L220 ! OKF4

SX   Male

CA   Telomerase immortalized cell line

//

ID   OKF6

AC   CVCL_L222

SY   OK-F6; OKF-6; OKF/6

DR   BTO; BTO:0005374

RX   PubMed=10648628;

RX   PubMed=22546478;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   OKF6/E6E7

AC   CVCL_L223

SY   OKF6 E6E7

DR   GEO; GSM1431133

RX   PubMed=25169794;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L222 ! OKF6

SX   Male

CA   Transformed cell line

//

ID   OKF6/TERT-1

AC   CVCL_L224

SY   OKF6 Tert 1; OKF6 TERT1

DR   GEO; GSM1431135

RX   PubMed=10648628;

RX   PubMed=21868764;

RX   PubMed=25169794;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

CC   Transfected with: HGNC; 11730; TERT.

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 14,15

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L222 ! OKF6

SX   Male

CA   Telomerase immortalized cell line

//

ID   OKF6/TERT-2

AC   CVCL_L225

SY   OKF6 Tert 2; OKF6 TERT2

DR   GEO; GSM1431130

RX   PubMed=10648628;

RX   PubMed=21868764;

RX   PubMed=25169794;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

CC   Transfected with: HGNC; 11730; TERT.

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 14,15

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L222 ! OKF6

SX   Male

CA   Telomerase immortalized cell line

//

ID   OKG12

AC   CVCL_L231

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L241 ! GingF12

SX   Male

CA   Finite cell line

//

ID   OKG4

AC   CVCL_L229

SY   OK-G4

RX   PubMed=1708735;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L230 ! OKHP1

SX   Sex undetermined

CA   Finite cell line

//

ID   OKH

AC   CVCL_D042

SY   OK/H; Opossum Kidney clone H

RX   PubMed=2539748;

OX   NCBI_TaxID=9267; ! Didelphis virginiana

HI   CVCL_0472 ! OK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   OKHP1

AC   CVCL_L230

SY   OK-HP1

RX   PubMed=1708735;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L229 ! OKG4

SX   Sex undetermined

CA   Finite cell line

//

ID   OKIBA

AC   CVCL_L499

RX   PubMed=15767549;

CC   Part of: JFCR45 cancer cell line panel.

CC   From: Kawaguchi T.; Department of Pathology; Cancer Institute, Japanese Foundation for Cancer Research; Tokyo; Japan.

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OKM-2T

AC   CVCL_5849

DR   BTO; BTO:0004184

RX   PubMed=9802061;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OKM-4

AC   CVCL_C396

DR   RCB; AES0050

DR   RCB; RCB2199

CC   Discontinued: RCB; RCB2199; true.

CC   Breed/subspecies: ICR.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   OKM1

AC   CVCL_G132

SY   OKM 1

DR   CLO; CLO_0008247

DR   ATCC; CRL-8026

DR   BCRC; 60271

DR   ECACC; 88012702

DR   KCLB; 28026

DR   TKG; TKG 0432

DR   Wikidata; Q27554393

RX   Patent=US4364936;

RX   PubMed=6342816;

CC   Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OKM10

AC   CVCL_2G58

RX   PubMed=6342816;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   OKM3

AC   CVCL_2E68

RX   PubMed=6342816;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   OKM5

AC   CVCL_2G54

RX   PubMed=3900210;

RX   PubMed=6342816;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   OKM6

AC   CVCL_2G55

RX   PubMed=6342816;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   OKM8

AC   CVCL_2G56

RX   PubMed=6342816;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   OKM9

AC   CVCL_2G57

RX   PubMed=6342816;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Oko

AC   CVCL_R798

RX   PubMed=1690682;

RX   PubMed=8891732;

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla

SX   Female

CA   Transformed cell line

//

ID   OKO160

AC   CVCL_W461

SY   OKO 160

RX   PubMed=10612458;

CC   Breed/subspecies: 129/Ola.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3987 ! CGR8

SX   Male

CA   Embryonic stem cell

//

ID   OKP

AC   CVCL_D040

SY   OK/P; OK-P; Opossum Kidney clone P

DR   TOKU-E; 4061

RX   PubMed=2539748;

OX   NCBI_TaxID=9267; ! Didelphis virginiana

HI   CVCL_0472 ! OK

CA   Spontaneously immortalized cell line

//

ID   OKP-GS

AC   CVCL_L980

DR   CLO; CLO_0008248

DR   CLDB; cl3767

WW   http://www.rccc.cytspb.rssi.ru/ecellbank/human/hokp-gs.htm

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OKP4

AC   CVCL_L221

SY   OK-P4

RX   PubMed=1708735;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L219 ! OKB2

OI   CVCL_L220 ! OKF4

SX   Male

CA   Finite cell line

//

ID   OKP7

AC   CVCL_L232

DR   GEO; GSM1431136

RX   PubMed=25169794;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   OKP7/bmi1/TERT

AC   CVCL_L233

SY   OKP7 bmi1 TERT; OKP7 bmi Tert

DR   GEO; GSM1431128

RX   PubMed=25169794;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

CC   Transfected with: HGNC; 1066; BMI1.

CC   Transfected with: HGNC; 11730; TERT.

CC   Omics: CNV analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L232 ! OKP7

SX   Male

CA   Telomerase immortalized cell line

//

ID   OKP8

AC   CVCL_L235

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L234 ! OFP8

SX   Sex undetermined

CA   Finite cell line

//

ID   OKT 1

AC   CVCL_2662

SY   OKT1

DR   CLO; CLO_0008249

DR   ATCC; CRL-8000

DR   ECACC; 86022705

DR   NCBI_Iran; H164

DR   TKG; TKG 0459

RX   Patent=US4363799;

CC   Monoclonal antibody target: UniProtKB; P06127; Human CD5.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OKT 10

AC   CVCL_2663

SY   OKT10

DR   CLO; CLO_0008250

DR   ATCC; CRL-8022

DR   ECACC; 87021903

DR   NCBI_Iran; H103

RX   Patent=US4364935;

CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OKT 11

AC   CVCL_2664

SY   OKT11

DR   CLO; CLO_0008251

DR   ATCC; CRL-8027

DR   CCRID; 3131C0001000600056

DR   ECACC; 86050802

DR   KCLB; 28027

DR   NCBI_Iran; H105

RX   Patent=US4364937;

CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OKT 3

AC   CVCL_2665

SY   OKT3

DR   CLO; CLO_0008252

DR   CLDB; cl5239

DR   ATCC; CRL-8001

DR   BCRC; 60154

DR   CCRID; 3131C0001001200019

DR   ECACC; 86022706

DR   IZSLER; BS Hy 12

DR   NCBI_Iran; H104

RX   Patent=US4361549;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OKT 4

AC   CVCL_2666

SY   OKT4

DR   CLO; CLO_0008253

DR   CLDB; cl5240

DR   ATCC; CRL-8002

DR   BCRC; 60235

DR   ECACC; 87012602

DR   IZSLER; BS Hy 13

DR   KCLB; 28002

DR   NCBI_Iran; H101

RX   Patent=US4381295;

CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OKT 5

AC   CVCL_2667

SY   OKT5

DR   CLO; CLO_0008254

DR   CLO; CLO_0008255

DR   ATCC; CRL-8013

DR   ATCC; CRL-8016

DR   ECACC; 88070705

RX   Patent=US4364932;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OKT 6

AC   CVCL_2668

SY   OKT6

DR   CLO; CLO_0008256

DR   ATCC; CRL-8020

DR   ECACC; 87091001

DR   NCBI_Iran; H111

RX   Patent=US4364933;

CC   Monoclonal antibody target: UniProtKB; P06126; Human CD1A.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OKT 8

AC   CVCL_2669

SY   OKT8

DR   CLO; CLO_0008257

DR   CLDB; cl5241

DR   ATCC; CRL-8014

DR   BCRC; 60257

DR   ECACC; 85112802

DR   IZSLER; BS Hy 16

DR   NCBI_Iran; H102

RX   Patent=US4361550;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OKT 9

AC   CVCL_2670

SY   OKT9

DR   CLO; CLO_0008258

DR   ATCC; CRL-8021

DR   ECACC; 86022707

DR   NCBI_Iran; H125

RX   Patent=US4364934;

CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OKT1

AC   CVCL_E233

RX   PubMed=9826457;

DI   NCIt; C7982; Cervical small cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OKT4

AC   CVCL_L236

SY   OK-T4

RX   PubMed=1708735;

WW   http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Finite cell line

//

ID   OKTr-1

AC   CVCL_9U40

RX   PubMed=7724618;

CC   Group: Crustacean cell line.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=29019; ! Litopenaeus stylirostris

CA   Transformed cell line

//

ID   OKTr-23

AC   CVCL_9U41

RX   PubMed=7724618;

CC   Group: Crustacean cell line.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=29019; ! Litopenaeus stylirostris

CA   Transformed cell line

//

ID   Oku-BL

AC   CVCL_7206

RX   PubMed=12219084;

RX   PubMed=16051863;

RX   PubMed=21088132;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OL-1

AC   CVCL_U377

RX   PubMed=17306496;

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Finite cell line

//

ID   OL-17

AC   CVCL_M762

SY   Oryzias Latipes-17

RX   DOI=10.1007/BF02628830;

CC   Group: Fish cell line.

CC   Breed/subspecies: Orange-red.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Male

CA   Spontaneously immortalized cell line

//

ID   OL-32

AC   CVCL_M755

SY   OL32; Oryzias Latipes-32

RX   DOI=10.1007/BF02628830;

RX   PubMed=7881826;

RX   PubMed=16341864;

CC   Group: Fish cell line.

CC   Breed/subspecies: HB32.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Olare

AC   CVCL_IU25

RX   PubMed=178913;

RX   PubMed=4122458;

RX   PubMed=4364259;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OLC2-1

AC   CVCL_U897

DR   RCB; AES0154

CC   Breed/subspecies: 129/Ola.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   OLCAB-2

AC   CVCL_M756

RX   PubMed=16341864;

CC   Group: Fish cell line.

CC   Breed/subspecies: CAB.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLCAB-e1

AC   CVCL_M757

SY   OLCAB-e31

DR   CLO; CLO_0051614

DR   RCB; RCB2944

RX   PubMed=16341864;

CC   Group: Fish cell line.

CC   Breed/subspecies: CAB.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLCAB-e21

AC   CVCL_6D98

RX   PubMed=20624282;

CC   Group: Fish cell line.

CC   Breed/subspecies: CAB.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLCAB-e3

AC   CVCL_M758

DR   CLO; CLO_0051615

DR   RCB; RCB2946

RX   PubMed=16341864;

RX   PubMed=20624282;

CC   Group: Fish cell line.

CC   Breed/subspecies: CAB.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLCAB-e31

AC   CVCL_6D99

RX   PubMed=20624282;

CC   Group: Fish cell line.

CC   Breed/subspecies: CAB.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLD1612

AC   CVCL_F504

DR   Cosmic; 1522777

DR   GEO; GSM726281

RX   PubMed=21642991;

CC   Omics: SNP array analysis.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OLES1

AC   CVCL_6F85

SY   Oryzias Latipes Embryonic Stem cells 1

RX   PubMed=8000476;

WW   https://kaken.nii.ac.jp/d/p/06680717.ja.html

CC   Group: Fish cell line.

CC   Breed/subspecies: HNI.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   OLF-124

AC   CVCL_R980

SY   Oryzias Latipes Fin-124

RX   CelloPub=CLPUB00092;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLF-136

AC   CVCL_3766

SY   Oryzias Latipes Fin-136

DR   CLO; CLO_0051619

DR   RCB; RCB0184

RX   CelloPub=CLPUB00092;

RX   PubMed=20624282;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLF10.1.8

AC   CVCL_6F60

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF3.3

AC   CVCL_M961

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF3.6

AC   CVCL_M962

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF4.1

AC   CVCL_M963

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF4.3

AC   CVCL_M964

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF4.4.1

AC   CVCL_M965

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF4.4.2

AC   CVCL_M966

SY   OLF442

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF4.5.1

AC   CVCL_M967

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF4.6.1

AC   CVCL_M968

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF4.6.2

AC   CVCL_M969

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF4.6.3

AC   CVCL_M970

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLF4.7.8

AC   CVCL_M971

RX   PubMed=8841984;

CC   Transfected with: MGI; MGI:97357; Mycn.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OLGA

AC   CVCL_E797

SY   Olga; OLL; TER175; TER215; TER346; TER363

DR   dbMHC; 48991

DR   dbMHC; 48992

DR   ECACC; 88052071

DR   IHW; IHW9071

DR   IHW; IHW9100

DR   IMGT/HLA; 11212

DR   IMGT/HLA; 11213

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl71.html

WW   http://bioinformatics.hsanmartino.it/ecbr/cl100.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   OLGA-PH-J/92

AC   CVCL_U272

SY   OLGA PH J/92; OL-J/92

DR   ATCC; CRL-2576

DR   BioSample; SAMN03152023

RX   CelloPub=CLPUB00251;

RX   PubMed=11125551;

RX   PubMed=21938590;

WW   http://www.atcc.org/Global/FAQs/2/7/OLGAPHJ92%20OLJ92%20ATCC%20CRL2576-1052.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified. Shown not to originate from the crayfish Orconectes limosus. May have been derived from contaminating fresh water amoeba that could have been present in the neural tissue of the originating crayfish (PubMed=21938590).

CC   Discontinued: ATCC; CRL-2576; true.

OX   NCBI_TaxID=32644; ! Unidentified

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLGS1

AC   CVCL_EJ00

DR   Cosmic; 1494008

RX   PubMed=21381030;

DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OLHdrR-e3

AC   CVCL_M759

DR   CLO; CLO_0051613

DR   RCB; RCB2943

RX   PubMed=16341864;

RX   PubMed=20624282;

CC   Group: Fish cell line.

CC   Breed/subspecies: HdrR.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLHE-131

AC   CVCL_4873

SY   Oryzias Latipes HEpatoma-131

DR   CLO; CLO_0051617

DR   RCB; RCB0187

RX   CelloPub=CLPUB00092;

RX   PubMed=20624282;

CC   Group: Fish cell line.

CC   Breed/subspecies: H04C.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Cancer cell line

//

ID   OLHNI-1

AC   CVCL_M754

RX   PubMed=16341864;

RX   PubMed=20624282;

CC   Group: Fish cell line.

CC   Breed/subspecies: HNI.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLHNI-2

AC   CVCL_J027

DR   CLO; CLO_0051616

DR   RCB; RCB2942

RX   PubMed=16341864;

RX   PubMed=20624282;

CC   Group: Fish cell line.

CC   Breed/subspecies: HNI.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLKaga-e1

AC   CVCL_6D97

RX   PubMed=20624282;

CC   Group: Fish cell line.

CC   Breed/subspecies: Kaga.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLKaga-e2

AC   CVCL_M760

RX   PubMed=16341864;

CC   Group: Fish cell line.

CC   Breed/subspecies: Kaga.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLME-104

AC   CVCL_3767

SY   Oryzias Latipes MElanoma-104

DR   CLO; CLO_0051620

DR   RCB; RCB0188

RX   CelloPub=CLPUB00092;

RX   PubMed=20624282;

CC   Group: Fish cell line.

CC   Breed/subspecies: HB32.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Cancer cell line

//

ID   OLN-93

AC   CVCL_5850

SY   OLN93; OLN 93

DR   BTO; BTO:0002400

DR   NCBI_Iran; C617

RX   PubMed=8843033;

CC   Breed/subspecies: Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Spontaneously immortalized cell line

//

ID   OLP6

AC   CVCL_U466

DR   CLO; CLO_0051390

DR   RCB; RCB2864

RX   PubMed=16181743;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Conditionally immortalized cell line

//

ID   OLSOK-e7

AC   CVCL_M761

RX   PubMed=16341864;

CC   Group: Fish cell line.

CC   Breed/subspecies: SOK.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OLV2-1

AC   CVCL_U896

DR   RCB; AES0153

CC   Breed/subspecies: 129/Ola.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   OM 3-1.1

AC   CVCL_G238

SY   OM3-1.1

DR   CLO; CLO_0008261

DR   ATCC; HB-134

CC   Monoclonal antibody target: UniProtKB; P02771; Human AFP.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OM-1

AC   CVCL_W941

SY   OM1

DR   CGH-DB; 359-2

DR   ChEMBL-Cells; CHEMBL3307304

DR   ChEMBL-Targets; CHEMBL614136

DR   Cosmic; 930342

DR   Cosmic; 1046036

DR   Cosmic; 1120713

DR   Cosmic; 1123044

RX   PubMed=17052259;

RX   PubMed=17599052;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OM-2

AC   CVCL_W942

SY   OM2

DR   CGH-DB; 362-2

DR   Cosmic; 930343

DR   Cosmic; 1046037

RX   PubMed=17052259;

RX   PubMed=17599052;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OM1

AC   CVCL_L098

DR   ATCC; PTA-5938

RX   Patent=US7611707;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OM10.1

AC   CVCL_D567

SY   OM-10.1

DR   NIH-ARP; 1319-337

RX   PubMed=1678437;

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0002 ! HL-60

SX   Female

CA   Cancer cell line

//

ID   OM2

AC   CVCL_L099

DR   ATCC; PTA-5939

RX   Patent=US7611707;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OM3

AC   CVCL_L097

DR   ATCC; PTA-5940

RX   Patent=US7611707;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   Om37

AC   CVCL_N327

SY   OM37

DR   ATCC; HB-8233

RX   Patent=US4643971;

CC   Discontinued: ATCC; HB-8233; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OM4

AC   CVCL_L100

DR   ATCC; PTA-5941

RX   Patent=US7611707;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   OM421

AC   CVCL_X145

RX   PubMed=6386741;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OM431

AC   CVCL_J308

SY   OM-431

RX   PubMed=1531323;

RX   PubMed=6386741;

RX   PubMed=7641843;

RX   PubMed=7573309;

RX   PubMed=16772116;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OM439

AC   CVCL_X146

RX   PubMed=6386741;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OM443

AC   CVCL_X147

RX   PubMed=6386741;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OM449

AC   CVCL_X148

RX   PubMed=6386741;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OM464

AC   CVCL_J309

RX   PubMed=1531323;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OM467

AC   CVCL_J310

RX   PubMed=1531323;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OM482

AC   CVCL_J311

RX   PubMed=1531323;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Om5

AC   CVCL_N328

SY   OM5

DR   ATCC; HB-8270

RX   Patent=US4643971;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   OM9;22

AC   CVCL_A663

SY   OM9:22; OM9-22; OM 9;22; OM 9:22

DR   Cosmic; 996293

DR   Cosmic; 998696

DR   Cosmic; 999743

DR   Cosmic; 1037735

DR   Cosmic; 2491089

RX   PubMed=9067587;

DI   NCIt; C9143; Adult B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OMA-AML-1

AC   CVCL_A110

DR   Cosmic; 787474

DR   Cosmic; 975296

DR   Cosmic; 1281351

RX   PubMed=1379848;

DI   NCIt; C7463; Acute myelomonocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OMA-BL-1

AC   CVCL_M553

SY   OMA BL-1; OMA-BL1; Oma

RX   PubMed=1848532;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Omaka cells

AC   CVCL_6F86

RX   PubMed=810810;

CC   Group: Fish cell line.

OX   NCBI_TaxID=197572; ! Atule mate

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OMB3

AC   CVCL_U136

RX   PubMed=9185613;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   OMB4

AC   CVCL_U137

DR   CLO; CLO_0050330

DR   RCB; RCB2048

RX   PubMed=9185613;

CC   Monoclonal antibody target: N-linked neutral oligosaccharides of glycoproteins.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   OMC-1 [Human cervical carcinoma]

AC   CVCL_1623

DR   CLO; CLO_0050939

DR   BioSample; SAMN03472225

DR   ChEMBL-Cells; CHEMBL3308213

DR   ChEMBL-Targets; CHEMBL2366339

DR   Cosmic; 949154

DR   Cosmic; 1152541

DR   Cosmic; 1995602

DR   Cosmic-CLP; 949154

DR   GDSC; 949154

DR   GEO; GSM1670305

DR   RCB; RCB0753

RX   DOI=10.1267/ahc.26.515;

RX   PubMed=2486664;

RX   PubMed=2531191;

RX   PubMed=3746026;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Virchow's lymph node.

ST   Source(s): Cosmic-CLP; RCB

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 8,12

ST   D16S539: 11,12

ST   D5S818: 10,11

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C4028; Cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OMC-1 [Human ovarian carcinoma]

AC   CVCL_9T73

DR   Cosmic; 2429302

RX   CelloPub=CLPUB00307;

RX   PubMed=19154404;

RX   PubMed=22246397;

CC   Doubling time: 24 hours (CelloPub=CLPUB00307).

DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OMC-2

AC   CVCL_3353

DR   CLO; CLO_0050887

DR   BioSample; SAMN03471931

DR   Cosmic; 1152551

DR   RCB; RCB2830

RX   PubMed=2624581;

CC   Doubling time: 55-139 hours (PubMed=2624581).

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   TH01: 7

ST   TPOX: 9,12

ST   vWA: 15

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OMC-3

AC   CVCL_3354

SY   OMC3

DR   CLO; CLO_0051448

DR   BioSample; SAMN03472226

DR   Cosmic; 1152555

DR   RCB; RCB0755

RX   DOI=10.1267/ahc.26.515;

RX   PubMed=2010102;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 9,11

ST   D5S818: 13

ST   D7S820: 8

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OMC-4

AC   CVCL_A108

SY   OMC4

DR   Cosmic; 877474

DR   Cosmic; 1152547

RX   DOI=10.1267/ahc.26.515;

RX   PubMed=2531191;

RX   PubMed=3598280;

CC   Doubling time: 63 hours (PubMed=3598280).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OMC-5

AC   CVCL_9U42

RX   DOI=10.11437/sanpunosinpo1949.40.17;

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: ICR.

DI   NCIt; C24077; Mouse cervical squamous cell carcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   OMC-6

AC   CVCL_A109

DR   Cosmic; 1152554

RX   DOI=10.1267/ahc.26.515;

RX   PubMed=3225484;

DI   NCIt; C8973; Endometrioid stromal sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OMC-9

AC   CVCL_3355

DR   CLO; CLO_0050888

DR   BioSample; SAMN03471932

DR   RCB; RCB2832

RX   PubMed=18397474;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,10

ST   D16S539: 9,12

ST   D5S818: 13

ST   D7S820: 8,12

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 19,20

DI   NCIt; C8973; Endometrioid stromal sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OME/CTVM21

AC   CVCL_Z172

DR   TCB; 3136

RX   PubMed=19252822;

RX   PubMed=21955214;

RX   PubMed=22743047;

CC   Group: Tick cell line.

OX   NCBI_TaxID=6938; ! Ornithodoros moubata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OME/CTVM22

AC   CVCL_Z173

DR   TCB; 3141

RX   PubMed=19252822;

RX   PubMed=21955214;

RX   PubMed=22743047;

CC   Group: Tick cell line.

OX   NCBI_TaxID=6938; ! Ornithodoros moubata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OME/CTVM24

AC   CVCL_Z174

DR   TCB; 3146

RX   PubMed=19252822;

RX   PubMed=22743047;

CC   Group: Tick cell line.

OX   NCBI_TaxID=6938; ! Ornithodoros moubata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OME/CTVM25

AC   CVCL_Z175

RX   PubMed=19252822;

RX   PubMed=22743047;

CC   Group: Tick cell line.

OX   NCBI_TaxID=6938; ! Ornithodoros moubata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OME/CTVM26

AC   CVCL_Z176

RX   PubMed=19252822;

RX   PubMed=22743047;

CC   Group: Tick cell line.

OX   NCBI_TaxID=6938; ! Ornithodoros moubata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OME/CTVM27

AC   CVCL_Z177

RX   PubMed=19252822;

RX   PubMed=22743047;

CC   Group: Tick cell line.

OX   NCBI_TaxID=6938; ! Ornithodoros moubata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   OMEGA-E

AC   CVCL_2151

SY   Omega E

DR   CLO; CLO_0008264

DR   CLDB; cl3772

DR   DSMZ; ACC-253

DR   Ximbio; 151463

RX   PubMed=2194165;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-237.html

CC   Group: Retrovirus packaging cell line.

CC   Doubling time: ~20-30 hours (DSMZ).

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   OMEGA-Z

AC   CVCL_DC35

RX   PubMed=7153601;

DI   NCIt; C4646; Gestational choriocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OMK-210

AC   CVCL_L983

SY   OMK210; Owl Monkey Kidney-210

RX   CelloPub=CLPUB00093;

RX   PubMed=76312;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9505; ! Aotus trivirgatus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   OMK-637

AC   CVCL_4264

SY   OMK637; OMK (637-69); OMK(637-69); Owl Monkey Kidney-637

DR   CLO; CLO_0008265

DR   CLO; CLO_0008266

DR   CLDB; cl3773

DR   ATCC; CRL-1556

DR   ECACC; 90110510

RX   PubMed=76312;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9505; ! Aotus trivirgatus

SX   Female

CA   Finite cell line

//

ID   OML clone 13C

AC   CVCL_6427

SY   OML, clone 13C; Owl monkey 13C; Owl Monkey Lymphoblast clone 13C

DR   CLO; CLO_0008267

DR   ATCC; CRL-2312

RX   PubMed=9081215;

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9505; ! Aotus trivirgatus

SX   Female

CA   Transformed cell line

//

ID   OMM-1

AC   CVCL_6939

SY   OMM1; Omm1

DR   Cosmic; 848331

DR   Cosmic; 899895

DR   Cosmic; 916147

DR   Cosmic; 1628402

DR   Cosmic; 1669126

DR   Cosmic; 2036704

RX   PubMed=8621261;

RX   PubMed=16772116;

RX   PubMed=22236444;

RX   PubMed=24994677;

CC   Doubling time: 34 hours (PubMed=24994677).

CC   Derived from metastatic site: Hypodermis.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OMM-2

AC   CVCL_6940

SY   OMM2

DR   Cosmic; 848332

DR   Cosmic; 899896

RX   PubMed=8621261;

CC   Derived from metastatic site: Hypodermis.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OMM-3

AC   CVCL_6941

SY   OMM3

DR   Cosmic; 848333

DR   Cosmic; 899897

RX   PubMed=8621261;

CC   Derived from metastatic site: Hypodermis.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OMM2.2

AC   CVCL_C305

SY   OMM2_2; OMM 2-2

DR   Cosmic; 899899

RX   PubMed=9247253;

CC   From: Ksander B.; Schepens Eye Research Institute; Boston; USA.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C302 ! Mel270

OI   CVCL_C306 ! OMM2.3

OI   CVCL_C307 ! OMM2.5

OI   CVCL_C308 ! OMM2.6

SX   Male

CA   Cancer cell line

//

ID   OMM2.3

AC   CVCL_C306

SY   Omm2.3; OMM2_3; OMM-2.3; OMM 2-3; OMM1.3; Omm1_3; OMM1_3

DR   Cosmic; 899900

DR   Cosmic; 916145

DR   Cosmic; 1628397

DR   Cosmic; 1669127

DR   Cosmic; 2036705

RX   PubMed=9247253;

RX   PubMed=16772116;

RX   PubMed=22236444;

CC   From: Ksander B.; Schepens Eye Research Institute; Boston; USA.

CC   Derived from metastatic site: Liver.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C302 ! Mel270

OI   CVCL_C305 ! OMM2.2

OI   CVCL_C307 ! OMM2.5

OI   CVCL_C308 ! OMM2.6

SX   Male

CA   Cancer cell line

//

ID   OMM2.5

AC   CVCL_C307

SY   Omm2.5; OMM2_5; OMM1.5; Omm1_5

DR   Cosmic; 916146

DR   Cosmic; 1628398

RX   PubMed=9247253;

RX   PubMed=22236444;

RX   PubMed=24994677;

CC   From: Ksander B.; Schepens Eye Research Institute; Boston; USA.

CC   Doubling time: 50 hours (PubMed=24994677).

CC   Derived from metastatic site: Liver.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C302 ! Mel270

OI   CVCL_C305 ! OMM2.2

OI   CVCL_C306 ! OMM2.3

OI   CVCL_C308 ! OMM2.6

SX   Male

CA   Cancer cell line

//

ID   OMM2.6

AC   CVCL_C308

SY   OMM2_6; OMM 2-6

DR   Cosmic; 899901

RX   PubMed=9247253;

CC   From: Ksander B.; Schepens Eye Research Institute; Boston; USA.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C302 ! Mel270

OI   CVCL_C305 ! OMM2.2

OI   CVCL_C306 ! OMM2.3

OI   CVCL_C307 ! OMM2.5

SX   Male

CA   Cancer cell line

//

ID   OMMT-ARK-1

AC   CVCL_IW23

RX   PubMed=22498937;

DI   NCIt; C9192; Ovarian carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OMMT-ARK-2

AC   CVCL_IW24

RX   PubMed=22498937;

DI   NCIt; C9192; Ovarian carcinosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OMR5

AC   CVCL_U138

DR   CLO; CLO_0050331

DR   RCB; RCB2049

RX   PubMed=9185613;

CC   Monoclonal antibody target: F1-linked neutral oligosaccharides of glycoproteins.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   OMR6

AC   CVCL_U139

DR   CLO; CLO_0050332

DR   RCB; RCB2050

RX   PubMed=9185613;

CC   Monoclonal antibody target: M1-linked neutral oligosaccharides of glycoproteins.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   OMT-1

AC   CVCL_0G03

DR   CGH-DB; 9027-4

RX   PubMed=10570904;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OMW

AC   CVCL_E798

DR   dbMHC; 48993

DR   ECACC; 98092903

DR   IHW; IHW9058

DR   IMGT/HLA; 11215

WW   http://bioinformatics.hsanmartino.it/ecbr/cl58.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   On Ser

AC   CVCL_U693

SY   OnSer

DR   ATCC; CRL-1112

CC   Discontinued: ATCC; CRL-1112; true.

DI   NCIt; C61255; Lesch-Nyhan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Onc-M10

AC   CVCL_0U30

DR   ATCC; HB-9244

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9244; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M11

AC   CVCL_0U31

DR   ATCC; HB-9245

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9245; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M12

AC   CVCL_0U32

DR   ATCC; HB-9246

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9246; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M15

AC   CVCL_0U33

DR   ATCC; HB-9247

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9247; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M16

AC   CVCL_0U34

DR   ATCC; HB-9216

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9216; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M21

AC   CVCL_0U35

SY   ONC M21

DR   ATCC; HB-9248

RX   Patent=US5849876;

RX   Patent=US6004761;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M22

AC   CVCL_0U36

DR   ATCC; HB-9249

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9249; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M23

AC   CVCL_0U37

DR   ATCC; HB-9250

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9250; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M25

AC   CVCL_0U38

DR   ATCC; HB-9217

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9217; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M26

AC   CVCL_0U39

DR   ATCC; HB-9212

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9212; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M27

AC   CVCL_0U40

DR   ATCC; HB-9229

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9229; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M29

AC   CVCL_0U41

DR   ATCC; HB-9210

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9210; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M29.41

AC   CVCL_0U42

SY   ONC M29.41

DR   ATCC; HB-9243

RX   Patent=US5849876;

RX   Patent=US6004761;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0U41 ! Onc-M29

CA   Hybridoma

//

ID   Onc-M30

AC   CVCL_0U43

DR   ATCC; HB-9211

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9211; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M38

AC   CVCL_0U44

SY   ONC M38

DR   ATCC; HB-9365

RX   Patent=US5849876;

RX   Patent=US6004761;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Onc-M8

AC   CVCL_0U45

DR   ATCC; HB-9209

RX   Patent=US5849876;

RX   Patent=US6004761;

CC   Discontinued: ATCC; HB-9209; true.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   ONCO-DG-1

AC   CVCL_1882

SY   ONCO-DG 1; ONCO-DG1; ONCODG1

DR   BTO; BTO:0004847

DR   BioSample; SAMN03151879

DR   CCLE; ONCODG1_OVARY

DR   DSMZ; ACC-507

RX   PubMed=1381131;

RX   PubMed=20143388;

RX   PubMed=23839242;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OVCAR-3 derivative (PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~30 hours (DSMZ).

CC   Derived from metastatic site: Ascites.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 12

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C105555; High grade ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0465 ! OVCAR-3

SX   Female

CA   Cancer cell line

//

ID   Onda 10

AC   CVCL_3075

SY   no.10; no-10; Case 6

DR   BioSample; SAMN03472789

DR   CGH-DB; 151-1

DR   ChEMBL-Cells; CHEMBL3308838

DR   ChEMBL-Targets; CHEMBL2366071

DR   Cosmic; 687579

DR   Cosmic; 908452

DR   Cosmic; 2367541

DR   Cosmic-CLP; 908452

DR   GDSC; 908452

DR   GEO; GSM1670281

DR   IFO; IFO50368

DR   JCRB; JCRB1606

DR   RCB; RCB4499

RX   CelloPub=CLPUB00089;

RX   PubMed=3188836;

RX   PubMed=8878451;

RX   PubMed=10551321;

RX   PubMed=16232199;

RX   PubMed=18415661;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 12,13

ST   D7S820: 8,11

ST   TH01: 7,9

ST   TPOX: 9

ST   vWA: 17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Onda 11

AC   CVCL_3076

SY   no.11; no-11; Case 3

DR   BioSample; SAMN03481112

DR   CGH-DB; 152-1

DR   ChEMBL-Cells; CHEMBL3308224

DR   ChEMBL-Targets; CHEMBL2366326

DR   Cosmic; 687580

DR   Cosmic; 908450

DR   Cosmic; 2367542

DR   Cosmic-CLP; 908450

DR   GDSC; 908450

DR   GEO; GSM1670282

DR   IFO; IFO50369

DR   JCRB; JCRB1605

DR   RCB; RCB4500

RX   CelloPub=CLPUB00089;

RX   PubMed=3188836;

RX   PubMed=8878451;

RX   PubMed=10551321;

RX   PubMed=16232199;

RX   PubMed=18415661;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 10,11

ST   D7S820: 11

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Onda 7

AC   CVCL_4W67

SY   Case 9

DR   JCRB; JCRB1575

RX   PubMed=8878451;

RX   PubMed=10551321;

RX   PubMed=18415661;

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 10,11

ST   D16S539: 9,13

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Onda 8

AC   CVCL_4W68

SY   Case 8

DR   JCRB; JCRB1578

RX   PubMed=8878451;

RX   PubMed=10551321;

RX   PubMed=18415661;

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 13

ST   D16S539: 11,12

ST   D5S818: 10,12

ST   D7S820: 10,12

ST   TH01: 6

ST   TPOX: 9

ST   vWA: 18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Onda 9

AC   CVCL_1R14

SY   no.9; Case 10

DR   JCRB; JCRB1576

RX   PubMed=3188836;

RX   PubMed=8878451;

RX   PubMed=10551321;

RX   PubMed=18415661;

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 11,13

ST   D5S818: 9,12

ST   D7S820: 12

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 14,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4W69 ! Onda 9R

SX   Male

CA   Cancer cell line

//

ID   Onda 9R

AC   CVCL_4W69

DR   JCRB; JCRB1583

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 11,13

ST   D5S818: 9,12

ST   D7S820: 12

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 14,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1R14 ! Onda 9

SX   Male

CA   Cancer cell line

//

ID   Onda 9R-B12

AC   CVCL_4W70

DR   JCRB; JCRB1607

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 11,13

ST   D5S818: 9,12

ST   D7S820: 12

ST   TH01: 9

ST   TPOX: 8,9

ST   vWA: 14,18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4W69 ! Onda 9R

SX   Male

CA   Cancer cell line

//

ID   ONE58

AC   CVCL_2671

DR   CBA; CBA-0143

DR   Cosmic; 1522773

DR   Cosmic; 1963332

DR   ECACC; 10092313

DR   GEO; GSM726282

RX   PubMed=1703129;

RX   PubMed=21642991;

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Onesmas

AC   CVCL_IU26

RX   PubMed=4122458;

RX   PubMed=4364259;

RX   PubMed=4932228;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ONS-12

AC   CVCL_S732

SY   ONS12

RX   PubMed=9310141;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ONS-21

AC   CVCL_5G58

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2395860;

DI   NCIt; C4326; Anaplastic oligodendroglioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ONS-21-C2

AC   CVCL_5G59

RX   PubMed=2395860;

DI   NCIt; C4326; Anaplastic oligodendroglioma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5G58 ! ONS-21

SX   Male

CA   Cancer cell line

//

ID   ONS-75

AC   CVCL_S733

RX   PubMed=9310141;

DI   NCIt; C9477; Anaplastic astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ONS-76

AC   CVCL_1624

SY   ONS76

DR   BCRJ; 0294

DR   BioSample; SAMN03470886

DR   CCLE; ONS76_CENTRAL_NERVOUS_SYSTEM

DR   ChEMBL-Cells; CHEMBL3308540

DR   ChEMBL-Targets; CHEMBL2366068

DR   Cosmic; 909248

DR   Cosmic; 1995603

DR   Cosmic-CLP; 909248

DR   GDSC; 909248

DR   GEO; GSM887477

DR   GEO; GSM888558

DR   GEO; GSM919364

DR   GEO; GSM1670306

DR   IFO; IFO50355

RX   CelloPub=CLPUB00094;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2818910;

RX   PubMed=22460905;

RX   PubMed=22951319;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,13

ST   D16S539: 9,10

ST   D18S51: 14,21

ST   D19S433: 14,15.2

ST   D21S11: 29,30.3

ST   D2S1338: 17,19

ST   D3S1358: 15

ST   D5S818: 9,10

ST   D7S820: 11,12

ST   D8S1179: 10

ST   FGA: 24

ST   Penta D: 12,13

ST   Penta E: 15,16

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ONS-81

AC   CVCL_M702

RX   CelloPub=CLPUB00094;

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=2818910;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ONS-B11

AC   CVCL_S734

RX   PubMed=22951319;

CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1624 ! ONS-76

SX   Female

CA   Cancer cell line

//

ID   ONS-F11

AC   CVCL_S735

RX   PubMed=22951319;

CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1624 ! ONS-76

SX   Female

CA   Cancer cell line

//

ID   ONS-F8

AC   CVCL_S736

RX   PubMed=22951319;

CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1624 ! ONS-76

SX   Female

CA   Cancer cell line

//

ID   ONSA-8

AC   CVCL_M601

SY   ONSA 8; ONcology SArcoma, line 8

RX   PubMed=4471180;

DI   NCIt; C2946; Chondrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OnyCap-1

AC   CVCL_IQ33

SY   Onycap-1; ONYCAP-1; ONYCAP1

RX   Patent=US7303911;

CC   From: Onyvax, Ltd; UK.

CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 00032802.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Caution: Was originally thought to arise from the ascitic fluid of a prostate carcinoma patient and described as such in patent application GB008032.5 from Jan. 4, 2000.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4889 ! PNT2-C2

SX   Male

CA   Transformed cell line

//

ID   OnyCap-23

AC   CVCL_IQ34

SY   Onycap-23; ONYCAP-23; Onycap23; ONYCAP23; Ony-Cap 23

RX   Patent=US7303911;

CC   From: Onyvax, Ltd; UK.

CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 00032801.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Caution: Was originally thought to arise from the ascitic fluid of a prostate carcinoma patient and described as such in patent application GB008032.5 from Jan. 4, 2000.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4889 ! PNT2-C2

SX   Male

CA   Transformed cell line

//

ID   OOS [Dog osteosarcoma]

AC   CVCL_L369

RX   PubMed=9673952;

CC   Doubling time: 45.0 +- 0.5 hours (PubMed=9673952).

CC   Breed/subspecies: Maltese.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OOS [Human B-cell IHW]

AC   CVCL_1M75

SY   GM06827

DR   CLO; CLO_0036521

DR   Coriell; GM06827

RX   PubMed=6417008;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   OP-1

AC   CVCL_DG77

SY   OP1

DR   Cosmic; 1524811

DR   GEO; GSM236800

DR   GEO; GSM236836

RX   PubMed=8142640;

RX   PubMed=9446662;

DI   NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OP-9S

AC   CVCL_HC57

DR   ATCC; PTA-10785

RX   Patent=US9121008;

RX   PubMed=15650053;

CC   Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.

CC   Doubling time: 58-72 hours; slow-growing derivative of OP9.

CC   Discontinued: ATCC; PTA-10785; probable.

CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4398 ! OP9

CA   Stromal cell line

//

ID   OP-9S/LMJSN

AC   CVCL_HC58

RX   Patent=US9121008;

RX   PubMed=15650053;

CC   Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.

CC   Doubling time: 58-72 hours; slow-growing derivative of OP9.

CC   Transfected with: MGI; MGI:1098270; Jag2.

CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_HC57 ! OP-9S

CA   Stromal cell line

//

ID   OP42

AC   CVCL_D676

DR   BCRJ; 0193

RX   PubMed=7561035;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   OP9

AC   CVCL_4398

SY   OP-9

DR   BTO; BTO:0003295

DR   CLO; CLO_0008268

DR   ATCC; CRL-2749

DR   BCRC; 60566

DR   BCRJ; 0309

DR   CCRID; 3131C0001000300017

DR   RCB; RCB1124

RX   PubMed=8066449;

RX   PubMed=8990620;

RX   PubMed=23469264;

RX   PubMed=28176856;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=op9

CC   Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.

CC   Characteristics: Used as feeder cells for the differentiation of ES cells and iPS cells into hematopoietic cells.

CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   OP9/G

AC   CVCL_B217

DR   CLO; CLO_0050190

DR   RCB; RCB2121

DR   RCB; RCB2924

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Discontinued: RCB; RCB2121; true.

CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4398 ! OP9

CA   Stromal cell line

//

ID   OP9/G-DLL1

AC   CVCL_B218

DR   CLO; CLO_0050191

DR   RCB; RCB2122

DR   RCB; RCB2925

CC   Transfected with: MGI; MGI:104659; Dll1.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Discontinued: RCB; RCB2122; true.

CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4398 ! OP9

CA   Stromal cell line

//

ID   OP9/N

AC   CVCL_B219

DR   CLO; CLO_0050189

DR   RCB; RCB2123

DR   RCB; RCB2926

CC   Transfected with: HGNC; 7809; NGFR.

CC   Discontinued: RCB; RCB2123; true.

CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4398 ! OP9

CA   Stromal cell line

//

ID   OP9/N-DLL1

AC   CVCL_B220

DR   CLO; CLO_0050188

DR   RCB; RCB2124

DR   RCB; RCB2927

CC   Transfected with: HGNC; 7809; NGFR.

CC   Transfected with: MGI; MGI:104659; Dll1.

CC   Discontinued: RCB; RCB2124; true.

CC   Breed/subspecies: (C57BL/6 x C3H) F2-op/op.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4398 ! OP9

CA   Stromal cell line

//

ID   OPA1-null MEFs

AC   CVCL_L694

DR   ATCC; CRL-2995

CC   Knockout cell: Method=KO mouse; MGI:1921393; Opa1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OpC-109

AC   CVCL_T723

RX   PubMed=4795513;

CC   Group: Reptilian cell line.

OX   NCBI_TaxID=8597; ! Heterodon platirhinos

CA   Spontaneously immortalized cell line

//

ID   OpC-115

AC   CVCL_T722

RX   PubMed=4795513;

CC   Group: Reptilian cell line.

OX   NCBI_TaxID=35024; ! Crotalus horridus

OI   CVCL_T718 ! OpC-89

OI   CVCL_T719 ! OpC-90

OI   CVCL_T720 ! OpC-91

OI   CVCL_T721 ! OpC-94

SX   Male

CA   Spontaneously immortalized cell line

//

ID   OpC-80

AC   CVCL_T717

RX   PubMed=4795513;

CC   Group: Reptilian cell line.

OX   NCBI_TaxID=165023; ! Lampropeltis getula nigrita

CA   Spontaneously immortalized cell line

//

ID   OpC-89

AC   CVCL_T718

SY   C-89

RX   PubMed=4347028;

RX   PubMed=4795513;

CC   Group: Reptilian cell line.

OX   NCBI_TaxID=35024; ! Crotalus horridus

OI   CVCL_T719 ! OpC-90

OI   CVCL_T720 ! OpC-91

OI   CVCL_T721 ! OpC-94

OI   CVCL_T722 ! OpC-115

SX   Male

CA   Cancer cell line

//

ID   OpC-90

AC   CVCL_T719

RX   PubMed=4795513;

CC   Group: Reptilian cell line.

OX   NCBI_TaxID=35024; ! Crotalus horridus

OI   CVCL_T718 ! OpC-89

OI   CVCL_T720 ! OpC-91

OI   CVCL_T721 ! OpC-94

OI   CVCL_T722 ! OpC-115

SX   Male

CA   Spontaneously immortalized cell line

//

ID   OpC-91

AC   CVCL_T720

RX   PubMed=4795513;

CC   Group: Reptilian cell line.

OX   NCBI_TaxID=35024; ! Crotalus horridus

OI   CVCL_T718 ! OpC-89

OI   CVCL_T719 ! OpC-90

OI   CVCL_T721 ! OpC-94

OI   CVCL_T722 ! OpC-115

SX   Male

CA   Spontaneously immortalized cell line

//

ID   OpC-94

AC   CVCL_T721

RX   PubMed=4795513;

CC   Group: Reptilian cell line.

OX   NCBI_TaxID=35024; ! Crotalus horridus

OI   CVCL_T718 ! OpC-89

OI   CVCL_T719 ! OpC-90

OI   CVCL_T720 ! OpC-91

OI   CVCL_T722 ! OpC-115

SX   Male

CA   Spontaneously immortalized cell line

//

ID   OPC1

AC   CVCL_HP89

SY   Osteoblastic Precursor Cell line 1

RX   PubMed=10491220;

WW   https://www.abmgood.com/Immortalized-Osteoprecursor-Cells-(OPC1)-T0230.html

CC   Doubling time: 1.8 days (PubMed=10491220).

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMx-1-SV40T].

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   OPCA-iPSC1

AC   CVCL_L661

SY   OPCA-iPS1

DR   ISCR; 1985

RX   PubMed=22301348;

CC   From: Guangzhou Medical College; China.

DI   NCIt; C82341; Spinocerebellar ataxia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L662 ! OPCA-iPSC2

OI   CVCL_L663 ! OPCA-iPSC3

SX   Female

CA   Induced pluripotent stem cell

//

ID   OPCA-iPSC2

AC   CVCL_L662

SY   OPCA-iPS2

DR   ISCR; 1986

RX   PubMed=22301348;

CC   From: Guangzhou Medical College; China.

DI   NCIt; C82341; Spinocerebellar ataxia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L661 ! OPCA-iPSC1

OI   CVCL_L663 ! OPCA-iPSC3

SX   Female

CA   Induced pluripotent stem cell

//

ID   OPCA-iPSC3

AC   CVCL_L663

SY   OPCA-iPS3

DR   ISCR; 1987

RX   PubMed=22301348;

CC   From: Guangzhou Medical College; China.

DI   NCIt; C82341; Spinocerebellar ataxia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L661 ! OPCA-iPSC1

OI   CVCL_L662 ! OPCA-iPSC2

SX   Female

CA   Induced pluripotent stem cell

//

ID   OPCN-1

AC   CVCL_5566

SY   OPCN 1; OPCN1

RX   CelloPub=CLPUB00242;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5569 ! OPCT-1

SX   Male

CA   Transformed cell line

//

ID   OPCN-2

AC   CVCL_5567

SY   OPCN 2; OPCN2

RX   CelloPub=CLPUB00242;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5570 ! OPCT-2

SX   Male

CA   Transformed cell line

//

ID   OPCN-3

AC   CVCL_5568

SY   OPCN 3; OPCN3

RX   CelloPub=CLPUB00242;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5571 ! OPCT-3

SX   Male

CA   Transformed cell line

//

ID   OPCT-1

AC   CVCL_5569

SY   OPCT 1; OPCT1

RX   CelloPub=CLPUB00242;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5566 ! OPCN-1

SX   Male

CA   Transformed cell line

//

ID   OPCT-2

AC   CVCL_5570

SY   OPCT 2; OPCT2

RX   CelloPub=CLPUB00242;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5567 ! OPCN-2

SX   Male

CA   Transformed cell line

//

ID   OPCT-3

AC   CVCL_5571

SY   OPCT 3; OPCT3

RX   CelloPub=CLPUB00242;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5568 ! OPCN-3

SX   Male

CA   Transformed cell line

//

ID   OPL-1

AC   CVCL_X743

RX   PubMed=8690530;

RX   PubMed=17488335;

RX   PubMed=18079737;

DI   NCIt; C45691; Pyothorax-associated lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OPL-2

AC   CVCL_X744

RX   PubMed=8690530;

RX   PubMed=17488335;

RX   PubMed=18079737;

DI   NCIt; C45691; Pyothorax-associated lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OPL-3

AC   CVCL_X745

RX   PubMed=14556658;

RX   PubMed=17488335;

RX   PubMed=18079737;

DI   NCIt; C45691; Pyothorax-associated lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OPL-4

AC   CVCL_X746

RX   PubMed=14556658;

RX   PubMed=17488335;

RX   PubMed=18079737;

DI   NCIt; C45691; Pyothorax-associated lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OPL-5

AC   CVCL_X747

RX   PubMed=14556658;

RX   PubMed=17488335;

RX   PubMed=18079737;

DI   NCIt; C45691; Pyothorax-associated lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OPL-7

AC   CVCL_X748

RX   PubMed=14556658;

RX   PubMed=17488335;

RX   PubMed=18079737;

DI   NCIt; C45691; Pyothorax-associated lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OPM-1

AC   CVCL_5210

SY   OPM1

DR   Cosmic; 720768

DR   Cosmic; 2081431

DR   Cosmic; 2367299

RX   PubMed=3926660;

RX   PubMed=10087940;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1625 ! OPM-2

SX   Female

CA   Cancer cell line

//

ID   OPM-2

AC   CVCL_1625

SY   OPM2

DR   BTO; BTO:0005919

DR   CLO; CLO_0008269

DR   EFO; EFO_0006716

DR   CLDB; cl3774

DR   BioSample; SAMN03473240

DR   CCLE; OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   CGH-DB; 36-1

DR   CGH-DB; 9158-4

DR   ChEMBL-Cells; CHEMBL3308883

DR   ChEMBL-Targets; CHEMBL2366353

DR   Cosmic; 720767

DR   Cosmic; 735529

DR   Cosmic; 759901

DR   Cosmic; 759907

DR   Cosmic; 760390

DR   Cosmic; 760403

DR   Cosmic; 909249

DR   Cosmic; 1889515

DR   Cosmic; 2081432

DR   Cosmic; 2302417

DR   Cosmic; 2367300

DR   Cosmic; 2391792

DR   Cosmic-CLP; 909249

DR   DSMZ; ACC-50

DR   GDSC; 909249

DR   GEO; GSM143336

DR   GEO; GSM290303

DR   GEO; GSM887478

DR   GEO; GSM888559

DR   GEO; GSM1374799

DR   GEO; GSM1670307

RX   PubMed=3926660;

RX   PubMed=8943038;

RX   PubMed=10087940;

RX   PubMed=10583232;

RX   PubMed=10936422;

RX   PubMed=15215163;

RX   PubMed=16956823;

RX   PubMed=17171682;

RX   PubMed=18700954;

RX   PubMed=19306352;

RX   PubMed=21173094;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 50 hours (PubMed=25984343); ~50-60 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 11

ST   D16S539: 9,13

ST   D18S51: 13,14

ST   D21S11: 30,33.2

ST   D3S1358: 15,18

ST   D5S818: 13

ST   D7S820: 12

ST   D8S1179: 10,13

ST   FGA: 20,21

ST   Penta D: 9

ST   Penta E: 12,21

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5210 ! OPM-1

SX   Female

CA   Cancer cell line

//

ID   OPM-2/BTZ

AC   CVCL_4V72

SY   OPM2/BTZ

RX   PubMed=20555361;

CC   Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1625 ! OPM-2

SX   Female

CA   Cancer cell line

//

ID   OPM-3

AC   CVCL_M529

RX   PubMed=9858236;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OPMDCl2

AC   CVCL_6B29

RX   PubMed=22040608;

CC   Transfected with: HGNC; 1773; CDK4.

CC   Transfected with: HGNC; 11730; TERT.

DI   NCIt; C84942; Oculopharyngeal muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Telomerase immortalized cell line

//

ID   Or De

AC   CVCL_3322

DR   CLO; CLO_0008270

DR   CLDB; cl3775

DR   ATCC; CRL-1366

DR   BioSample; SAMN03471358

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C125698; Ehlers-Danlos syndrome, type III

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ORL-115

AC   CVCL_S690

RX   PubMed=17273794;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ORL-136

AC   CVCL_S691

RX   PubMed=17273794;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ORL-48

AC   CVCL_S692

DR   Cosmic; 2296300

RX   PubMed=17273794;

RX   PubMed=25275298;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

ST   Source(s): PubMed=25275298

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 11,13

ST   D18S51: 14

ST   D21S11: 29,32.2

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 12,15

ST   FGA: 24,25

ST   Penta D: 9,11

ST   Penta E: 7,18

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 19

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ORMES-1

AC   CVCL_2U86

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Embryonic stem cell

//

ID   ORMES-10

AC   CVCL_2U95

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Embryonic stem cell

//

ID   ORMES-11

AC   CVCL_2U96

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Embryonic stem cell

//

ID   ORMES-12

AC   CVCL_2U97

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Embryonic stem cell

//

ID   ORMES-13

AC   CVCL_2U98

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Embryonic stem cell

//

ID   ORMES-14

AC   CVCL_2U99

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Embryonic stem cell

//

ID   ORMES-15

AC   CVCL_2V00

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Embryonic stem cell

//

ID   ORMES-16

AC   CVCL_2V01

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Embryonic stem cell

//

ID   ORMES-17

AC   CVCL_2V02

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Embryonic stem cell

//

ID   ORMES-18

AC   CVCL_2V03

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Embryonic stem cell

//

ID   ORMES-2

AC   CVCL_2U87

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Embryonic stem cell

//

ID   ORMES-3

AC   CVCL_2U88

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Embryonic stem cell

//

ID   ORMES-4

AC   CVCL_2U89

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Embryonic stem cell

//

ID   ORMES-5

AC   CVCL_2U90

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Embryonic stem cell

//

ID   ORMES-6

AC   CVCL_2U91

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Embryonic stem cell

//

ID   ORMES-7

AC   CVCL_2U92

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Male

CA   Embryonic stem cell

//

ID   ORMES-8

AC   CVCL_2U93

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Embryonic stem cell

//

ID   ORMES-9

AC   CVCL_2U94

RX   PubMed=16741224;

CC   Group: Non-human primate cell line.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Embryonic stem cell

//

ID   ORS [Goat]

AC   CVCL_IR22

SY   Outer Root Sheath

RX   PubMed=22105552;

CC   Doubling time: ~52 hours (PubMed=22105552).

CC   Breed/subspecies: Jining Grey.

OX   NCBI_TaxID=9925; ! Capra hircus

SX   Female

CA   Finite cell line

//

ID   ORS [Human Ewing sarcoma]

AC   CVCL_U565

DR   Cosmic; 2250465

RX   PubMed=25223734;

CC   From: Delattre O.; Institut Curie; Paris; France.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ORS-Pop-93

AC   CVCL_Z460

SY   Pop 1

RX   PubMed=8826086;

RX   PubMed=22358547;

CC   Group: Insect cell line.

CC   Doubling time: 40 hours, at 50th passage (PubMed=8826086).

OX   NCBI_TaxID=192464; ! Phthorimaea operculella

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ORS-Pop-93 Pop 2

AC   CVCL_Z461

SY   Pop 2; ORS-Pop-2

RX   PubMed=22358547;

CC   Group: Insect cell line.

OX   NCBI_TaxID=192464; ! Phthorimaea operculella

HI   CVCL_Z460 ! ORS-Pop-93

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ORS-Pop-93 Pop 3

AC   CVCL_Z462

SY   Pop 3; ORS-Pop-3

RX   PubMed=22358547;

CC   Group: Insect cell line.

OX   NCBI_TaxID=192464; ! Phthorimaea operculella

HI   CVCL_Z460 ! ORS-Pop-93

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ORS-Pop-93 Pop 4

AC   CVCL_Z463

SY   Pop 4; ORS-Pop-4

RX   PubMed=22358547;

CC   Group: Insect cell line.

OX   NCBI_TaxID=192464; ! Phthorimaea operculella

HI   CVCL_Z460 ! ORS-Pop-93

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ORS-Pop-93 Pop cl 1A

AC   CVCL_Z464

SY   Pop cl 1A

RX   PubMed=22358547;

CC   Group: Insect cell line.

OX   NCBI_TaxID=192464; ! Phthorimaea operculella

HI   CVCL_Z460 ! ORS-Pop-93

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ORS-Pop-93 Pop cl 2B

AC   CVCL_Z465

SY   Pop cl 2B

RX   PubMed=22358547;

CC   Group: Insect cell line.

OX   NCBI_TaxID=192464; ! Phthorimaea operculella

HI   CVCL_Z460 ! ORS-Pop-93

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ORS-Pop-94A

AC   CVCL_Z466

SY   Pop A

RX   PubMed=22358547;

CC   Group: Insect cell line.

OX   NCBI_TaxID=192464; ! Phthorimaea operculella

OI   CVCL_Z467 ! ORS-Pop-94B

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ORS-Pop-94B

AC   CVCL_Z467

SY   Pop B

RX   PubMed=22358547;

CC   Group: Insect cell line.

OX   NCBI_TaxID=192464; ! Phthorimaea operculella

OI   CVCL_Z466 ! ORS-Pop-94A

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ORS-Pop-95

AC   CVCL_Z468

SY   Pop 95

RX   PubMed=9338147;

RX   PubMed=22358547;

CC   Group: Insect cell line.

OX   NCBI_TaxID=192464; ! Phthorimaea operculella

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ORT

AC   CVCL_N815

DR   Cosmic; 1656045

RX   PubMed=15274292;

RX   PubMed=22426987;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OS 179

AC   CVCL_FA10

SY   OS-179

RX   PubMed=15026342;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OS 187

AC   CVCL_1R50

SY   OS-187; OS187

DR   BioSample; SAMN03151646

RX   PubMed=15026342;

RX   PubMed=18483362;

RX   PubMed=24046071;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HCT 15 derivative (PubMed=24046071). Was originally thought to originate from an osteosarcoma.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0292 ! HCT 15

SX   Male

CA   Cancer cell line

//

ID   OS 99-1

AC   CVCL_F502

SY   OS99-1

RX   PubMed=18247100;

RX   PubMed=20309879;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Os Te

AC   CVCL_3323

DR   CLO; CLO_0008272

DR   ATCC; CRL-1262

DI   NCIt; C26837; Osteogenesis imperfecta

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   OS-1

AC   CVCL_S988

RX   PubMed=16035505;

DI   NCIt; C40439; Ovarian small cell carcinoma, hypercalcemic type

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OS-A

AC   CVCL_0C23

DR   Cosmic; 2239090

RX   PubMed=7736387;

RX   PubMed=9559344;

RX   PubMed=9815546;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OS-P2/HTLV-I

AC   CVCL_1T58

SY   OS-P2

DR   NIH-ARP; 1393-338

CC   Characteristics: HTLV-1 producing cell line.

CC   Doubling time: ~6 days (NIH-ARP).

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   OS-RC-2

AC   CVCL_1626

SY   RC-2

DR   BTO; BTO:0002403

DR   CLO; CLO_0050889

DR   BioSample; SAMN03472222

DR   CCLE; OSRC2_KIDNEY

DR   CCRID; 3111C0001CCC000292

DR   CCRID; 3131C0001000700040

DR   ChEMBL-Cells; CHEMBL3308274

DR   ChEMBL-Targets; CHEMBL2366188

DR   Cosmic; 909250

DR   Cosmic-CLP; 909250

DR   GDSC; 909250

DR   GEO; GSM1670310

DR   KCB; KCB 200779YJ

DR   RCB; RCB0735

RX   PubMed=4008433;

RX   PubMed=14534724;

RX   PubMed=15604581;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 8,12

ST   D16S539: 11

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OS1 [Human lung carcinoma]

AC   CVCL_Z602

RX   PubMed=1325431;

RX   PubMed=2161815;

RX   PubMed=8075973;

RX   PubMed=12569360;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OS1 [Human osteosarcoma]

AC   CVCL_F864

RX   PubMed=2823272;

RX   PubMed=19746444;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OS1-CLS

AC   CVCL_5851

DR   CLS; 500369/p620_OS1-CLS

CC   Breed/subspecies: Sprague-Dawley.

DI   NCIt; C60487; Rat osteosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Sex undetermined

CA   Cancer cell line

//

ID   OS10

AC   CVCL_Z611

RX   PubMed=12569360;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OS15

AC   CVCL_Z612

RX   PubMed=12569360;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OS17

AC   CVCL_Z613

RX   PubMed=12569360;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OS18A

AC   CVCL_Z614

RX   PubMed=12569360;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OS2 [Human lung carcinoma]

AC   CVCL_Z603

RX   PubMed=1325431;

RX   PubMed=2161815;

RX   PubMed=8075973;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Z604 ! OS2-RA

SX   Female

CA   Cancer cell line

//

ID   OS2 [Human osteosarcoma]

AC   CVCL_F865

RX   PubMed=2823272;

RX   PubMed=19746444;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OS2-RA

AC   CVCL_Z604

SY   OS2RA; OS2-R

RX   PubMed=1325431;

RX   PubMed=8075973;

RX   PubMed=12569360;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Z603 ! OS2 [Human lung carcinoma]

SX   Female

CA   Cancer cell line

//

ID   OS2.4

AC   CVCL_L370

SY   OS2_4

DR   GEO; GSM1974796

RX   PubMed=9585065;

RX   PubMed=21801068;

RX   PubMed=27197945;

CC   Part of: FACC canine tumor cell line panel.

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   OS2.4/Doxo

AC   CVCL_L371

RX   PubMed=17916018;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_L370 ! OS2.4

CA   Cancer cell line

//

ID   OS2000

AC   CVCL_D881

RX   PubMed=12898310;

RX   PubMed=19818766;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OS3 [Human lung carcinoma]

AC   CVCL_Z605

RX   PubMed=1325431;

RX   PubMed=2161815;

RX   PubMed=8075973;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Z606 ! OS3-R5

CA   Cancer cell line

//

ID   OS3 [Human osteosarcoma]

AC   CVCL_F866

DR   Cosmic; 1077282

RX   PubMed=2823272;

RX   PubMed=19746444;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OS3 [Mouse adrenocortical tumor]

AC   CVCL_5F73

RX   PubMed=4311571;

RX   PubMed=6270152;

RX   PubMed=7588376;

RX   PubMed=15541570;

WW   http://www.flintbox.com/public/project/2353

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0585 ! Y1

SX   Male

CA   Cancer cell line

//

ID   OS3 [Mouse brain]

AC   CVCL_U177

DR   CLO; CLO_0050904

DR   RCB; RCB1593

CC   Breed/subspecies: C3H/HeN.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   OS3-HGPRT-

AC   CVCL_5G25

RX   PubMed=198663;

RX   PubMed=6270152;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5F73 ! OS3 [Mouse adrenocortical tumor]

SX   Male

CA   Cancer cell line

//

ID   OS3-R5

AC   CVCL_Z606

SY   OS3R5

RX   PubMed=12569360;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Z605 ! OS3 [Human lung carcinoma]

CA   Cancer cell line

//

ID   OSA-80

AC   CVCL_EQ73

SY   OSA 80

DR   GDSC; 1298361

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OSA344

AC   CVCL_6264

SY   OSA-344

DR   BTO; BTO:0004885

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OS4

AC   CVCL_Z607

RX   PubMed=12569360;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OS5

AC   CVCL_Z608

RX   PubMed=8075973;

RX   PubMed=12569360;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OS6

AC   CVCL_Z609

RX   PubMed=1325431;

RX   PubMed=12569360;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OS7

AC   CVCL_Z610

RX   PubMed=1325431;

RX   PubMed=8075973;

RX   PubMed=12569360;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OSC-1 [Human esophageal squamous cell carcinoma]

AC   CVCL_E312

SY   OSC1

RX   PubMed=9216685;

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OSC-1 [Human tongue squamous cell carcinoma]

AC   CVCL_HF91

RX   PubMed=7703799;

CC   Doubling time: 38.6 hours (PubMed=7703799).

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OSC-19

AC   CVCL_3086

SY   OSC19; Osc19

DR   BioSample; SAMN03471655

DR   Cosmic; 1120701

DR   Cosmic-CLP; 1298362

DR   GDSC; 1298362

DR   GEO; GSM1670308

DR   JCRB; JCRB0198

RX   CelloPub=CLPUB00244;

RX   CelloPub=CLPUB00295;

RX   CelloPub=CLPUB00296;

RX   PubMed=19123955;

RX   PubMed=21868764;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Cervical lymph node.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9,12

ST   D5S818: 10,13

ST   D7S820: 9,11

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14 (Cosmic-CLP; JCRB)

ST   vWA: 14,18 (PubMed=21868764)

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OSC-19LN1

AC   CVCL_AT74

SY   OSC19LN1

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Cervical lymph node.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 10,13

ST   D7S820: 9,11

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14,18

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3086 ! OSC-19

SX   Male

CA   Cancer cell line

//

ID   OSC-19LN2

AC   CVCL_AT75

SY   OSC19LN2

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Cervical lymph node.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 10,13

ST   D7S820: 9,11

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14,18

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_AT74 ! OSC-19LN1

SX   Male

CA   Cancer cell line

//

ID   OSC-19LN3

AC   CVCL_AT76

SY   OSC19LN3

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Cervical lymph node.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 10,13

ST   D7S820: 9,11

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14,18

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_AT75 ! OSC-19LN2

SX   Male

CA   Cancer cell line

//

ID   OSC-19LN4

AC   CVCL_AT77

SY   OSC19LN4

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Cervical lymph node.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 10,13

ST   D7S820: 9,11

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14,18

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_AT76 ! OSC-19LN3

SX   Male

CA   Cancer cell line

//

ID   OSC-19LN5

AC   CVCL_AT78

SY   OSC19LN5

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Cervical lymph node.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 10,13

ST   D7S820: 9,11

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14,18

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_AT77 ! OSC-19LN4

SX   Male

CA   Cancer cell line

//

ID   OSC-2 [Human esophageal squamous cell carcinoma]

AC   CVCL_E313

SY   OSC2

RX   PubMed=9216685;

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OSC-2 [Human gingival squamous cell carcinoma]

AC   CVCL_HF92

RX   PubMed=7703799;

CC   Doubling time: 22.9 hours (PubMed=7703799).

CC   Derived from metastatic site: Submandibular lymph node.

DI   NCIt; C129857; Gingival squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OSC-20

AC   CVCL_3087

SY   OSC20

DR   Cosmic; 1120702

DR   Cosmic; 1995604

DR   Cosmic-CLP; 1240196

DR   GDSC; 1240196

DR   GEO; GSM827220

DR   GEO; GSM1670309

DR   JCRB; JCRB0197

RX   CelloPub=CLPUB00095;

RX   CelloPub=CLPUB00244;

RX   PubMed=19123955;

RX   PubMed=27397505;

CC   Doubling time: 27.4 hours, at 35th passage (CelloPub=CLPUB00095).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Cervical lymph node.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 8

ST   D16S539: 9,13

ST   D5S818: 13

ST   D7S820: 10

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OSC-3

AC   CVCL_HF93

RX   PubMed=7703799;

CC   Doubling time: 31.3 hours (PubMed=7703799).

CC   Derived from metastatic site: Cervical lymph node.

DI   NCIt; C129857; Gingival squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OSC-30

AC   CVCL_A399

SY   OSC30

DR   Cosmic; 1120703

RX   CelloPub=CLPUB00244;

RX   PubMed=19123955;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OSC-4

AC   CVCL_HF94

SY   OSC4

DR   Cosmic; 2546838

RX   PubMed=7703799;

RX   PubMed=17325662;

CC   Doubling time: 21.2 hours (PubMed=7703799).

CC   Derived from metastatic site: Submandibular lymph node.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OSC-40

AC   CVCL_A400

SY   OSC40

RX   CelloPub=CLPUB00244;

RX   PubMed=19123955;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OSC-5

AC   CVCL_HF95

SY   OSC5

DR   Cosmic; 2546839

RX   PubMed=7703799;

RX   PubMed=17325662;

CC   Doubling time: 32.5 hours (PubMed=7703799).

CC   Derived from metastatic site: Submandibular lymph node.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OSC-6

AC   CVCL_HF96

SY   OSC6

DR   Cosmic; 2546840

RX   PubMed=7703799;

RX   PubMed=17325662;

CC   Doubling time: 39.4 hours (PubMed=7703799).

CC   Derived from metastatic site: Cervical lymph node.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OSC-7

AC   CVCL_HF97

RX   PubMed=7703799;

CC   Doubling time: 54.7 hours (PubMed=7703799).

CC   Derived from metastatic site: Cervical lymph node.

DI   NCIt; C102872; Pharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OSC-70

AC   CVCL_A401

SY   OSC70

DR   Cosmic; 1120704

RX   CelloPub=CLPUB00244;

RX   PubMed=19123955;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OSCA-00

AC   CVCL_0A73

SY   OSCA-0

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-01

AC   CVCL_L372

SY   OSCA-1

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-02

AC   CVCL_0A74

SY   OSCA-2

RX   PubMed=21621658;

RX   PubMed=23365669;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-03

AC   CVCL_0A75

SY   OSCA-3

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-04

AC   CVCL_L388

SY   OSCA-4

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Caution: Indicated as being from a male dog in PubMed=21621658 and a female dog in PubMed=23311495.

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-05

AC   CVCL_0A76

SY   OSCA-5

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-06M

AC   CVCL_L397

SY   ACCR-6; OSCA-6

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Derived from metastatic site: Lung.

CC   Breed/subspecies: Rhodesian Ridgeback.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-07

AC   CVCL_0A77

SY   OSCA-7

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-08

AC   CVCL_L405

SY   OSCA-8; OSA8

DR   GEO; GSM1974797

RX   PubMed=20594083;

RX   PubMed=21621658;

RX   PubMed=23311495;

RX   PubMed=23365669;

RX   PubMed=27197945;

RX   PubMed=27257868;

WW   https://www.kerafast.com/product/2246/canine-osteosarcoma-cell-line-osca-8

CC   Part of: FACC canine tumor cell line panel.

CC   Doubling time: ~22 hours (Kerafast).

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-09

AC   CVCL_0A78

SY   OSCA-9

RX   PubMed=21621658;

CC   Breed/subspecies: Irish Setter.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-10

AC   CVCL_0A79

RX   PubMed=21621658;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-109

AC   CVCL_L373

RX   PubMed=23311495;

CC   Breed/subspecies: Irish Setter.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-11M

AC   CVCL_L374

SY   OSCA-11

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Caution: Indicated as being from a female dog in PubMed=21621658 and a male dog in PubMed=23311495.

CC   Derived from metastatic site: Lung.

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-12

AC   CVCL_L375

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-13

AC   CVCL_0A80

RX   PubMed=21621658;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-14

AC   CVCL_0A81

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-15

AC   CVCL_0A82

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-16

AC   CVCL_L376

SY   OSCA-16M; OSA16

RX   PubMed=20594083;

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Derived from metastatic site: Lung.

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-17

AC   CVCL_L377

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-18

AC   CVCL_0A83

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-19

AC   CVCL_L378

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-20

AC   CVCL_L379

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-21

AC   CVCL_L380

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-22

AC   CVCL_L381

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-23

AC   CVCL_L382

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-24

AC   CVCL_0A84

RX   PubMed=21621658;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-25

AC   CVCL_L383

SY   OSCA 25

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-26

AC   CVCL_0A85

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-27

AC   CVCL_0A86

RX   PubMed=21621658;

CC   Breed/subspecies: Irish Setter.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-28

AC   CVCL_0A87

RX   PubMed=21621658;

CC   Breed/subspecies: Greyhound.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-29

AC   CVCL_L384

RX   PubMed=21621658;

RX   PubMed=23311495;

RX   PubMed=23365669;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-30

AC   CVCL_L385

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: German Shepherd.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-31

AC   CVCL_0A88

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-32

AC   CVCL_L386

SY   OSCA 32; OSA32

RX   PubMed=20594083;

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Pyrenean mountain dog.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-33

AC   CVCL_L387

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-35

AC   CVCL_0A89

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-36

AC   CVCL_0A90

SY   OSA36

RX   PubMed=20594083;

RX   PubMed=21621658;

CC   Breed/subspecies: Doberman Pinscher.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-37

AC   CVCL_0A91

RX   PubMed=21621658;

CC   Breed/subspecies: Greyhound.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-38

AC   CVCL_0A92

RX   PubMed=21621658;

CC   Breed/subspecies: Pyrenean mountain dog.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-39

AC   CVCL_0A93

RX   PubMed=21621658;

CC   Breed/subspecies: Great Dane.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-40

AC   CVCL_L389

RX   PubMed=21621658;

RX   PubMed=23311495;

RX   PubMed=23365669;

WW   https://www.kerafast.com/product/2248/canine-osteosarcoma-cell-line-osca-40

CC   Doubling time: ~22 hours (Kerafast).

CC   Breed/subspecies: Saint Bernard.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-41

AC   CVCL_L390

SY   OSCA 41

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Alaskan Malamute.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-42

AC   CVCL_0A94

RX   PubMed=21621658;

CC   Breed/subspecies: Pyrenean mountain dog.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-43

AC   CVCL_0A95

RX   PubMed=21621658;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-44

AC   CVCL_0A96

RX   PubMed=21621658;

CC   Breed/subspecies: Leonberger.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-45

AC   CVCL_L391

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Irish Setter.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-46

AC   CVCL_0A97

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-47

AC   CVCL_0A98

RX   PubMed=21621658;

CC   Breed/subspecies: Irish Setter.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-48

AC   CVCL_0A99

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-49

AC   CVCL_0B00

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-50

AC   CVCL_L392

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-51

AC   CVCL_0B01

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-52

AC   CVCL_0B02

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-53M

AC   CVCL_0B03

RX   PubMed=21621658;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-54

AC   CVCL_0B04

RX   PubMed=21621658;

CC   Breed/subspecies: Boxer.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-55

AC   CVCL_L393

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Borzoi.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-56

AC   CVCL_L394

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-57

AC   CVCL_L395

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-58

AC   CVCL_0B05

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-59

AC   CVCL_L396

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-60

AC   CVCL_L398

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Mastiff.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-61

AC   CVCL_0B06

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-62

AC   CVCL_0B17

RX   PubMed=21621658;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-63

AC   CVCL_0B07

RX   PubMed=21621658;

CC   Breed/subspecies: Scottish Deerhound.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-64M

AC   CVCL_0B08

RX   PubMed=21621658;

CC   Derived from metastatic site: Not specified.

CC   Breed/subspecies: Rhodesian Ridgeback.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-65

AC   CVCL_0B09

RX   PubMed=21621658;

CC   Breed/subspecies: American Bulldog.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-66

AC   CVCL_0B10

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-67

AC   CVCL_L399

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Mastiff.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-68

AC   CVCL_0B11

RX   PubMed=21621658;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-69

AC   CVCL_0B12

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-70

AC   CVCL_0B13

RX   PubMed=21621658;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-71

AC   CVCL_L400

RX   PubMed=21621658;

RX   PubMed=23311495;

RX   PubMed=23365669;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-72

AC   CVCL_0B14

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-73

AC   CVCL_L401

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-74

AC   CVCL_0B15

RX   PubMed=21621658;

CC   Breed/subspecies: Doberman Pinscher.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-75

AC   CVCL_L402

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Golden Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-76

AC   CVCL_0B16

RX   PubMed=21621658;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-77

AC   CVCL_L403

RX   PubMed=21621658;

RX   PubMed=23311495;

CC   Breed/subspecies: Malinois.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-78

AC   CVCL_L404

RX   PubMed=21621658;

RX   PubMed=23311495;

RX   PubMed=23365669;

WW   https://www.kerafast.com/product/2249/canine-osteosarcoma-cell-line-osca-78

CC   Doubling time: ~22 hours (Kerafast).

CC   Breed/subspecies: German Shepherd.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-84

AC   CVCL_L406

RX   PubMed=23311495;

CC   Breed/subspecies: Rottweiler.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-96

AC   CVCL_L407

RX   PubMed=23311495;

CC   Breed/subspecies: Mastiff.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCA-98

AC   CVCL_L408

RX   PubMed=23311495;

CC   Breed/subspecies: Labrador Retriever.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OSCA-99

AC   CVCL_L409

RX   PubMed=23311495;

CC   Breed/subspecies: Labrador Retriever mix.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Cancer cell line

//

ID   OSCAR

AC   CVCL_B020

SY   INSERMe001-A; INSRMe001-A

DR   hPSCreg; INSRMe001-A

WW   http://www.agence-biomedecine.fr/IMG/pdf/inserm_oscar.pdf

CC   From: INSERM; France.

CC   Registration: French Agence de la Biomedecine; FE08-088-L1.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   OSCC-3

AC   CVCL_L894

SY   OSCC3

DR   Cosmic; 2550366

RX   PubMed=8686749;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OSCC-BD

AC   CVCL_2H27

RX   PubMed=26234610;

CC   Omics: Proteome analysis.

DI   NCIt; C129863; Oral dysplasia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1180 ! DOK

SX   Male

CA   Cancer cell line

//

ID   OSE10 sv

AC   CVCL_6703

RX   PubMed=11277643;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   OSE2a sv

AC   CVCL_6704

RX   PubMed=11277643;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6705 ! OSE2b sv

SX   Female

CA   Transformed cell line

//

ID   OSE2b sv

AC   CVCL_6705

RX   PubMed=11277643;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6704 ! OSE2a sv

SX   Female

CA   Transformed cell line

//

ID   OSE2b-2 sv

AC   CVCL_6706

RX   PubMed=11277643;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6705 ! OSE2b sv

SX   Female

CA   Transformed cell line

//

ID   OSE4 sv

AC   CVCL_6707

RX   PubMed=11277643;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   OSE6 sv

AC   CVCL_6708

RX   PubMed=11277643;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   OSE7 sv

AC   CVCL_6709

RX   PubMed=11277643;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   OSHU-1

AC   CVCL_M604

RX   PubMed=6931250;

DI   NCIt; C2946; Chondrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   OSQ1

AC   CVCL_Z081

RX   PubMed=12569360;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OSrb/N-M

AC   CVCL_IP67

RX   PubMed=10077219;

CC   Doubling time: 84.7 hours (PubMed=10077219).

CC   Miscellaneous: Patient suffered from bilateral retinoblastoma at infancy.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   OSRGa

AC   CVCL_4459

SY   OSRGA

DR   BTO; BTO:0003967

RX   PubMed=15894525;

CC   Transformant: NCIt; C129639; Cerium-144 beta radiation.

CC   Breed/subspecies: Sprague-Dawley.

DI   NCIt; C60487; Rat osteosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   OSS

AC   CVCL_1B46

SY   Ovarian Somatic Sheath

DR   EFO; EFO_0005835

DR   DGRC; 190

DR   ENCODE; ENCBS977DNJ

RX   PubMed=17056713;

RX   PubMed=24434506;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_1B45 ! fGS/OSS

SX   Female

CA   Spontaneously immortalized cell line

//

ID   OST

AC   CVCL_8399

DR   BioSample; SAMN03151751

DR   ChEMBL-Cells; CHEMBL3307563

DR   ChEMBL-Targets; CHEMBL614210

DR   RCB; RCB0454

RX   PubMed=12645653;

RX   PubMed=15150091;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Discontinued: RCB; RCB0454; true.

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   OST 10 PT

AC   CVCL_W923

SY   OST10T

DR   Cosmic; 2053615

RX   PubMed=24190505;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OST 7 PT

AC   CVCL_W924

SY   OST7T

DR   Cosmic; 2053621

RX   PubMed=24190505;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OST 8 PT

AC   CVCL_W925

SY   OST8T

DR   Cosmic; 2053622

RX   PubMed=24190505;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   OSU-CLL

AC   CVCL_Y382

RX   PubMed=24130782;

CC   Doubling time: ~50 hours (PubMed=24130782).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C3163; Chronic lymphocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IV04 ! OSU-NB

SX   Male

CA   Transformed cell line

//

ID   OSU-NB

AC   CVCL_IV04

RX   PubMed=24130782;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y382 ! OSU-CLL

SX   Male

CA   Transformed cell line

//

ID   OSU1

AC   CVCL_6428

SY   57.Thy

DR   CLO; CLO_0008273

DR   ATCC; CRL-6178

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6178; true.

OX   NCBI_TaxID=9685; ! Felis catus

SX   Sex undetermined

CA   Finite cell line

//

ID   OSW

AC   CVCL_0B19

SY   Oswald

DR   ATCC; PTA-9116

DR   GEO; GSM1974798

RX   Patent=US7897150;

RX   PubMed=17532464;

RX   PubMed=21908323;

RX   PubMed=23365669;

RX   PubMed=26842912;

RX   PubMed=27197945;

RX   PubMed=27257868;

CC   Part of: FACC canine tumor cell line panel.

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: Airedale Terrier.

DI   NCIt; C128121; Canine lymphoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   OT11

AC   CVCL_T370

SY   OT-11

DR   CLO; CLO_0050531

DR   RCB; RCB1926

RX   PubMed=9374409;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   OT13

AC   CVCL_T371

SY   OT-13

DR   CLO; CLO_0050532

DR   RCB; RCB1927

RX   PubMed=9374409;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   OT145

AC   CVCL_CW44

DR   NCBI_Iran; H155

RX   PubMed=3464003;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   OTCD1TKB

AC   CVCL_L557

DR   CLO; CLO_0050656

DR   BioSample; SAMN03472272

DR   RCB; RCB0492

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D5S818: 12,13

ST   D7S820: 11,12

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C84957; Ornithine carbamoyltransferase deficiency disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   OTH-74D4

AC   CVCL_2152

SY   OTH74D4

DR   CLO; CLO_0008275

DR   DSMZ; ACC-478

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   OTT1

AC   CVCL_5345

RX   PubMed=1883955;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=OTT1

CC   Characteristics: CFS2, IL3 or IL5 dependent.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Factor-dependent cell line

//

ID   OTT6050

AC   CVCL_5572

SY   OTT 6050; OTT-6050

DR   JCRB; JCRB0720

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0E97 ! OC15

SX   Male

CA   Cancer cell line

//

ID   OTT6050(A)

AC   CVCL_4U63

SY   OTT6050 (A); OTT6050-A

DR   TKG; TKG 0329

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5572 ! OTT6050

SX   Male

CA   Cancer cell line

//

ID   OTT6050(B)

AC   CVCL_4U64

SY   OTT6050 (B); OTT6050-B

DR   TKG; TKG 0330

CC   Breed/subspecies: 129/Sv.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5572 ! OTT6050

SX   Male

CA   Cancer cell line

//

ID   OU-AML-1

AC   CVCL_8391

DR   BioSample; SAMN03151867

RX   PubMed=10027306;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1619 ! OCI-AML2

SX   Male

CA   Cancer cell line

//

ID   OU-AML-2

AC   CVCL_8392

DR   BioSample; SAMN03151868

RX   PubMed=10027306;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1619 ! OCI-AML2

SX   Male

CA   Cancer cell line


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 90及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。